dermatology consulting services, pllcdermatology consulting services, pllc-editorial board, aging...

Dermatology Consulting Services, PLLC

CURRICULUM VITAE

PERSONAL INFORMATIONNAME: Zoe Diana Draelos, MD SEX: Female

OFFICE ADDRESS: Dermatology Consulting Services, PLLC 2444 North Main StreetHigh Point, NC 27262

PHONE: (336) 841-2040 FAX: (336) 841-2044 E-MAIL: [email protected]

of 66 Version Date: January 2020


LICENSURE-Board Certified, American Board of Dermatology - 1988 -Board Certified, National Board of Medical Examiners - 1984, #286101 -Medical License North Carolina - #31273

EDUCATION-Dermatology Resident, University of Arizona College of Medicine, Tucson, Arizona, 1984 - 1987 -Internal Medicine Internship, University of Arizona College of Medicine, Tucson, Arizona, 1983 - 1984 -Medical School, University of Arizona College of Medicine, Tucson, Arizona, AOA - Top 10% Graduating Class, 1979 -

1983 -Mechanical Engineering Bachelor of Science, University of Arizona, Tucson, Honors and Highest Distinction, 1976 - 1979 -Music Major, University of Michigan, Ann Arbor, Michigan, 1976

PROFESSIONAL APPOINTMENTS-President and Principal Investigator, Dermatology Consulting Services, PLLC, High Point, North Carolina, 1998 – present-Solo Private Practice, Zoe Diana Draelos, MD, PA, High Point, North Carolina, 1997 - present-Large Group Private Practice, Central Carolina Dermatology Clinic, Inc., High Point, North Carolina 1988 - 1997 -Small Group Private Practice, Asheboro, North Carolina 1987 - 1988 -Department of Pediatrics Research Associate, University of Arizona, Tucson, Arizona, 1977 - 1983 -Junior Engineer, Mountain States Engineering Company, Tucson, Arizona, 1977

ACADEMIC APPOINTMENTS -Consulting Professor, Duke University, Dept of Dermatology, Durham, North Carolina, 2009 - present

-Clinical Associate Professor, Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, 1997 - 2007

-Visiting Associate Professor, Section of Dermatology, Department of Dermatology, University of Arizona School of Medicine, Tucson, Arizona, 2001 - 2006

-Clinical Assistant Professor, Department of Dermatology, Bowman Gray School of Medicine Winston-Salem, North Carolina 1988 - 1997

-Clinical Instructor, Department of Dermatology, Bowman Gray School of Medicine Winston-Salem, North Carolina 1987 - 1988

EDITORIAL APPOINTMENTS-Editor in Chief, Journal of Cosmetic Dermatology, Wiley, 2005 – 2015-Editorial Board, Cosmetics & Toiletries, 2008-present-Editorial Board and Quarterly Editorial Writer, Dermatology Times, 2000 – present-Editorial Advisory Board, International Journal of Cosmetic Dermatology, 2014 – present-Skin Appendage Disorders, Editorial Board, 2015-present-Editorial Advisory Board, Skin, Inc, 2010 - 2011-Editorial Board, Journal of the American Academy of Dermatology, 2007 - present-Editorial Board, Cutis, 2008 - present-International Editorial Board, Journal of Drugs in Dermatology, 2007 - present-Editorial Advisory Board, Journal of Clinical and Aesthetic Dermatology, 2008 – present-Medical Director, Aesthetic Dermatology News, 2006 - 2010-Editorial Advisory Board, Dermatologic Surgery, 2001 - present -Associate Editor, Journal of Cosmetic and Laser Therapy, 2002 – present-Editorial Board, Dermatology NetGuide, 2004 – 2011-Editorial Advisory Board, Global Cosmetic Industry, 2003 - 2007-Editorial Board, Cosmetic Dermatology, 1989 - present-Editorial Board, Cosmetic Dermatology Patient Edition, 2000 - 2006-Editorial Advisory Council, Dermatology Times, 1999 - present-Medical Council, Skin Cancer Foundation, 2001 - 2005

Version Date: January 2017


-Editorial Board, Aging Skin, 1998 - present-Editorial Board, Skin Peeling (Spanish), 1997 - present-Editorial Board, International Journal of Cosmetic Surgery and Aesthetic Dermatology, 2000 – 2002-Editorial Board, Aesthetic Dermatology and Cosmetic Surgery, 2000-2001 -Specialty Advisory Board, Modern Medicine, 1988 -1995 -Editorial Board, Patient Edition Cosmetic Dermatology, 1990 - 1994 -Editorial Board, Skin Cancer Foundation Journal, 1994 - 1995 -Editorial Board, Journal of Geriatric Dermatology, 1997 - 1998 -Editorial Board, Journal of Aesthetic Science, 1998 - 1999 -Editorial Advisory Board, Journal of Clinical Dermatology, 1998 - 2000 -Dermatology Editor, Prevention Magazine, 1998 - 2000 -Section Editor, Journal of Dermatologic Surgery and Oncology, 1996 - 1998 -Reviewer, Journal of the American Academy of Dermatology, 1993 - present -Reviewer, Journal of the Society of Cosmetic Chemists, 1996 - present -Reviewer, Journal of Contact Dermatitis, 1999 - 2007 -Book Reviewer, Archives of Dermatology, 1995 - 2007 -Book Reviewer, Journal of Dermatologic Surgery and Oncology, 1996 - 1998 -Book Reviewer, Cosmetic Dermatology, 1998 - 2012 -Contributor of Abstracts, Journal of the American Academy of Dermatology, 1996 – 1999

AMERICAN ACADEMY OF DERMATOLOGY APPOINTMENTS-Vice President, American Academy of Dermatology, 2012-Vice-President Elect American Academy of Dermatology, 2011-Board of Directors-American Academy of Dermatology, 2011-AAD Liasion to the American Medical Association Patient Advisory Board 2008 - 2011-Chair, Council on Communications, 2010 - 2014

-Editorial Mentor, Journal of the American Academy of Dermatology (JAAD), 2014 - present-Dermatology Research Council, 2012-RUC Observer, 2012-Dermatology Delegate, American Medical Association, 2012-Legislative Delegate, Washington, DC, 2011-2012-Member, AAD Executive Search Committee, 2012 - 2013-Member, AAD Member Advisory Board, 2012 - 2013-Deputy Chair, Communications Council, 2009 - 2010-Chairman, Pamphlets Committee, 2006 - 2014-Council on Communications, 2006 - 2010-American Academy of Dermatology, Board of Directors, 2000 - 2004-Task Force on Disclosure of Interest, 2003-Task Force to Examine the Review Process for Public Relation Campaigns, 2003-Industry Liaison Committee, 2003-2005-Council on Communications, 2004-2005-Executive Director Search Committee, 2004-Task Force for Leadership Mentoring, 2004-Task Force on Sunscreen Seal of Approval, 2004-Task Force for the Dermatologic Surgery Journal, 2005-Task Force for to Examine the Nominating and Election Process, 2005

EDITORIAL CONTRIBUTIONS-Monthly column, Cosmetic Consultation, Cosmetic Dermatology, 1989 - 2013-Monthly column, Cosmetic Conundrums, Dermatology Times, 2000 - present-Quarterly editorial contributor, Dermatology Times, 1998 - present-Quarterly editorial contributor, Aesthetic Dermatology News, 2008 - 2010-Quarterly editorial contributor, Journal of Cosmetic Dermatology, 2005 - 2013-Emedicine Textbook, Cosmetic Dermatology Section Editor, 2000 - present



-Contributor, Rosacea Review 1999-Contributor, WebMD (former eMedicine), 1999 - present

ADVISORY BOARD APPOINTMENTS-Aclaris Advisory Board, 2017 – present-Novatrtis Advisory Board, 2017 – present-Menlo Advisory Board 2017 - present-Occulus Advisory Board 2017 – present-Pfizer Home Health Advisory Board 2017 - present-Pfizer/Anacor Advisory Board 2016 – present

-Promius Pharma, 2013 – present-Sun Pharma, 2013 – present-Dermatology Times, Editorial Advisory Board, 2010 – present-Taro Advisory Board 2012 – 2014-Gillette Advisory Board 2013 – 2014-Journal of Clinical & Experimental Dermatology, Editorial Board Member, 2010 - present-Good Housekeeping, Anti-Aging Awards Advisory Board, 2010 - 2012-American Society for Dermatologic Surgery, Board of Directors, 2003 – 2007-American Academy of Dermatology, Board of Directors, 2000 – 2004-American Medical Association Patient Education Advisory Board, 2008-Reckitt Benkiser Dermatology Advisory Board, 2010 - present-Spectragenics Advisory Board, 2004 – 2008-Allergan Advisory Board 2004 – present-Beiersdorf Advisory Board 2005 - present-Intendis Advisory Board 2003 – 2011-Bayer Dermatology Advisory Board 2011 - present-Stiefel Advisory Board 2004 – 2012-NuSkin Advisory Board 2004 – present-Neutrogena Advisory Board 2010 – 2013-Johnson & Johnson Advisory Board 2009 - 2013-Dermtech International, San Diego, California, 2000 - 2005-Procter & Gamble Beauty Care Advisory Board, 1997 - 2010-Galderma Advisory Board, 2000 - present-Dermatology Foundation State Chair, 2000 - 2001-Dermik Laboratories RoC Advisory Board, 1993 - 1994 -Chesebrough-Ponds Advisory Board, 1993 - 1995 -Shene' Cosmetics Advisory Board, 1993 - 1994 -Almay Medical Advisory Board, 1994 - 1995 -MelanX Medical Advisory Board, 1996 - 1999 -GlaxoWellcome WellSkin Advisory Board, 1997 - 1998 -MD Forte Advisory Board, Allergan, 1998 - 2000 -Oclassen Pharmaceuticals Advisory Board, 1999 - 2000 -Dermik Advisory Board, 1999 - 2000 -Dermplace Advisory Board, 1999 – 2000-Aveeno Advisory Board, 2004 - 2006-Stable Photoprotection Advisory Board, Johnson & Johnson, 2005-Allergan/Clinique Medical Advisory Board, 2007 - 2009

PROFESSIONAL COMMITTEES-State Leaders Society Chairman, Dermatology Foundation, 2001-Committee on Expert Resource Groups, American Academy of Dermatology, 2001 - 2003-Media Relations Committee, American Academy of Dermatology, 1998 - present-Government Liaison Committee, American Academy of Dermatology, 2001 -Public Relations Committee, American Society for Dermatologic Surgery, 1999 - 2003



-Government Liaison Committee, American Society for Dermatologic Surgery, 2000 - 2005-Fund Raising Committee, American Society for Dermatologic Surgery, 2001 - 2003-American Society for Testing and Materials, Sensory Subcommittee, 1997 - 1998-Chairman's Society, United Way 1997 - 2012-American Academy of Dermatology / Cosmetic, Toiletry and Fragrance Association Liaison Committee, 1991 - 1993 -Pamphlets Committee, American Academy of Dermatology, 1994 - 1998 -Pamphlets Committee Chairperson, American Academy of Dermatology, 1996 - 1998 -Health Liaison Committee, American Academy of Dermatology, 1994 - 1999 -Industry Recognition Subcommittee, American Academy of Dermatology, 1994 - 1999 -Product Labeling Subcommittee, American Academy of Dermatology, 1996 – 1999-Skin Cancer Foundation Medical Council, 2001-Ad Hoc Task Force for Sunscreen Seal of Recognition, 2005-Ad Hoc Task Force for the Dermatologic Surgery Journal, 2005-Body of Knowledge Implementation Team-Research Agenda Ad Hoc Work Group, ASDS, 2005-Council on Communications, Consultant, American Academy of Dermatology, 2005-2006-National Rosacea Society Expert Committee on the Classification and Staging of Rosacea, 2007-Skin Cancer Foundation’s Medical Council, 2001 -Development and Industry Liaison Committee, American Academy of Dermatology, 2006-Hair Foundation Board of Trustees, 2007 - 2014-Sounding Board Initiative, American Society for Dermatologic Surgery, 2007-2010-Deputy Chair, American Academy of Dermatology, Communications Council, 2009-Chair, American Academy of Dermatology, Pamphlets Editorial Board, 2007 – 2014-Search Committee for Director of Communications, American Academy of Dermatology, 2013-Search Committee for American Academy of Dermatology CEO, 2013-Women’s Dermatologic Society (WDS), Fund Raising Committee, 2013-2014-Women’s Dermatologic Society (WDS), Industry Committee, 2013-2014-Board of Directors, National Rosacea Society (NRS), 2018 - present

DERMATOLOGIC CONSULTING ACTIVITIES-Burt's Bees 2016 - present-Reckitt Benckiser 2010 – present

-Chattem (Division of Sanofi-Adventis) 2005 – present -Sanofi/Regeneron 2016 – present -Revance 2016 – present

-ReGenica 2013 – present -Pharminex 2014 - present

-Lululemon 2013 - 2014-Gillette 2013 - 2015-Henkel Consumer Products 2010 - present-Makucell 2011 - 2013-Johnson & Johnson, 1996 - 2014-Aveeno, 2007 - 2014-S.C. Johnson and Sons 1995 - 2005-Colgate - Palmolive 1995 - present- Procter & Gamble 1996 - 2018-Schick 1994 - 2000 -Neutrogena 1996 - 2013-Glaxo Pharmaceuticals 1996 - 2000 -Ortho Pharmaceuticals 1996 - 1999-Merck Pharmaceuticals 1996 - 1999 -MelanX 1997 - 1999-Hydron 1997 - 1999 -Andrew Jergens Company (Kao) 1998 - present-Allergan 1997 - present-Collagen Corporation 1998 - 2000



-Healthpoint/ DPT Laboratories 1998 - 2004 -Primary Technologies 1998 - 2000-Ferndale Laboratories 1999 - 2006 -Coloplast 1999 - 2000 -Roche 1999 - 2000-Ciba 1999 - 2000 -Whitehall Robins 1999 - 2004-Westwood Squibb 1999 - 2000 -Bayer Consumer Products 2001 - 2004-Medicis 2001 - 2004-Johnson and Johnson Worldwide Consumer Products 1994 - 1998 -Lane and Coady Public Relations 1995 - 2005-Cutanix 2000 - 2006-The Body Shop 1999 - 2000-Abgenix 1999 - 2002-Niadyne 2001 - 2007-Galderma 2000 - present-Pharmacia 2000 - 2001-Wyeth 2003 – 2011-Pfizer Consumer Healthcare 2012 - present-Coria 2005 - 2010-Intendis 2005 - 2011-Bayer Dermatology 2012 - present-Altana, Inc. 2005 - 2012

-Amgen 2005 - 2006, 2013 - present-Avon 2005 - 2010-Clay-Parks Laboratories 2004 - 2005-Combe 2002 - 2003-General Mills 2007 - 2008-L’Oreal 2006 - present (Vichy, SkinCeuticals, LaRoche Posay)-Milliken 2005 - 2006-NeoStrata 2006 - 2010-Novartis 2003 - present-NuSkin 2003 - present-Pacific Biosciences Laboratories 2004 - present-Paddock Laboratories 2005 - 2006-Pfizer 2006 - present-TEVA Pharmaceuticals, USA 2004 - present-Taro 2005 - present-Wrigley Corporation 2008 - 2009 -Perrigo 2009 - present -Glenmark 2000 - 2012

SCIENTIFIC SOCIETY MEMBERSHIPS-Fellow, American Academy of Dermatology 1988 - present-Dermatology Foundation, Leader’s Society 1999 - 2012-Society for Investigative Dermatology 2001 - 2011-Guilford County Medical Society 1988 - present -North Carolina Medical Society 1988 - present

-North Carolina Dermatology Association 1988 - present-North Carolina Dermatology Association, Vice President, 1999 -North Carolina Dermatology Association, President, 2000 -Southern Medical Association 1997 - 1999 -American Medical Association 1988 - 2011-International Society of Cosmetic Dermatology 1996 - present



-Women's Dermatologic Society, (Secretary 1992, Newsletter 2000-2004), 1988 - present -American Association of University Women 1988 - 1999 -Sigma Xi Research Honorary 1983 - present -Alpha Omega Alpha (AOA), Wake Forest Chapter 1983 - present -American Contact Dermatitis Society, Board of Directors, 1995 - 1998 -American Contact Dermatitis Society 1994 - 2010-Council for Nail Disorders 1998 - present-American Hair Research Council 1999 - 2013-Society of Cosmetic Chemists Carolina Chapter 1996 - present -Society of Cosmetic Chemists National Organization 1996 - present -American Society for Testing and Materials 1997 - 2001 -American Society for Dermatologic Surgery, 1998 – present-Tau Beta Pi, 1979 - present

HOSPITAL COMMITTEES-Decubitus Care Committee 1993 -Occupational Hand Care Committee 1994 -Pharmacy and Therapeutics Committee 1997 - 1998 -Cancer Committee 1998 - 2013-Supervisor, Physician’s Assistant Training 2001 - 2003-North Carolina Cancer Control Plan 2004

HONORS AND AWARDS-Maison G. deNavarre Medal Award, Society of Cosmetic Chemists, Outstanding Contributions to the Art and Science of

Cosmetics, 2017-Best Speaker Award, North Carolina Chapter of the Society of Cosmetic Chemists, 2017-American Academy of Dermatology, President’s Award for Research Excellence, 2016-Albert Kligman Envision Award for Research and Clinical Excellence, 2010-eMedicine Certificate of Recognition, 2010-Lifetime Achievement Award, Health Beauty America, 2007-DermARTs Award for Clinical Excellence, 2008-Golden Triangle Award, American Academy of Dermatology, Best Educational Physician Brochure, Rosacea Roadmap,

2005-Society of Cosmetic Chemists Best Scientific Paper, Symatec Award, 2004-Americas Best Doctors 2003 - present-Best Doctors in North Carolina 2004 - present-North American Hair Research Society Mentorship Award, 2003-Who’s Who 1998 - present-Who’s Who in Science and Engineering 2001 - present-21st Century Award of Achievement, International Biographical Center, 2001-Society of Cosmetic Chemists Best Scientific Paper, Dragoco Award, 2000-Women’s Dermatologic Society, Student Mentorship Award 2001-AMWA Outstanding Female Medical Student 1983-Merck Index Outstanding Medical Student 1983 -Alpha Omega Alpha (Top 10% Medical School Class) 1983 -Outstanding Young Women of America 1981 -University of Arizona Medical School Student Paper Contest Winner 1981 -Young Investigator Research Paper Award, American Society of Mechanical Engineers 1980 -RHODES Scholar (Oxford, England) 1979 -University of Arizona Outstanding Undergraduate Honors Thesis 1979 -University of Arizona Outstanding Honors Student 1978 -Tau Beta Pi Engineering Honorary (Top 10% Academic) 1977 -University of Arizona Outstanding Sophomore Student 1978 -Phi Beta Sigma Honorary 1976 - 1979



-Merit Progress Scholar Engineering Academic Scholarship 1976 -Baird Scholar Full Academic Scholarship University of Arizona 1976 - 1979

RESEARCH GRANTS-Arizona Disease Control Research Commission Grant 1977 -Family Practice Student Assistantship 1982 -Arizona Cancer Foundation Research Grant 1983 -National Institute of Health Student Research Grant 1983 -Medical Student Research Travel Award University of Arizona 1983 -Medical Student Research Grant University of Arizona 1981, 1982, 1983 -Skin Research Foundation Grant 1999

CLINICAL STUDIES (Principal Investigator)I have 32 years clinical research experience. In total, I have conducted 671 studies. I have conducted FDA phase II, III, and IV studies including 510K device submission work in addition to investigator initiated research. The breakdown of my research experience by study type and indication are presented in the table below followed by a detailed listing.

Study Phase Corporate Use Phase II Phase III Phase IV 510KNumber of Studies

474 85 76 24 12

Indication Number of StudiesAcne 115Actinic Keratoses 18Alopecia 4Antiperspirants 4Atopic Dermatitis 54Body Odor 1Candidiasis 1Cellulite 6Chelitis 2Chemodenervation 7Cleansers 35Colored Cosmetics 8Comedogenicity Testing 5Contact Dermatitis 3Dermatoheliosis 64Diabetes 3Eczema 16Face Peels 9Facial Filler 2Folliculitis 1Genital Warts 1Hair Growth 4Hair Shampoos and Cosmetics 12Hand Dermatitis 2Hidradenitis Supperativa 1Hyperhidrosis 1Impetigo 1Insect Repellent 1Itching 8



Lipolysis 1Medical Clothing 6Moisturizers 15Nail Cosmetics 2Neurotoxins 2Nutritional Supplements 10Oil Control 1Onychomycosis 1Perioral Dermatitis 1Periorbital Wrinkling 1Pigmentation 15Prurigo Nodularis 1Psoriasis 86Radiation Dermatitis 1Repeat Insult Patch Testing (RIPT) 6Rosacea 68Scar Treatment 4Seborrheic Dermatitis 9Seborrheic Keratoses 1Sebum Control 1Sensitive Skin 7Sunscreens 7Tinea Capitis 3Tinea Pedis 12Verruca Vulgaris 3Wound Healing 9

The following list contains the details of my research experience:-Propecia for Frontal Male Hair Loss, Merck, FDA Phase 3, 1994 - 1996 -Diptheria Toxin Ligand in the Treatment of Plaque Psoriasis, Seragen, Division of Eli Lilly, FDA Phase 3, 1995 -Evaluation of Razor Design, Schick, Division of Warner Lambert, 1995 -Cosmetic Compatibility of Triaz Acne Preparation, Medicis, 1996 -Socioeconomic Evaluation of Patch Testing, Glaxo, 1995 - 1996 -Scalp Itching in Postmenopausal Women, Procter & Gamble, 1997 -Azelex Cosmetic Compatibility, Allergan, 1997 -Comparison of Hair Removal Methods, Schick Razor Company, 1997 -Topical Antifungals in the Treatment of Tinea Pedis, Piedmont Research Associates, 1997 -Zinc Oxide Photoprotection in a Sensitive Skin Population, Procter & Gamble, 1998 -Evaluation of a Novel Oral Hair Loss Medication, FDA Phase 2, Glaxo, 1997 - 1999 -Hydrogels as Barrier Creams, Hydron Technologies, 1998 -Pigments for Eyelid Cosmetics in a Sensitive Skin Population, Estee Lauder, 1998 -Surface Characteristics and Migration of Facial Foundations, Neutrogena, 1997 - 1998 -Evaluation of a Novel Dermatologic Face Peel, Collagen Corporation, 1998 -Treatment of Eczema with a Petrolatum Containing Body Wash Oil of Olay, Procter & Gamble, 1998-Evaluation of a Skin Lightening Moisturizer in Oriental Skin, Procter & Gamble, 1999 -Evaluation of a Novel Gel for Skin Lightening of the Hands, MelanX Corporation, 1997 - 1998 -Evaluation of a Novel Gel for Skin Lightening of the Face, MelanX Corporation, 1998 - 1999 -Barriers Creams in the Prevention of Hand Dermatitis, Healthpoint, 1999 -Prevention of Itching in Subjects with Mild Eczema, Andrew Jergens Company, 1999 -Evaluation of an Oil Absorbing Polymer in Oily Complected Subjects, Ferndale Laboratories, 1999 -Botanicals in the Treatment of Mild Facial Acne, Nature's Dream, 1999 -Tazorac in the Treatment of Mild to Moderate Facial Acne, Allergan, 1999 -A comparison of Tazorac vs. Differin in the Treatment of Acne, Allergan, FDA Phase 4, 1999 -CLEAR Acne Treatment Trial, Allergan, FDA Phase 4, 1999



-Efficacy of an Antiperspirant in the Treatment of Hyperhidrosis, Procter & Gamble, 1999 -Oral Treatment of Male Pattern Hair Loss with Dutasteride, Glaxo, FDA Phase 3, 1999 -Use of Propecia for Male Pattern Hair Loss in Subjects Age 45-60, Merck, FDA Phase 4, 1999-Use of Iontophoresis for Measuring Interstitial Glucose in Diabetics, Cygnus, FDA Phase 2, 1999-Development of a GlucoWatch Biographer, Cygnus, FDA Phase 2, 1999-Evaluation of an Oil Absorbing Polymer in Rosacea, Ferndale Laboratories, 2000-The Effect of Niacinamide in Rosacea Subjects, Procter & Gamble, 2000-Comdeogenicity of a Moisturizing Lip Balm, Whitehall-Robins, 2000-Evaluation of Copper, Salicylic Acid, and Glycerin in the Treatment of Brittle Nails, Neutrogena, 2000-Topical Tretinoin as a Peeling Agent, Skin Incorporated, 2000-A Safety Evaluation of Tacrolimus Ointment in Children with Atopic Dermatitis, Fujisawa, FDA Phase 3, 2000-Physicians’ and patients’ perspectives on office-based dispensing: the central role of the physician-patient relationship,

Bristol-Myers Squibb, 2000-The Effect of Naicinamide, Vitamin E, and Panthenol in Subjects Treated With Topical) 0.025% Tretinoin, 2001-Use of an Intravenous Interleukin in the Treatment of Plaque Psoriasis, Agbenix, FDA Phase 3, 2001-An Evaluation of a Skin Care Regimen in the Treatment of Razor Burn, Nature’s Dream, 2001-Helioblock in the Treatment of Polymorphous Light Eruption, Galderma, 2001-Vitamin E in Liquid Cleansers, Colgate-Palmolive, 2001-Comdeogenicity of a Sunscreen Stick, Whitehall-Robins, 2001-Claims Substantiation of a Novel Sunscreen Stick, Whitehall-Robins, 2001-Evaluation of a Balanced Ceramide Formulation in Xerosis, Whitehall-Robins, 2001-Development of a Plumping Lip Moisturizer, Whitehall-Robins, 2001-Assessment of a Minoxidil Formulation for Male Pattern Hair Loss, Pharmacia, FDA Phase 4, 2001 -Development of a Skin Care Product Line for Male Facial Dyspigmentation, Nature’s Dream, 2001-Evaluation of a Novel Pantyhose Design in Cellulite Treatment, Primary Technologies, 2001-Evaluation of a Novel Garment Design in Cellulite Treatment, Primary Technologies, 2001-An Evaluation of Cleanser Design in Black Subjects with Ashen Skin, Colgate-Palmolive, 2001-Evaluation of a Novel Anti-inflammatory in Sunburn, Cutanix, 2000 - 2001-Evaluation of a Novel Anti-inflammatory in Facial Erythema, Cutanix 2001-An Assessment of Tacrolimus 0.03% in Children with Atopic Dermatitis, Fujisawa, FDA Phase 4, 2001-Medical Director, Evaluation of a Clindamycin Topical for Acne, Ferndale, 2001 -A Vehicle-Controlled, Randomized, Double-Blind, Multi-Center Study of the Efficacy and Safety of 1% Cyclopirox

Shampoo in the Treatment of Seborrheic Dermatitis of the Scalp, Medicis, 2001 -Assessment of a Novel Vitamin E Bodywash on Skin Appearance, Colgate-Palmolive Co., 2001 -Clinical Evaluation of a Novel Soap Formulation in the Reduction of Ashen Skin, Colgate-Palmolive Co., 2001-Optimizing the Use of Tazarotene in Acne Vulgaris through Combination Therapy, Allergan, 2001-A 12-Month, Multi-Center, Open Label, Noncomparative Design Study of 5% Dapsone Topical Gel in Patients with Acne

Vulgaris, Atrix Laboratories, Inc., 2002 -Clinical Evaluation of a Novel Soap Bar on Skin Appearance, Colgate-Palmolive Co., 2002-Tolerability of a Cosmetic Antioxidant in a Sensitive Skin Population, Cutanix, 2002-Facial Treatment Products for Acne, Avon, 2002-The Effects of Clinac OC Oil Control Gel on the Overall Facial Appearance on Patients with Mild to Moderate Rosacea,

Ferndale Laboratories, Inc., 2002-An Open Label Safety and Efficacy Study of Solage (2% 4-Hydroxyanisole/0.01% Tretinoin) to Assess Pigmentary

Changes in Ethnic Groups of Asian, Latin/Hispanic, and African American Descent with Skin Types II-V, Galderma, 2002-A Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group Study Comparing the Bioequivalence of TEVA

Pharmaceuticals USA’s Generic Formulation of Metronidazole Topical Gel 0.75% and Metrogel Metronidazole Topical Gel 0.75% in the Treatment of Inflammatory Papules and Pustules of Rosacea, TEVA Pharmaceuticals USA, 2002

-A Randomized, Double-Blind Study of Protopic 0.03% (Tacrolimus Ointment) vs. Vehicle Ointment in Pediatric Patients with Mild to Moderate Atopic Dermatitis, FujiSawa Healthcare, 2002

-A 13-Day, Randomized, Multi-Center, Investigator-Blind, Parallel Group Pharmacokinetic, Safety and Local Tolerability Comparison of Elidel Cream 1% with Tacrolimus Ointment 0.1% in the Treatment of Adult Subjects with Moderate to Severe Atopic Dermatitis, Followed by 24 weeks of Treatment with Elidel Cream 1% to Evaluate Long Term Safety, Novartis, 2002



-A Randomized, Third Party Blind, Multi-Center Trial Comparing the Efficacy and Safety of Diflucan (Fluconazole) for 3 Weeks vs. Diflucan for 6 Weeks vs. Grifulvan V (Griseofulvin) for 6 Weeks Given Once Daily to Pediatric Patients with Tinea Capitis, Pfizer, 2002

-A 12-Week, Multi-Center, Double-Blind, Randomized, Parallel Design Study of 5% Dapsone Topical Gel and Vehicle Control in Patients with Acne Vulgaris, Atrix Laboratories, Inc., 2002

-An Efficacy Evaluation of Novel Topical Niacin Derivatives to Improve the Fullness of Scalp Hair in Women, Niadyne, Inc., 2002

-An Open Label, Multi-Center Trial of Diflucan (Fluconazole) for 6 Weeks Given Once Daily to Pediatric Patients with Tinea Capitis, Pfizer, 2002

-A Randomized, Double-Blind Assessment of Wound Healing with Bactin First Aid Liquid vs. 3% Hydrogen Peroxide in Subjects with Dermal Lesion Wounds, Bayer, Inc., 2002

-Assessment of Facial Skin Tightness Following Cleansing: Part I, Colgate-Palmolive Co., 2002-Photo study of Cutaneous Fungal Infections, MD Photoderm, 2002-Clinical Evaluation of a Cosmetic Skin Lightening Preparation, Cutanix, 2003-An 8-Week, Randomized, Double-Blind, Placebo Controlled, Multi-Center Study in Adults to Assess the Efficacy and

Safety of Pimecrolimus 1% Cream Twice Daily in the Treatment of Inverse Psoriasis, Novartis, 2003-An Evaluation of TEVA Vehicle vs. Metrogel Vehicle on Skin Barrier, TEVA Pharmaceuticals USA, 2003-An Assessment of a Topically Applied Oxygen Containing Emulsion in Reducing Cutaneous Inflammation, Therox, 2003-A Multi-Center, Phase III, Randomized, Double-Blind, 4-Arm Clinical Trial to Compare the Safety and Efficacy of Clin-RA

Gel vs. Clindamycin Phosphate 1.2% Gel vs. Tretinoin 0.025% Gel vs. Clin-RA Gel Vehicle in Treatment of Acne Vulgaris, Dow Pharmaceuticals, 2003

-A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel Group Study Comparing Altana, Inc.’s Clotrimazole, 1%/Betamethasone Dipropoinate, 0.05% Lotion to Lotrisone Lotion (Clotrimazole, 1%/Betamethasone Dipropoinate, 0.05% Lotion) and Both Active Treatments to a Vehicle Control in the Treatment of Tinea Pedis (Athlete’s Foot), Altana, Inc., 2003

-Assessment of Facial Skin Tightness Following Cleansing: Part II, Colgate-Palmolive Co., 2003-An Evaluation of a Novel Hand Moisturizer in Mild to Moderate Hand Eczema, Galderma, 2003-An Evaluation of Ideal Eyes New Formulas, NuSkin, 2003-A Randomized, Parallel Group, Placebo-Controlled, Evaluator-Blind, Multi-Center Study to Evaluate the Clinical

Equivalence of a Generic Podofilox Gel 0.5% vs. Condylox Gel 0.5% (Podofilox Gel) in Subjects with Anogenital (External Genital and/or Perianal) Warts, Paddock Laboratories, 2003

-A Randomized, Double-Blind, Parallel Group, Multi-Center, Vehicle-Controlled Study of Flucocinonide 0.1% Cream Once Daily (QD) and Twice Daily (BID) in the Treatment of Plaque Psoriasis, Medicis, 2003

-A Mildness and Efficacy Evaluation of TruFace Revealing Gel, NuSkin, 2003-Comparison of the Use of Topical 3% Salicylic Acid, 1% Hydrocortisone, and Use of Both in the Treatment of Scalp

Pruritus, Combe, 2003-Efficacy and Safety of Ciclopirox, 1% Shampoo in the Prevention of Relapse of Seborrheic Dermatitis of the Scalp,

Medicis, 2003-An Evaluation of a Novel Oxygen Emulsion on Papular/Pustular Acne, Therox, 2003-A Multi-Center, Open Label Study to Observe the Effect of Etanercept on Joint and Skin Disease in Subjects with Psoriatic

Arthritis, Amgen, 2003-The Efficacy and Safety of Combination Therapy of Differin Gel, 0.1% with Doxycycline Hyclate (100mg capsules)

Compared to Differin Gel Vehicle with Doxycycline Hyclate (100mg capsules) in Subjects with Acne Vulgaris, Galderma, 2003

-An Assessment of Two Novel Fabrics in Addressing the Needs of Sensitive Skin, Milliken, 2003-The Skin Tolerability of Lotion vs. Alcohol Based DEET Formulation, Sawyer, 2003-An Evaluation of the Efficacy and Tolerability of Avage Used Alone vs. Avage Used in Combination with 4% Hydroquinone

in the Treatment of Subjects with Sun-Damaged Skin, Allergan, 2003-A Randomized, Double-Blind, Placebo-Controlled, Parallel Designed, Multiple Site Study to Evaluate the Clinical

Equivalence of Two Ketoconazole 2% Shampoos in Patients with Tinea (Pityriasis) Versicolor, Novum, 2003-The Evaluation of Maintenance Therapy of Differin Gel 0.1% vs. Differin Gel Vehicle in Acne Vulgaris Subjects-A Follow-

Up of a Combination Study, Galderma, 2003-A Phase IIIb, Open-Label, Multi-Center Study to Evaluate the Safety of 1.0% mg/kg Subcutaneously Administered

Efalizumab in Adults with Moderate to Severe Plaque Psoriasis, Including Those Who Are Receiving Concomitant Antipsoriatic Therapies or Have Recently Transitioned From Systemic Therapies, Genetech, 2003

-An Evaluation of Cellulite Reduction with a Gel and Galvanic Instrument, NuSkin, 2003



-Systemic Exposure of Pimecrolimus cream 1% and Tacrolimus Ointment 0.1% in Adult Patients with Moderate to Severe Atopic Dermatitis, Novartis Pharma AG. 2003

-A Pilot Study Evaluating Two Prototype No Sting Film Protectants and One Marketed No Sting Protectant Film in Patients with Perineal Candidiasis, Coloplast Inc., 2004

-An Efficacy Assessment of a Novel Skin Cleansing Device, Pacific Biosciences, 2004-A Double-Blind, Randomized, Parallel Group, Vehicle-Controlled, Multi-Center Study to Evaluate the Safety and Clinical

Equivalence of a Generic Ciclopirox Olamine Cream, USP (Clay-Park Labs, Inc.) to Loprox (Clicopirox) Cream 0.77% (Medicis) in the Treatment of Tinea Pedis, Symbio, 2004

-A Double-Blind, Randomized, Parallel Group, Placebo-Controlled, Multi-Center Study to Compare the Clinical Equivalenceof Metronidazole Topical Gel USP, 0.75%-Generic Atrix Laboratories, Inc. and Metronidazole Topical Gel 0.75% (Metrogel) in Subjects with Moderate to Severe Acne Rosacea, Atrix Laboratories, Inc., 2004

-The Tolerability of a Powder Foundation in Subjects with Rosacea or Acne, Pharmacosmetix, 2004-Factors Conducive to Scalp Skin and Hair Shaft Improvement, The Proctor and Gamble Co., 2004 -A Randomized, Evaluator-Blind, 3-Arm, Multi-Center Study to Evaluate the Safety and Efficacy of Topically Applied

Desonide Gel 0.05% vs. Desonide Gel Vehicle and DesOwen Lotion for the Treatment of Pediatric Subjects with Mild To Moderate Atopic Dermatitis, Dow Pharmaceuticals, 2004

-A Double-Blind, Randomized, Parallel-Group, Vehicle-Controlled, Multi-Center Study To Evaluate the Safety and Clinical Equivalence of a Generic Ciclopirox Olamine Topical Suspension, USP (Clay-Park Labs, Inc.) To Loprox (Ciclopirox) Topical Suspension 0.77% (Medicis) In the Treatment of Tinea Pedis, Clay-Park Laboratories, Inc., 2004

-Clinical Study to Evaluate the Effect of Facial Moisturizer Products on the Skin of Subjects With Red Facial Blotchiness, The Proctor and Gamble Co., 2004

-An Open Label Adrenal Suppression Study of Hydrocortisone Butyrate Lotion 0.1% Used Three Times Daily in Pediatric Subjects Aged 3 Months To Less Than 18 Years With Moderate to Severe Atopic Dermatitis, Ferndale Laboratories, Inc.,2004

-A Double-Blind, Randomized, Vehicle-Controlled Trial To Determine the Efficacy and Safety of Hydrocortisone Butyrate Lotion 0.1% in the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Subjects Aged 3 Months To Less Than 18Years, Ferndale Laboratories, Inc., 2004

-The Efficacy of Duac Topical Gel in the Treatment of Perioral Dermatitis, Stiefel Laboratories, 2004-An Evaluation of the Tolerance and Efficacy of Finacea Gel For Rosacea When Used in Combination With a Polyhydroxy

Acid-Containing Skin Care Regimen Compared With the Use of a Non-Standardized Skin Care Regimen, NeoStrata Company, 2004

-The Efficacy of a Novel Topical MMP Regulator in Aging Skin, Greystone Medical Group, 2004-The Cosmetic Compatibility of a Novel Topical 6% Benzoyl Peroxide Acne Treatment Pad, Medicis, 2004-Clinical Evaluation of a Novel Body Wash in Producing Skin Firming, Colgate-Palmolive, 2005-The Ability of a Cosmetic Cream to Lighten Age Spots, NuSkin, 2005-The Effect of Metronidazole Gel 1% on Skin Barrier Function, Galderma, 2005-An Evaluation of the Effect of TruFace Revealing Gel in Combination with Polishing Peel, NuSkin, 2005-A Multi-Center, Double-Blind, Vehicle-Controlled Study Comparing Altana Inc.’s Generic Ciclopirox Gel 0.77% To Loprox

Gel (Ciclopirox) 0.77% And Both Active Treatments To A Vehicle Control in the Treatment of Tinea Pedis (Athlete’s Foot),Altana, 2005

-An Assessment of Microneedle Delivery as a Methodology for Botulinum Toxin A Administration in the Treatment of AxillaryHyperhydrosis, Procter & Gamble, 2005

-A Phase 3, Randomized, Double-Blind, Multi-Dose Study to Evaluate the Safety and Efficacy of 5% Dapsone Topical Gel (DTG 5%) When Co-Administered with Vehicle Control, Adapalene Gel 0.1% or Benzoyle Peroxide Gel 4% in the Treatment of Acne Vulgaris, QLT USA, Inc., 2005

-An Evaluation of the Moisturizing Efficacy of Six Liquid Body Cleansers for Shower Use, Colgate-Palmolive, 2005-An Efficacy Assessment of a Novel Skin Cleansing Device, Part II, Pacific Biosciences Laboratories, Inc., 2005-A Double-Blind, Randomized, Parallel-Group, Vehicle-Controlled, Multi-Center Study To Evaluate the Safety and Clinical

Equivalence of a Generic Ciclopirox Gel 0.77% To Loprox Gel (Ciclopirox) 0.77% in the Treatment of Interdigital Tinea Pedis, Paddock Laboratories, 2005

-The Effect of Revival Soy on Health and Appearance of Skin, Hair, and Nails in Post-Menopausal Women, Revival Soy, 2005

-A Multi-Center, Randomized, Double-Blind, Vehicle-Controlled Study of the Safety and Efficacy of EF Clobetasol Propionate Foam, 0.05% in the Treatment of Mild to Moderate Plaque-type Psoriasis, Connectics Corporation, 2005

-A Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, Bilateral Split Face Comparison Study of Auriderm Cream Versus Its Vehicle in the Treatment of Mild to Moderate Acne Rosacea, Ferndale Laboratories, 2005



-The Investigation of Potential Benefits of Using A Skin Moisturizing Lotion and Cleanser in Combination With a Mid-Potency Topical Steroid in the Treatment of Atopic Dermatitis/Eczema, Healthpoint, 2005

-A Novel Hair Care, Facial Care, and Body Care System, ENCA, LLC, 2005-The Effect of a Gentle Skin Cleanser on Skin Barrier in Subjects With Mild To Moderate Rosacea, Galderma, 2005-The Effect of a Gentle Daily Facial Cleanser on Skin Barrier and Sebum Removal in Subjects With Mild Facial Acne,

Galderma, 2005-The Ability of a Gentle Moisturizing Cream To Improve Skin Hydration and Flaking in Subjects With a History of Mild

Plaque Psoriasis Covering 5%-10% of the Body, Galderma, 2005-The Ability of an AHA Peel to Improve Skin Texture, NuSkin, 2005-A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Study to Evaluate the Safety and Clinical

Equivalence of a Generic Mupirocin Calcium Cream 2% vs Bactroban Cream 2% in the Treatment of Secondarily Infected Traumatic Skin Lesions Due to Strains of Staphylococcus Aureus or Streptococcus Pyogenes, TEVA Pharmaceuticals, 2005

-Open-Label Safety and Pharmacokinetic Study of Aldara (Imiquimod) Cream, 5% for One, Two, or Three Treatment Cycles to Surface Areas Greater Than 25 cm2 with Actinic Keratosis, 3M Pharmaceuticals, 2005

-An Evaluation of the Effect of Idebenone Alone and in Combination with Tazarotene in the Treatment of Photodamage, Allergen, 2005

-A Double-Blind, Randomized, Vehicle-Controlled Trial to Determine the Efficacy and Safety of Locoid Lipocream (Hydrocortisone Butyrate 0.1%) Cream in the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Subjects, Ferndale Laboratories, 2005

-A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing Imiquimod Cream 5% to Aldara (Imiquimod) Cream 5% and Both Active Treatments to a Vehicle Control in the Treatment of Actinic Keratosis ofthe Face or Scalp, TEVA Pharmaceuticals, 2005

-An Evaluation of the Efficacy of a Novel Sunscreen in Subjects with Polymorphous Light Eruption, Neutrogena, 2005-A Randomized, Three-Center, Split-Face, Preference and Tolerability Study Comparing Duac Topical Gel to BenzaClin Gel

in Combination with Retin-A 0.025% Cream in Adult Female Acne Patients, Stiefel Laboratories, 2005-Photographic Assessment of Plexion Cloths in Rosacea, Medicis, 2005-The Efficacy of Novel Garments in the Treatment of Sensitive Skin, Milliken, 2005-The Use of a Novel Hand Held Blue Light Device in the Treatment of Mild to Moderate Acne, SpectraGenics, 2005-Clinical Evaluation of a Novel Body Wash in Producing Skin Firming, Colgate-Palmolive Co, 2005-The Ability of a Cosmetic Cream to Lighten Age Spots, NuSkin, 2005-The Ability of a Novel Anti-Inflammatory to Reduce Facial Redness in Subjects With Mild to Moderate Rosacea, BioForm

Medical, 2005-A Phase II, Randomized, Partial-Blind, Parallel-Group, Active and Vehicle-Controlled, Multicenter Study of the Safety and

Efficacy of ACZONE™ (Dapsone) Gel, 5% in Subjects With Papulopustular Rosacea, QLT USA, 2006-Efficacy Evaluation of a Patented Niacin Molecule to Determine NAD Content in the Hair Follicle and Assess Hair Density

and Health, Niadyne, 2006-The Ability of a Novel Ceramide-based Skin Care System to Enhance Eczema Resolution, Coria Laboratories, 2006-A Multi-Center, Double-Blind Clinical Comparison of the Efficacy and Safety of Duac Topical Gel (Benzoyl Peroxide 5%/

Clindamycin 1%), Benzoyl Peroxide 4%/ Clindamycin 1% Gel, Benzoyl Peroxide 2%/ Clindamycin 1% Gel, and Vehicle Gel in the Once Daily Treatment of Acne Vulgaris for 12 Weeks, Stiefel Laboratories, 2006

-An Evaluation of the Effectiveness and Tolerability of CE Ferulic Skin Serum, L’Oreal USA, 2006-A Study To Evaulate the Efficacy of a Topical Cosmetic Cream on Photo-Aged Skin, Dior, 2006-An Evaluation of the Use of Human Recombinant Lactoferrin on Mild to Moderate Rosacea, Ventria Bioscience, 2006-A Prospective Single-Arm, Open-label Evaluation of Solaraze® Gel (3% diclofenac sodium 2.5% hyaluronic acid) for the

Treatment of Solar Lentigines, Bradley Pharmaceuticals, Inc., 2006-A Clinical Study for the Evaluation of a Dual Stream Skin Cleansing Body Wash Technology in Atopic Dermatitis Patients,

The Proctor and Gamble Co., 2006-An Observational Study to Develop Psychometrically Validated Patient Reported Outcome Measures for Oily Skin, Pfizer,

2006-A Multi-Center, Randomized, Double-Blind, Parallel-Group Study to Demonstrate the Efficacy and Safety of

Adapalene/Benzoyl Peroxide Topical Gel Compared with Adapalene Topical Gel, 0.1%; Benzoyl Peroxide Topical Gel, 2.5%; and Topical Gel Vehicle in Subjects with Acne Vulgaris, Galderma, 2006



-Phase 2a Single-Dose, Randomized, Double-Blind, Multi-Center, Parallel-Group, Placebo-Controlled Proof of Concept Study to Assess the Efficacy, Safety, Tolerability, and Population Pharmacokinetics of AIN457 in Patients with Stable Plaque-type Psoriasis, Novartis, 2006

-Evaluation of the Efficacy and Tolerance of Facial Products on Subjects with Rosacea, L’Oreal, 2006-Effect of Revival Soy on Weight Loss and Appearance of Skin, Hair, and Nails in High BMI Pre-Menopausal Women,

Revival Soy, 2006-A Prospective Single-Arm, Open-label Evaluation of Solaraze® Gel (3% diclofenac sodium 2.5% hyaluronic acid) for the

Treatment of Solar Lentigines, Bradley Pharmaceuticals, 2006-A Clinical Study for the Evaluation of a Dual Stream Skin Cleansing Body Wash Technology in Atopic Dermatitis Patients,

Proctor and Gamble, 2006-An Observational Study To Develop Psychometrically Validated Patient Reported Outcome Measures For Oily Skin, Pfizer,

2006-The Ability of Onion Extract Gel to Reduce the Appearance of Post Surgical Scars, Merz Pharmaceuticals, 2006-ProDerm 2.0 Evaluation of Changes in Discoloration Due to Prescription Skin Lightening Product Use, NuSkin, 2006-To Obtain Skin, Blood, and Saliva Specimens to Analyze in a Laboratory for Signs of Aging, NuSkin, 2006-A Phase III Randomized, Evaluator Blind, Parallel-Group Study of the Safety and Efficacy of Itraconazole Tablets,

Itraconazole Capsules, and Placebo in the Treatment of Onychomycosis of the Toenail, Barrier, 2006-Comparative Tolerability and Efficacy of Tazorac® 0.1% Cream and Retin-A-Micro® 0.04% in the Treatment of Mild to

Moderate Facial Acne Vulgaris, Allergan, 2006-A Clinical Trial to Evaluate the Effectiveness of an Acne Treatment Product, L’Oreal, 2006-Effectiveness and Tolerance of an L’Oreal Moisturizer SPF 15 Fla. 291860, L’Oreal, 2006-An Assessment of the Dermatologic Benefits of Coffee Berry Extract, Stiefel Laboratories, 2007-The Effectiveness of a Topical Preparation to Reduce Itch in Subjects with Dry Mature Skin, Symrise, 2007-Evaluating the Effect of 15% Azelaic Acid Gel on the Skin Barrier in Rosacea, Intendis, 2007-A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing Altana Inc.’s Generic

Adapalene Gel 0.1% to Differin® (Adapalene Gel) Gel, 0.1%, and Both Active Treatments to a Vehicle Control in the Treatment of Acne Vulgaris, Altana, 2007

-Tolerability and Efficacy Comparison of a Topical Retinoid/Minocycline Acne Regimen With and Without Anti-Inflammatory Skin Care Products, Triax Pharmaceuticals, 2007

-A Double-Blind, Randomized, Parallel-Group, Vehicle-Controlled, Multicenter Study to Evaluate the Safety and Clinical Equivalence of a Generic Ciclopirox Cream 0.77% to Loprox® Cream (Ciclopirox) 0.77% in the Treatment of Tinea Pedis, Glenmark Pharmaceuticals, 2007

-An Evaluation of a Moisturizer Ingredient in the Reduction of Cutaneous Xerosis, Symrise, April 2007-Efficacy Evaluation of a Novel Topical Botanical Complex in Inflammatory Skin Conditions, Therametics Corporation, 2007-The Ability of Therosol to Inhibit the Development of Radiation Dermatitis, Therametics Corporation, 2007-Efficacy of a Vibrating Cleansing System, Neutrogena, 2007-Comparative Efficacy and Tolerability of Duac® Topical Gel Used in Combination with Retin-A Micro® 0.04% Compared to

Ziana® Used in Combination With 5% Benzoyl Peroxide Wash in the Treatment of Acne Vulgaris, Stiefel Laboratories, 2007

-The Clinical Effect of a Topical Cosmetic Product on the Appearance of Photoaging, AGI Dermatics, 2007-A Randomized, Double-Blind, Multiple-Site, Placebo-Controlled, Parallel Design, Clinical Study to Evaluate the

Bioequivalence of Adapalene Gel 0.1% (PLIVA Research and Development Ltd.) Compared to Differin® (adapalene 0.1%) Topical Gel (Galderma Laboratories) in Patients with Acne Vulgaris, Novum Pharmaceuticals, 2007

-The Ability of a Cosmetic Cream Combined with Galvanic Current to Improve Facial Wrinkles, NuSkin, 2007-Evaluating the Effect of 15% Azelaic Acid Gel on the Skin Barrier in Rosacea Over 8 Weeks, Intendis, 2007-A Randomized, Double-Blind, Multiple-Site, Placebo-Controlled, Parallel Design, Clinical Study to Evaluate the

Bioequivalence of Adapalene Gel 0.1% (Tolmar, Inc.) Compared to Differin® (adapalene 0.1%) Topical Gel (Galderma Laboratories) in Patients with Acne Vulgaris Novum Pharmaceuticals, 2007

-Effectiveness and Tolerance of a Face Gel Cream and Face Serum, L’Oreal, 2007-Effect of the Beauty Vitamin, Gorgeous Roses, on the Health and Appearance of Women’s Skin, Hair, and Nails, Physician

Pharmaceuticals, 2007-Clinical Study to Assess the Potential for a Facial Foundation Product to Improve Sensitive Skin, Proctor and Gamble,

2007-A Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Clinical

Equivalence of Generic Metronidazole Gel, 1% (Tolmar, Inc.) to METROGEL® (metronidazole gel), 1% (Galderma



Laboratories, LP) and Both Active Treatments to a Vehicle Control in the Treatment of Inflammatory Rosacea Lesions, Tolmar, 2007

-A Study of the Skin Substantivity of Tetrix Cream, Coria Laboratories, 2007-An Evaluation of Water-Lipid Based Foam in Cutaneous Barrier Repair, Quinnova, 2007-A Multi-Center, Double-Blind, Placebo-Controlled, Split-Face Study Comparing Vitaphenol Skin Cream to a Placebo

Control in the Treatment of Facial Elastosis of the Face, Eye, and Mouth Area, SpaMD, 2007-The Cutaneous Benefits of an Antioxidant Enriched Chewing Gum, Wrigley Jr. Company, 2007-Comparative Efficacy and Safety of Tazorac® 0.1% Cream and Differin® 0.3% Gel in the Treatment of Moderate to Severe

Facial Acne Vulgaris, Allergan, 2007-An Evaluation of the Effectiveness of an Anti-Aging Skin Care Line for Men, NeoStrata, 2007-The Cutaneous Benefits of an Oral Antioxidant Dietary Supplement, Lycored, 2007-A Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, MultiCenter Study to Evaluate the Safety and Clinical

Equivalence of a Generic Cream to a Currently Marketed Cream and both Active Treatments to a Vehicle Control in the Treatment of Actinic Keratosis of the Face or Scalp, Tolmar, 2008

-The Comparison of Onion Extract Gel to Onion Extract Cream to Improve the Appearance of Post Surgical Scars, Merz, 2008

-A MultiCenter, Double-Blind, Randomized, Vehicle Controlled, Parallel-Group Study Comparing NYCOMED US Inc.’s Tacrolimus Ointment 0.1% To Protopic® (Tacrolimus) Ointment 0.1% and Both Active Treatments to a Vehicle Control in the Treatment of Atopic Dermatitis, Nycomed, 2008

-An Open-Label Controlled Use Study to Evaluate the Effects of an Oral Nutritional Supplement on Circulating Metabolites, Beiersdorf, 2008

-A Randomized, Double-Blind, Multiple-Site, Placebo-Controlled, Parallel Design, Clinical Study to Evaluate the Bioequivalence of a Generic Drug to a Marketed Drug in Patients with Moderate to Severe Acne Vulgaris, Glenmark Pharmaceuticals, 2008

-A Clinical Demonstration of the Antioxidant Effect of Azelaic Acid Gel 15%, Intendis, 2008-A Clinical Demonstration of the Comedolytic Effect of Azelaic Acid Gel 15%, Intendis, 2008-A Clinical Demonstration of the Equivalence of Abolene and Mimyx in the Treatment of Mild to Moderate Eczema, DSE

Healthcare, 2008-A Multi-Center, Double-Blind, Placebo-Controlled, Split-Face Study Comparing Vitaphenol Skin Cream to a Placebo

Control in the Treatment of Facial Elastosis of the Face, Eye, and Mouth Area (Part II), SpaMD, 2008-Effectiveness and Tolerance of an Antiaging Facial Cream, L’Oreal, 2008-A Multi-Center, Randomized, Double-Blind, Parallel-Group Study to Demonstrate the Efficacy and Safety of Adapalene

Lotion, 0.1% Compared With Vehicle Lotion in Subjects With Acne Vulgaris, Galderma, 2008-A Double-Blind, Randomized, Parallel-Group, Vehicle-Controlled, Multi-Center Study to Evaluate The Safety and Clinical

Equivalence of a Generic Ciclopirox Gel 0.77% to Loprox Gel (Ciclopirox) 0.77% in the Treatment of Interdigital Tinea Pedis, Glenmark Pharmaceuticals, 2008

-The Ability of a Cosmetic Cream Combined with Galvanic Current to Improve Facial Wrinkles (Part II), NuSkin, 2008-The Cutaneous Benefits of an Oral Antioxidant Dietary Supplement (Part II), LycoRed, 2008-An Evaluation of Water-Lipid Based Foam in Cutaneous Barrier Repair (Part II), Quinnova, 2008-Comparative Evaluation of the Skin Lightening Benefits of Two Products, L’Oreal, 2008-Acne Over-the-Counter Blue Light Device Simulated Consumer Use Study, Trial I, TRIA Beauty, 2008-A Controlled Usage Study to Assess the Safety-In-Use and Efficacy of Two Face Treatment Products, Neutrogena, 2008-A Phase 3, Randomized, Double-blinded, Placebo-controlled, Multicenter, Efficacy and Safety Study of Four Weeks of

Treatment with Imiquimod Creams for Actinic Keratoses, Graceway, 2008-The Ability of a Cosmetic Cream to Improve Facial Wrinkles With and Without arNOX Inhibitors, NuSkin, 2008-A Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Phase 2 Study of the Safety and Efficacy of Benzoyl

Peroxide/Clindamycin Gel and Tazarotene Cream When Used in Combination in the Treatment of Acne Vulgaris, Stiefel, 2008

-A Phase 3 Double-Blind, Randomized, Placebo-Controlled, Multicenter, Parallel Group Evaluation of the Efficacy and Safety of NAFT-500 in Subjects with Tinea Pedis, Merz, 2008

-Acne Over-the-Counter Blue Light Device Simulated Consumer Use Study, Trial II, Tria Beauty, 2008-The Ability of an Onion Extract Cream to Improve the Overall Appearance of Stretch Marks, Merz, 2008-A Phase 3 Double-Blind, Randomized, Placebo-Controlled, Multicenter, Parallel Group Evaluation of the Efficacy and

Safety of NAFT-500 in Subjects with Tinea Cruris, Merz, 2008-An Evaluation of the Barrier Effects of Safflower Oleosomes, Botaneco, 2009



-Comparative Efficacy and Safety of Tazorac® 0.1% Cream Used in Combination with Aczone™ Gel and Tazorac® 0.1% Cream Monotherapy in the Treatment of Moderate to Severe Facial Acne Vulgaris, Allergan, 2009

-Phase II Single-Dose, Randomized, Double-Blind, Multi-Center, Parallel-Group, Placebo-Controlled Proof of Concept Study to Assess the Efficacy, Safety, Tolerability, and Population Pharmacokinetics of AIN457 in Patients With Stable Plaque-Type Psoriasis, Novartis, 2009

-A Clinical Evaluation of Sodium Sulfacetamide 10%, Sulfur 5% Emollient Foam in the Treatment of Inflammatory Facial Dermatosis, Onset Therapeutics, 2009

-A Randomized, Double-Blind, Multi-Center, Placebo Controlled, Parallel Design, Clinical Study to Evaluate the Bioequivalence of Imiquimod Cream 5% (Glenmark Generics LTD. India) Compared to Aldara® (Imiquimod Cream) 5% (3M Pharmaceuticals) in Patients with Actinic Keratosis, Glenmark, 2009

-A Phase II, Randomized, Double-Blind, Vehicle-Controlled Cross-Over Study to Determine the Anti-Pruritic Efficacy, Safety, and Local Dermal Toleration of SRD174 Cream in Subjects with Atopic Dermatitis, Serentis, 2009

-A Double-Blind, Randomized, Parallel-Group, Vehicle-Controlled, Multicenter Study to Evaluate the Safety and Bioequivalence of Diclofenac Sodium Gel, 3% (TOLMAR Inc.) and Solaraze™ (Diclofenac Sodium) Gel, 3% and Compare Both Active Treatments to a Vehicle Control in the Treatment of Actinic Keratosis, Tolmar, 2009

-A Double-Blind, Randomized, Parallel-Group, Vehicle-Controlled, Multicenter Study to Evaluate the Safety and Bioequivalence of Calcipotriene Cream, 0.005% (TOLMAR Inc.) and Dovonex® (Calcipotriene Cream) Cream, 0.005% and Compare Both Active Treatments to a Vehicle Control in the Treatment of Plaque Psoriasis, Tolmar 2009

-A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study to Evaluate the Clinical Bioequivalence of Fluorouracil Cream, 5% to Efudex® (Fluorouracil) Cream, 5% and Superiority Over Vehicle Cream in the Treatment of Multiple Actinic Keratosis, Paddock, 2009

-A Phase 3b, Multi-Center, Assessor-Blinded Study of the Tolerability of Clindamycin 1%-Tretinoin 0.025% Gel Used in Combination with Benzoyl Peroxide 4% Wash in Subjects with Mild to Moderate Facial Acne Vulgaris, Stiefel, 2009

-A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing Nycomed US Inc.’s Tacrolimus Ointment 0.03% To Protopic® (Tacrolimus) Ointment 0.03% and Both Active Treatments to a Vehicle Control in the Treatment of Atopic Dermatitis, Nycomed, 2009

-Consumer Labeling Comprehension and Lay User Efficacy Study for the TANDA Regenerate, Pharos Life, 2009-Assessment of the Wound Healing Efficacy of Two Topical Treatments for Post-Surgical Care of Wounds Following the Removal of Seborrheic Keratosis, Beiersdorf, 2009-The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage in Individuals with Multiple Skin Conditions A Double-Blind, Controlled Comparative Trial, Aria Aesthetics, 2009-Evaluating the Safety and Gentleness of a Sonic Applicator, Clarisonic, 2009-Beneficial effect of a 1% topical DVS603 cream on psoriatic plaques undergoing topical corticosteroid therapy, L’Oreal, 2009-The Presence and Activity of arNOX on the Skin Cell Surface, NuSkin, 2009-A Split-Face Study Evaluating the Tolerability and Effectiveness of Retinoic Acid used as a Post Treatment Product on Subjects Receiving a Full Face Peel Treatment, L’Oreal, 2009-An Evaluation of the Use of a Novel Skin Care Following Superficial Glycolic Acid Peeling, RoC Division of J&J, 2009-A Clinical Demonstration of the Efficacy of Relieva in Minimizing the Signs and Symptoms of Psoriasis, DSE Healthcare, 2009-A Clinical Demonstration of a Novel Topical Formulation for Sensitive Skin, Rodan and Fields Dermatologists, 2009-ChapStick® Ultra Lip Enhancement: Assessment of Product Efficacy to Give Lips a Fuller Appearance, Wyeth Consumer Healthcare, 2009-The Clinical and Antioxidant Effects of an Essential Serum, Skin Medica, 2009-Evaluating the Safety of a Cosmetic Serum for Professional Use and Distribution when applied using the Clarisonic Opal, Clarisonic, 2009-An Evaluation of Pseudoceramides in Mild to Moderate Atopic Dermatitis, Curel, 2009 -The Effectiveness of a Topical Preparation to Reduce Itch in Subjects with Tinea Pedis, Symrise, 2009-A Double-Blind Vehicle-Controlled Evaluation of Arazine in the Treatment of Mild to Moderate Facial Acne and Rosacea,Signum BioSciences, Inc.,2009-Acne Treatment Products 10-Week Clinical Efficacy Study, Avon, 2009-An Evaluation of the Healing Properties of a Topical Skin Formulation Containing Tropoelastin and Prolisel as a Pre andPost Treatment to Chemical Peel, Protein Genomics, 2009-A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study to Compare Perrigo Israel Pharmaceuticals, Ltd. Calcipotriene 0.005% and Betamethasone Dipropionate 0.064% Ointment to LEO Laboratories



Ltd. Taclonex® (calcipotriene 0.005% and betamethasone dipropionate 0.064%) Ointment and Both Active Treatments toa Vehicle Control in the Treatment of Psoriasis Vulgaris, Perrigo, 2009-A Clinical Demonstration of the Spreadability and Efficacy of Hylatopic Non-steroidal Emollient Foam. Onset Therapeutics, 2009-A Pilot Safety Study of the Capso Vision Video Capsule Diagnostic System to Assess Visualization and Imaging Capabilities of the Colon and the Effectiveness of a Standardized Bowel Preparation, Capso Vision, Inc., 2009 -Randomized, double-blind, vehicle-controlled, multicenter, parallel-group study to investigate safety and efficacy of Azelaic Acid Foam, 15% topically applied twice daily in subjects with papulopustular rosacea, Intendis, 2009 -A randomized, double-blind, placebo controlled, multicenter regimen finding study of subcutaneously administered AIN457, assessing Psoriasis Area and Severity Index (PASI) response in patients with moderate to severe chronic plaque-type psoriasis, Novartis, 2009-A multi-center, double-blind, randomized, vehicle-controlled, parallel-group study comparing Altana Inc’s metronidazole topical gel 1% to Metrogel 1% (Metronidazole gel), 1% and both active treatments to a vehicle control in the treatment of the inflammatory lesions of rosacea, Nycomed, 2009- A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study to Compare Perrigo Israei Pharmaceuticals, Ltd., Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel to BenzaClin® Topical Gel (Clindamycin/Benzoyl Peroxide Gel), and both Active Treatments to a Vehicle Control in the Treatment of Acne Vulgaris, Perrigo, 2009-A Double-Blind, Randomized, Parallel-Group, Vehicle-Controlled, Multicenter Study to Evaluate the Safety and Bioequivalence of Calcipotriene Cream, 0.005% (TOLMAR Inc.) and Dovonex® (Calcipotriene Cream) Cream, 0.005% and Compare Both Active Treatments to a Vehicle Control in the Treatment of Plaque Psoriasis, Tolmar, 2009-A Phase 4, Open-Label Study to Assess the Long-Term Safety of Extina (Ketoconazole) Foam, 2% in the Treatment of Seborrheic Dermatitis, Stiefel, 2009-A Randomized, Double-Blind Sham Control Clinical Trial to Evaluate the Safety and Efficacy of the Hair Max Lasercomb 2009, 9 and 12 Beam Models for the Treatment of Androgenetic Alopecia in Males, Lexington International L.L.C., 2009-Evaluation of the Efficacy and Tolerance of a Facial Product on Subjects with Rosacea. L’Oreal Research and Development, 2009-A Multi-Center, Randomized, Double-Blind, Vehicle –Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Tazarotene Foam 0.1% in Subjects with Acne Vulgaris, Steifel Laboratories, 2009-The Effectiveness of a Topical Preparation to Reduce Itch in Subjects with Tinea Pedis, Symrise/Novartis, 2009-A Clinical Demonstration of a Novel Anti-Aging Regimen, Rodan and Fields Dermatologists, 2010 -The Effect of a Peptide-Containing Moisturizer on the Appearance of Stretch Marks, Helix, 2010-Tolerance of Liquid Facial Cleansers on Clinical Sensitive Skin, Neutrogena, 2010-Acne Treatment Products 10-week Clinical Efficacy Study, Avon Products Inc, 2010-An Evaluation of the Immediate Relief of Sensitive Skin Discomfort by a Novel Moisturizer, KAO Brands Co, 2010-21-Day Cumulative Irritation Patch Test Study to Evaluate the Tolerance of Bennzoyl Peroxide Cleansers, Intendis, Inc, 2010-A Double-Blind, Vehicle-Controlled, Randomized, Parallel Design, Multiple-Site Clinical Study to Evaluate the Efficacy and Safely of Desoximetasone 0.25% Topical Spray in patients with moderate to severe plaque psoriasis, TARO Pharmaceuticals USA, Inc, 2010-A Multi-Center, Randomized, Double-Blind Study of the Safety and Efficacy of Calcipotriene Foam, 0.005% versus vehicle foam in the treatment of plaque-type psoriasis of the scalp, Steifel, 2010-An Open-Label Pilot Study to determine the efficacy and tolerability of a device, RD047-26 for the treatment of mild to moderate atopic dermatitis with associated pruritis in adults, Oculus Innovative Services Inc, 2010-The Cosmetic Compatibility of a Novel Topical Clindamycin/Benzoyl Peroxide Formulation, Valeant Pharmaceuticals, 2010- A 4-Week, Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Investigating the Efficacy and Safety of CD07805/47 Gel 0.5% Applied Topically Once Daily (QD), and CD07805/47 Gel 0.18% Applied Topically Once Daily (QD) or Twice Daily (BID), in Subjects with Moderate to Severe Facial Erythema Associated with Rosacea, Galderma R&D, 2010- A Clinical Demonstration of the Efficacy of Extra Strength Relieva in Minimizing the Signs and Symptoms of Psoriasis, DSE Healthcare, 2010-The Effect of an Eye Serum on Periorbital Rhytids, Helix, 2010-Evaluation of the Effectiveness and Tolerance of a Facial Product on Patients With Rosacea, L’Oreal Research & Development, 2010



-An Evaluation of the Tolerance and Skin Improving Properties of Two Moisturizing Creams in Diabetic Subjects, Chattem, 2010- A Multicenter, Randomized, Double-Blind Study Of The Safety And Efficacy Of Calcipotriene Foam, 0.005%, Versus Vehicle Foam In The Treatment Of Moderate Plaque-Type Scalp And Body Psoriasis, Stiefel, A GSK Company, 2010-The Effect of A Skin Care System on Facial Appearance, Greyson International, Inc., 2010-Safety and Efficacy of PERLE with MELAPLEX™ for Hyperpigmentation Associated with Skin Aging, NEOCUTIS, Inc., 2010-The Ability of Onion Extract Gel to Approve the Overall Appearance of Post Surgical Scars, Merz Pharmaceuticals. LLC,2010-A Double-blind, Randomized, Parallel-group, Vehicle-controlled, Multicenter Trial Comparing Generic to Innovator Clindamycin, 1% and Benzoyl Peroxide, 5% Topical Gel and Both Active Treatments to a Vehicle Control in the Treatment of Acne Vulgaris, TOLMAR, Inc., 2010-A Multi-Center, Double-Blind Clinical Trial to Evaluate the Safety and Efficacy of Two Acne Creams in Subject with Mild to Moderate Acne, LaRoche Posay, Division of L’Oreal, 2010-The Effect of A Blemish Product on Facial Appearance, Helix, 2010-A Phase IV, Open-Label Study Evaluating the Use of Solodyn® (Minocycline HCL Extended-Release Tablets), Ziana® and Triaz® Foaming Cloths as Combination Acne Therapy for PotentialIsotretinoin Candidates, Medicis Global Services Corporation, 2010

-A multi-center, randomized, vehicle-controlled, double-blind, study to evaluate the safety and efficacy of Epiduo® (adapalene and benzoyl peroxide) Gel 0.1%/2.5% administered once daily for the treatment of subjects 9 to 11 years of age with acne vulgaris, Galderma R&D, Inc., 2010

- A Multicenter, Randomized, Double-Blind, 12-Week Study of the Safety and Efficacy of AN2728 versus AN2728 Vehicle in the Treatment of Patients with Mild-to-Moderate Plaque-Type Psoriasis, Anacor, 2010

- An Open-Label Evaluation of the Adrenal Suppression Potential of Alclometasone Dipropionate Lotion 0.05% in the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric Subjects, Nycomed US, Inc., 2010

- A Non-Inferiority Study Comparing Aczone® Gel 5% and Differin® 0.3% Gel Dual Therapy to Dual Therapy with Duac® Topical Gel and Differin® 0.3% Gel for the Treatment of Facial Acne Vulgaris, Allergan, 2010

-Beneficial Effect of A Topical 79634 Cream on Psoriasis Plaques Undergoing Topical Corticosteroid Therapy, L’Oreal Research and Innovation, 2011

-A One-Day, 5-Cell to Evaluate Migration and Tolerance of Facial Foundation, Johnson & Johnson Consumer Products and Personal Products Worldwide, 2011

-The Effects a A Bio Marine Power Peptide on Skin Appearance, Skinergistics Clinical Skin Solutions,Inc., 2011

-An Evaluation of A Prototype SPF Formulation in Sensitive Skin, Neutrogena, 2011-Preliminary Clinical Evaluation of TDO on Intact Skin, Kimberly Clark Research and Development,

2011-Tolerance of Liquid Facial Cleansers on Clinical Sensitive Skin, Neutrogena Corporation, 2011-A Two Part Study Assessing Safety and Efficacy of A Clarisonic Acne Kit, Pacific Bioscience

Laboratories, 2011-Evaluation of the Efficacy and Tolerability of a Treatment to Minimize The Appearance of Cellulite

And Improve Body Firmness and Lifting, NuSkin Research and Development, 2011- Evaluation of the Efficacy and Tolerability of an ageLOC Treatment to Improve Body Firmness and Lifting, NuSkin Research and Development, 2011-A Clinical Demonstration of Relieva in Minimizing the Signs and Symptoms of Psoriasis, DSE

Healthcare, 2011 -A 7-Day Monadic Study to Evaluate the Ability of Aurstat to Reduce Pruritis in Subjects With Mild to moderate Atopic Dermatitis, Onset Dermatologics, 2011

-The Effect of a Novel Ingredient on the Symptoms Associated with Sensitive Skin, Symrise (2011)-The Effect of a Copper Peptide Serum on Periorbital Rhytids, Helix BioMedix (2011)-A Multicenter, Double-Blind, Randomized, Vehicle-controlled, Parallel-group Study ComparingAdapalene and Benzoyl Peroxide Topical Gel 0.1%/205% (Actavis Mid-Atlantic LLC) to EpiduoTM

(Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% (Galderma Laboratories, L.P.) and Both Active Treatments to Topical Gel Placebo (Actavis Mid-Atlantic LLC) in the Treatment of Mild to Severe Acne Vulgaris, Actavis, 2011-A Randomized, Double-Blind, Vehicle-Controlled, Exploratory Study Evaluating Topical Application of BBI-1111 in Subjects with Rosacea, Brickell Biotech, 2011



- A 4-Week, Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Investigating the Efficacy and Safety of CD07805/47 Gel 0.5% Applied Topically Once Daily (QD), and CD07805/47 Gel 0.18% Applied Topically Once Daily(QD) or Twice Daily (BID), in Subjects with Moderate to Severe Facial Erythema Associated with Rosacea, Galderma R&D, 2011-A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 3-Arm, Parallel Group Study Comparing the Efficacy and Safety of CD2475/101 40 mg Tablets versus Placebo and Doxycycline 100 mg Capsules Once Daily in the Treatment of Inflammatory Lesions in Subjects with Acne Vulgaris, Galderma R&D, 2011-A Multicenter, Double-Blind, Randomized, Parallelgroup, and Placebo-Controlled Study to Determine the Bioequivalence of a Generic Azelaic Acid Gel, 15% and the Reference Listed Finacea® (azelaic acid) Gel, 15% in Subjects with Moderate Papulopustular Rosacea, Glenmark Generics Ltd., 2010-Assessment of the Efficacy of a 10-Day Treatment with Topical 1% 20108C.L in 2 Formulations on Suction Blister Would Healing in Healthy Volunteers, L’Oreal, 2011-Beneficial effect of a topical 79634 cream on psoriatic plaques undergoing topical corticosteroid therapy, L’Oreal, 2011-A Randomized, Multi-Center, Double-Blind, Vehicle-Controlled Study Evaluating the Efficacy and Safety of Product 33525 in Subjects with Tinea Pedis, Medicis Pharmaceutical Corp., 2011-The Ability of Onion Extract Gel to Approve the Overall Appearance of Post Surgical Scars, Merz Pharmaceuticals. LLC, 2011- The Comparison of Onion Extract Gel (Mederma@) to Onion Extract Gel (Mederma@) with Massaging Microspheres to Reduce the Appearance of Post Surgical Scars, Merz Pharmaceuticals. LLC, 2011-Effectiveness and Tolerance of a Facial Regimen, Precision Dermatology, 2011-A Clinical Demonstration of the Efficacy of Relieva in Minimizing the Signs and Symptoms of Psoriasis, DSE Healthcare, 2011-An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the MaxClarity System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects with Acne, Stiefel A GSK Company, 2011 -A Double-blind, Randomized, Parallel-design, Vehicle-controlled, Multicenter Trial Comparing Generic to Innovator Clindamycin, 1% and Benzoyl Peroxide, 5% Topical Gel and Both Active Treatments to a Vehicle Control in the Treatment of Acne Vulgaris, Tolmar Inc., 2011-An Evaluation of the Effect of Hand Washing on the Amount of Residual Testosterone on the Hands After Application of AndroGel® 1.62%, Abbott Laboratories, 2011-Clinical Trial To Evaluate Botulinum Neurotoxin Type A (ANT-1207) In Subjects With Acne, Anterios Inc., 2011-An Open-Label Study to Evaluate the Safety of Long-Term Administration of Product 33525 in Subjects with Tinea Pedis, Tinea Corporis, or Tinea Cruris, Medicis Global Services Corporation, 2011-A Randomized, Double-blind, Placebo- controlled, Multicenter, Parallel-group Study to Assess the Pharmacodynamics of MK-0524 in Patients with Moderate to Severe Erythematotelangiectatic Rosacea, Merck Research Laboratories Merck & Co., Inc., 2011-A Randomized, Double-Blind, Placebo-Controlled, Multiple-Site, Study Comparing Metronidazole Topical Gel 1% (Taro Pharmaceuticals Industries, Ltd.) to METROGEL® (Metronidazole gel) 1% (Galderma) in the Treatment of Moderate to Severe Rosacea, TARO Pharmaceuticals USA Inc., 2011-A first–in-human study to evaluate safety and tolerability of repeated topical administrations of BPR277 ointment in healthy volunteers, and safety, tolerability, and preliminary efficacy of multiple topical administrations of BPR277 in patients with atopic dermatitis and Netherton syndrome, Novartis, 2011-A Phase 3, Multi-site, Randomized, Mixed-blind, Parallel-group Treatment Withdrawal and Re- treatment Study of the Efficacy and Safety of 2 Oral Doses of CP-690,550 in Subjects with Moderate to Severe Chronic Plaque Psoriasis, Pfizer, 2011-A multicenter extension trial of subcutaneously administered AIN457 in patients with moderate to severe chronic plaque-type psoriasis, Novartis, 2011-A randomized, double-blind, double-dummy, placebo controlled, multicenter study of subcutaneous secukinumab to demonstrate efficacy after twelve weeks of treatment, compared to placebo and etanercept, and to assess the safety, tolerability and long-term efficacy up to one year in subjects with



moderate to severe chronic plaque-type psoriasis, Novartis, 2011-A Phase 3 randomized, double-blind, 12-week vehicle-controlled, parallel-group study assessing the efficacy and safety of CD5024 1 % cream versus vehicle cream in subjects with papulopustular rosacea, followed by a 40-week investigator-blinded extension comparing the long-term safety of CD5024 1% cream versus azelaic acid 15 % gel. Galderma R&D Inc., 2011-Phase II Randomized double-blinded placebo controlled, multiple-dose regimen study to assess the rate of histological clearance and effect on molecular pathways as well as on biomarkers of 12 months secukinumab 300 mg s.c. treated patients with chronic plaque-type psoriasis, Novartis, 2011-A Phase 3, Multi-site, Open-label Study of the Long Term Safety and Tolerability of 2 Oral Doses of CP 690,550 in Subjects with Moderate to Severe Chronic Plaque Psoriasis, Pfizer, 2011-A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects with Moderate to Severe Acne Vulgaris, XOMA US LLC, 2011-Multicenter, randomized, double-blind, placebo-controlled, Phase 3 study of ATX-101 (sodium deoxycholate injection) versus placebo for the reduction of localized subcutaneous fat in the submental area, Kythera Biopharmaceuticals, Inc., 2011-A randomized, double-blind, multicenter study of subcutaneous secukinumab, assessing Psoriasis Area and Severity Index (PASI) response and maintenance of response in subjects with moderate to severe chronic plaque-type psoriasis on either a fixed dose regimen or on a retreatment at start of relapse regimen, Novartis, 2011-An Open-Label Study to Determine the Safety, Tolerability, and Pharmacokinetic Profile of AN2728 Ointment in Adolescents with Atopic Dermatitis, Anacor Pharmaceuticlas Inc., 2012-A randomized, multi-center, Investigator-blind, vehicle- and active-controlled, phase 2 study to assess the efficacy and safety of different concentrations of CD5789 cream applied once daily in subjects with moderate to severe acne vulgaris, Galderma R&D Inc., 2012-A Phase 3 Study to Evaluate the Efficacy and Safety of Induction and Maintenance Regimens of Brodalumab Compared With Placebo and Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis: AMAGINE-3, Amgen Inc., 2012-A Double-Blind Randomized, Parallel-Group Vehicle-Controlled Multi-Center Study to Evaluate the Safety and Bioequivalence of a Generic Calcipotriene Cream, 0.005% and Reference Listed Dovonex@ (Calcipotriene) Cream, 0.005% and Compare Both Active Treatments to a Vehicle Control in the Treatment of Plaque Psoriasis, Glenmark Generics, 2012-A Multi-Center, Double-Blind, Randomized, Vehicle-Controllede, Parallel-Group Study to Compare Perrigo Israel Pharmaceuticals, LTD. Clindamycin Phosphate and Benzol Peroxide Topical Gel 1.2%/2.5% to Acanya@ Topical Gel (Clindamycin Phosphate and Benzol Peroxide Gel 1.2%/2.5%) and Both Active Treatments to a Vehicle Control in the Treatment of Acne Vulgaris, Perrigo Pharmaceuticals, 2012-A 12-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of LY2439821 to Etanercept and Placebo in Patients with Moderate to Severe Plaque Psoriasis with a Long-Term Extension Period, Eli Lilly and Company, 2012-Oxymetazoline HCl Cream for the Treatment of Erythema Associated with Rosacea, Allergan North America, 2012-Multicenter, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing Taro Pharmaceuticals Inc.’s Clindamycin Phosphate and Benzoyl Peroxide Gel,1.2%/2.5% to the Reference Listed Acanya® (Clindamycin Phosphate and Benzoyl Peroxide) Gel, 1.2%/2.5%, and Both Active Treatments to a Vehicle Control in the Treatment of Acne Vulgaris, Taro Pharmaceuticals U.S.A., Inc., 2012-A Multiple-Dose (0.3%, 1%, and 3% [w/w]), Randomized, Blinded, Vehicle- and Active Comparator- Controlled, Sequential Dose Cohorts, Multi-Center Trial to Assess the Safety, Pharmacokinetics, and Proof-of-Concept Efficacy of Topical OPA-15406 Ointment, Applied Twice Daily for 28 days, in Adult Subjects With Atopic Dermatitis, Otsuka Pharmaceuticals, 2012-A multicenter, double-blind, randomized withdrawal extension study of subcutaneous secukinumab in prefilled syringes to demonstrate long-term efficacy, safety and tolerability up to 2 years in subjects with moderate to severe chronic plaque-type psoriasis completing preceding psoriasis phase III studies with secukinumab, Novartis, 2012-A multicenter, double-blind and open label, 2 year extension study of subcutaneous secukinumab in prefilled syringes, assessing long-term safety, tolerability and efficacy in subjects with moderate to



severe chronic plaque-type psoriasis treated with either a fixed dose regimen or on a retreatment at start of relapse regimen, Novartis, 2012-A Multicenter, Randomized, Double-Blind, Four-Week, Bilateral Study of the Safety and Efficacy of Two Concentrations of AN2728 Ointment Administered Once or Twice a Day in Adolescents with Atopic Dermatitis, Anacor Pharmaceuticals Inc., 2012-A randomized, double-blind, vehicle-controlled, multicenter, parallel-group clinical trial to assess the safety and efficacy of Azelaic Acid Foam, 15% topically applied twice daily for 12 weeks in patients with papulopustular rosacea, Intendis GmbH, Max-Dohrn-Str. 10, D-10589 Berlin, 2012-A 64-Week, Phase 3, Randomized, Placebo-Controlled, Parallel Design Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Subjects With Moderate-to-Severe Chronic Plaque Psoriasis, Merck Sharpe & Dohme Corp., 2012-Bimatoprost for the Treatment of Eyebrow Hypotrichosis, Allergan North America, 2012-A Randomized, Double-Blind, Placebo-Controlled, Parallel Design Multiple Site Clinical Study Comparing Naftifine HCI Cream 1% (Taro Pharmaceuticals, Inc) to Naftin@ (Naftifine HCI) Cream, 1% (Merz Pharmaceuticals) in the Treatment of Tinea Pedis, Taro Pharmaceuticals, 2012-A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study to Compare Perrigo Israel Pharmaceuticals, Ltd. Clindamycin Phosphate and Benzol Peroxide Topical Gel 1.2%/2.5% to Acanya@ Topical Gel (Clindamycin Phosphate and Benzol Peroxide Gel 1.2%/2.5%), and Both Active Treatments to a Vehicle Control in the Treatment of Acne Vulgaris, Perrigo Pharmaceuticals, 2012-A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Imiquimod Cream, 3.75% Generic to Reference Listed Drug in the Treatment of Actinic Keratosis of the Face or Balding Scalp, Tolmar, 2012-A Double-Blind, Randomized, Parallel-group, Vehicle-controlled, Multicenter Study Comparing Adapalene, 0.1% and Benzol Peroxide, 2.5% Gel Generic to Reference Listed Drug in the Treatment of Acne Vulgaris, Tolmar, 2012-A Randomized, Double-Blind, Placebo-Controlled, Parallel Design, Multiple-Site, Clinical Study Comparing Naftifine HCI Cream 1% (Taro Pharmaceuticals Inc.) to Naftin@ (Naftifine HCI) Cream, 1% (Merz Pharmaceuticals) in the Treatment of Tinea Pedis, Taro Pharmaceuticals, 2012- A Randomized, Double-Blind, Multiple-Site, Placebo-Controlled Parallel Design Study Comparing Diclofenac Sodium Gel 3% (Taro Pharmaceuticals, Inc.) to Solaraze@ (Diclofenac sodium) Gel 3% (Fougera Pharms) in the treatment of Actinic Keratosis, Taro Pharmaceuticals, 2012- A Randomized, Double-Blind, Multiple-Site, Placebo-Controlled, Parallel Design Study Comparing Clindamycin 1%/Benzol Peroxide 5% Topical Gel (Taro Pharmaceuticals, Inc.) to Duac@ Topical Gel (Clindamycin 1%/Benzol Peroxide 5%) (Stiefel) in the Treatment of Acne Vulgaris, Taro Pharmaceuticals, 2012- A Parallel-Group, Vehicle-Controlled, Randomized, Double-Blind Study of the Efficacy and Safety of Product 49778 and Product 10156 in Subjects with Seborrheic Dermatitis, Medicis, 2012- A Double-Blind, Randomized Study to Determine the Substantial Equivalence of Microcyn Scar Management HydoGel, K103161 vs Kelo-cote Scar Gel for the Management of the Hypertrophic or Keloid Scars, Oculus, 2012- A pilot practical use evaluation of a novel bio-enriched polymar gel to safely improve treatment outcomes in atopic eczema patients, Silipos, 2012- A Multi-center Split Face Evaluation of a Novel Pigment Lightening Agent as Compared to 4% Hydroquinone Study #1, Syneron, 2012- A Multi-center Split Face Evaluation of a Novel Pigment Lightening Agent as Compared to 4% Hydroquinone Study #2, Syneron, 2012- Evaluation of a Novel Shampoo in the Improvement of Dandruff, Reckitt Benckiser, 2012- A Parity Evaluation of Two Wounding Healing Gels, Kimberly-Clark, 2012- Determination of Anceiform Follicular Irritant Contact Dermatitis Potential After Use of a Facial Cleanser, KAO Corporation, 2012- Curel Intensive Healing Cream Safety-In-Use Study, KAO Corporation, 2012- A Multi-Center, Double-Blind Clinical Trial to Evaluate the Safety and Efficacy of Two Acne Creams in Subjects with Mild to Moderate Acne Vulgaris, L’Oreal, 2012- Effectiveness and Tolerance of a Facial Regimen, Precision Dermatology, 2012



- A Multi-Center Twelve Week Clinical Trial to Assess the Tolerance and Efficacy of Three Acne Regimens on Males and Females with Mild to Moderate Acne Vulgaris, Precision Dermatology, 2012- Effect of Laura 9 on Human Skin, Makucell, 2012- Short-term Effect of a Cream Containing A Symmtate to Mitigate Facial Fine Lines and Wrinkles, Makucell, 2012-The Ability of Several Sonicating Facial Cleansing Devices to Produce Sebum Plug Removal, Pacific Biosciences, 2012-A Clinical Demonstration of a Novel Roller Device in an Anti-Aging Regimen, Rodan & Fields, 2012-Impact of Exfoliation Tool on Benefits of Anti-Aging Skin Care Regimen, Rodan & Fields, 2012-Impact of Exfoliation Tool on Skin Texture, Rodan & Fields, 2012-Tolerance of Liquid Cleansers on Clinical Sensitive Skin, Neutrogena, 2012-Acnegenicity Testing of Tru Face Essencee Ultra, NuSkin, 2012-An Evaluation of Vehicle Effects on Skin Feel, Texture, and Ease of Application, Medicis, 2012-A Clinical Assessment Of a Novel Weekly Skin Care Regimen, Grayson, 2012-Moisturizer Cream Use Study in Infants with Atopic Dermatitis or Eczema, KAO USA, Inc, 2012-Clinical Evaluation Comparing the Skin Lightening Benefits of a Lotion to a Combination Prescription Treatment. L’Oreal USA, 2012-A Multicenter, Double-Blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Taro Pharmaceuticals Inc.’s Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/2.5% to the Reference Listed Acanya® (Clindamycin Phosphate and Benzoyl Peroxide) Gel, 1.2%/2.5%, and Both Active Treatments to a Vehicle Control on the Treatment of Acne Vulgaris, Taro Pharmaceuticals, U.S.A. Inc., 2012-A Double-blind, Randomized, Parallel-group, Vehicle-controlled, Multi-center Study Comparing Clindamycin Phosphate and Benzoyl Peroxide Gel 1.2%/2.5% Generic to Reference Listed Drug in the Treatment of Acne Vulgaris, TOLMAR Inc., 2012- A randomized, double-blind, placebo-controlled, multicenter study to demonstrate the efficacy at 16 weeks of secukinumab 150 and 300 mg s.c. and to assess safety, tolerability, and long term efficacy up to 80 weeks with subjects with moderate to severe palmoplantar psoriasis, Novartis, 2012 - A randomized, double-blind, placebo-controlled, multicenter study to demonstrate the efficacy at 16 weeks of secukinumab 150 and 300 mg s.c. and to assess safety, tolerability, and long term efficacy up to 80 weeks with subjects with moderate to severe nail psoriasis, Novartis, 2012 - The Effects of Topical Azelaic Acid Gel 15% in Barrier Restoration, Bayer, 2012- A Phase 2b, Multi-Site, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of the Efficacy, Safety, Local Tolerability, and Pharmacokinetics of 2 Dose Strengths and 2 Regimens of Tofacitinib Ointment in Subjects with Chronic Plaque Psoriasis, Pfizer, 2012- A Parity Evaluation of Two Wounding Healing Gels, Kimberly Clark, 2012- A 64-Week, Phase 3, Randomized, Placebo-Controlled, Parallel Design Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Subjects With Moderate-to-Severe Chronic Plaque Psoriasis, Merck, 2012- A Double-Blind, Randomized, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing TOLMAR Azelaic Acid Gel, 15% to Reference Listed Drug in the Treatment of Rosacea, TOLMAR, 2012- A randomized, double-blind, vehicle-controlled, multicenter, parallel-group clinical trial to assess the safety and efficacy of Azelaic Acid Foam, 15% topically applied twice daily for 12 weeks in patients with papulopustular rosacea, Bayer, 2012- A Multi-Center Evaluation to Assess the impact of the combined treatment of Sublative RF and a Novel Pigment Lightening Agent (eLure™) for Treatment of Facial Post Inflammatory Hyperpigmentation (PIH) and Melasma, Syneron Medical Ltd., 2012- Oxymetazoline HCl Cream for the Treatment of Erythema Associated with Rosacea, Allergan, 2013- Evaluation of the Tolerance and Skin Improvement Properties of a Moisturizing Cream in Subjects with Eczema, Chattem, 2013- A 14 Day Multi-center Study to Evaluate the Efficacy of a Bar Soap in Male and Female Subjects 13 to 30 Years of Age with Facial Acne, Henkel Consumer Products, 2013- A 14 Day Single-center Study to Evaluate The Efficacy of a Body Wash In Male and Female Subjects 16 to 48 Years of Age with Body Acne, Henkel Consumer Products, 2013- An Evaluation of Certain Dri and Secret Clinical Antiperspirants in Sweat Reduction, DSE Healthcare, 2013



- A 7 Day Single-center Study to Evaluate the Efficacy of a Facial Bar Soap in Male and Female Subjects 13 to 48 Yeas of Age with Acne, Henkel Consumer Products, 2013- A 10 Day Single-center Study to Evaluate the Efficacy of a Body Wash in Male and Female Subjects 13 to 48 Years of Age with Facial and Body Acne, Henkel Consumer Products, 2013- Human Repeat Insult Patch Testing for a Novel Cosmetic Ingredient, Carolinas Medical Center, 2013- A Phase IV Open Label Evaluation of the No-Rub Moisturizing Properties of Kenalog Spray, Ranbaxy, 2013- Evaluation of a Regimen for Scalp Itch Reduction and Hair Beautification, Scalp Therapeutics, 2013- Focus Group for Strateris Study, Living Proof, 2013- Strateris 16 Hour Durability Study, Living Proof, 2013- Pre-Comercialization Strateris Study, Living Proof, 2013- A Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Evaluation of Twice Daily PDI-192 0.1% in Comparison to PDI-192 0.15% in the Treatment of Mild to Moderate Atopic Dermatitis in Subjects 3 Months to 18 Years of Age, Precision Dermatology, 2013- A Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Comparison Study to Determine the Therapeutic Equivalence of Generic Imiquimod Cream, 2.5% and Zyclara (Imiquimod) Cream, 2.5% in Subjects with Actinic Keratosis, Actavis Elizabeth LLC, 2013- A Randomized, Double-Blind, Vehicle-Controlled, Multicenter, Parallel Group Study of the Safety of Betamethasone Dipropionate Spray 0.05% versus Diprolene® (augmented betamethasone dipropionate) Lotion 0.05% and the Efficacy of Betamethasone Dipropionate Spray 0.05% versus Vehicle Spray in the Treatment of Moderate Plaque Psoriasis, Promius Pharmaceuticals, 2013- Safety and Efficacy of Bimatoprost Solution Versus Vehicle in Men with Androgenic Alopecia, Allergan, 2013- The Effect of Two Skin Peel Regimens on Skin Appearance, Theraplex, 2013- Histologic Evaluation of Skin Exposed ONE, California Stem Cell, Inc., 2013- Dose Finding Study of BoNT/A In Subject's With Crow's Feet (Lateral Canthal Lines), Anterios, Inc, 2013- An Open-Label, Maximal Use, Systemic Use Study to Access the Safety and Pharmacokinetic Profile of AN2728 Topical Ointment, 2% in children and Adolescents with Atopic Dermatitis, Anacor Pharmaceuticals, Inc., 2013- A Phase 11a, Randomized, Double-Blind, Placebo-controlled, Multicenter, to Assess the Safety Tolerability, and Preliminary Efficacy of MED18968 in Subjects with Moderate to Severe Hidradenitis Suppurativa, AstraZeneca, 2013- A Safety and Efficacy Study to Compare Dapsone Dermal Gel With Vehicle Control in Patients with Acne Vulgaris, Allergan (North America), 2013- A Randomized, Vehicle-Controlled, Double-Blind, Parallel Group, Multi-Center Phase III Study to Evaluate the Safety and Efficacy of M518101 in Subject's with Plaque Psoriasis, Maruho, North America Inc., 2013- A Phase II, Randomized, Double-Blind, Parallel-Group, Placebo Controlled, Dose Finding, and Efficacy Study of VPD-737 in the Treatment of Subject's with Chronic Pruritis, Tigercat Pharma, Inc., 2013- Dose Finding Study of BoNT/A In Subjects With Crow’s Feet (Lateral Canthal Lines), Anterios, 2013- Cleansing Efficacy with Five Prototype Devices, NuSKin, 2013- A Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of An Anticholinergic Agent for the Treatment of Primary Axillary Hyperhidrosis, Watson, 2013- Bimatoprost for the Treatment of Eyebrow Hypotrichosis, Allergan, 2013- Five-Day Clinical Study to Examine the Effects of a Benzoyl Peroxide Treatment of Facial Acne Lesions, Stiefel, a GSK Company, 2013- A Randomized, Double-Blind, Multiple-Site, Placebo-Controlled, Parallel Design Study Comparing Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% (Glenmark Generics) to EPIDUO® Topical Gel Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% (Galderma) in the Treatment of Acne Vulgaris, Glenmark Generics Limited, 2013- A Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study of the Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitis, Anacor Pharmaceuticals, Inc., 2013- A Demonstration of the Biphasic Release Characteristics of Halog, Ranbaxy, 2013



- A Phase 2B, Multi-Site, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of the Efficacy, Safety, Local Tolerability and Pharmacokinetics of 2 Dose Strengths and 2 Regimens of Tofacitinib Ointment in Subjects With Chronic Plaque Psoriasis, Pfizer, 2013-The Tolerability and Efficacy of a Three Product Acne Treatment Regimen in Subjects with Moderate to Severe Acne-prone Skin, US CosmeceuTechs, LLC, 2014-The Tolerability and Efficacy of a Professional Hydration Treatment combined with a Three Product Home Care Hydration Regimen in Subjects with Moderate to Severe Dry Skin, US CosmeceuTechs, LLC, 2014-The Tolerability and Efficacy of a Three Product Depigmentation Treatment Regimen in Subjects with Moderate to Severe Skin Pigmentation, US CosmeceuTechs, LLC, 2014- An Evaluation of the Efficacy of a Novel Pillow on Sleep Induced Facial Wrinkles, JuveRest LLC, 2014-Epsilon Anti-Aging Clinical Study, NuSkin, 2014- An Evaluation of the Efficacy of a Dermatologist Tested Skin Care Regimen in the Improvement of Dry, Self Perceived Sensitive Skin, Palmer’s, ET Browne Company, 2014- A Demonstration of the Biphasic Release Characteristics of Halog, Ranbaxy,2014- Clinical Study to Evaluate the Efficacy and Tolerability of Two Anti-Acne Treatments, TPG (The Partnering Group), 2014-The Duration of Benefit of a Novel Hydration Patch, Rodan & Fields, 2014- A multi-center, randomized, double-blind, vehicle controlled, parallel group comparison study to determine the therapeutic equivalence of generic Imiquimod cream, 2.5% and Zyclara (Imiquimod) cream 2.5% in subjects with actinic keratoses, Actavis, 2014- A multi-center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis, Amderma, 2014- A multi-center, randomized, double-blind, vehicle-controlled, parallel group evaluation of twice daily PDI-192 0.1% in comparison to PDI-192 0.15% in the treatment of mild to moderate atopic dermatitis in subjects 3 months to less than 18 years of age, Precision Dermatology, 2014- A Randomized, Double-Blind, Vehicle-Controlled, Multi-center, Parallel Group Study of the Safety of Betamethasone Dipropionate Spray 0.05% versus Diprolene® (augmented betamethasone dipropionate) Lotion 0.05% and the Efficacy of Betamethasone Dipropionate Spray 0.05% versus Vehicle Spray in the Treatment of Moderate Plaque Psoriasis, Promius Pharmaceuticals, 2014- A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle-Controlled Clinical Study to Assess the Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis, Dow Pharmaceutical Sciences, 2014- A Randomized, Parallel, Open Label, Multicenter Study to Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing with Betamethasone Dipropionate Spray 0.05% versus Diprolene® (augmented betamethasone dipropionate) Lotion 0.05% in Subjects with Moderate to Severe Plaque Psoriasis, Promius Pharmaceuticals, 2014- Exaggerated Hand Wash Study of Foaming Hand Soap in a Pediatric Population, Henkel Consumer Goods, Inc., 2014- A Randomized Double Blind, Study Evaluating the Reduction in Erythema by Mirvaso® (brimonidine) Topical Gel 0.33% (Galderma) and Placebo Topical Gel in Patients with Moderate to Severe Facial Erythema of Rosacea, Watson Laboratories Inc., 2014- An Evaluation of the Efficacy of TrueLipids Ointment versus Aquaphor in the Improvement of Mild Eczema and Atopic Dermatitis, Cheryl Lee Eberting, 2014- 21-Day Cumulative Irritation Patch Test in Diabetic Subjects Followed by a Challenge Phase, Chattem, 2014- A Phase 2 , Randomized, Vehicle-Controlled, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Three Once-Daily CLS001 Topical Gels Versus Vehicle Administered for 12 Weeks to Subjects with Acne Vulgaris, Cutanea Life Sciences, Inc., 2014- A 7 Day Single-Center Study to Evaluate the Efficacy of a Facial Scrub in Male and Female Subjects 13 to 48 Years of Age With Facial Acne, Henkle Consumer Goods, Inc., 2014- An Evaluation of the Photoprotective Benefits of a Novel Photostable Antioxidant, Hallstar, 2014- A Double-Blind, Randomized, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing a Generic Tazarotene Cream, 0.1% to Reference Listed Drug Tazorac® (Tazarotene) Cream, 0.1% and Both Active Treatments to a Vehicle Control in the Treatment of Acne Vulgaris, G&W Laboratories, Inc., 2014- A Double-Blind, Randomized, Parallel-Group, Vehicle-Controlled, Multi-Center Study Comparing a Generic Tazarotene Cream, 0.05% to Reference Listed Drug Tazorac® (Tazarotene) Cream, 0.05% and Both Active Treatments to a Vehicle Control in the Treatment of Plaque Psoriasis, G&W Laboratories, Inc., 2014- A Randomized, Split-Body, Bilateral, Double-Blinded Study Evaluating the Efficacy and Tolerability of Two Products



on Subjects with Atopic Skin/Eczema, L’Oreal Research and Innovation, 2014- A Phase 2 Multi-center, Randomized, Doubleblind, Vehicle-controlled, Three-arm, Parallel Group Study to Assess the Safety, Tolerability, and Efficacy of Topical OPA-15406 Ointment, in Subjects With Mild/Moderate Atopic Dermatitis, Otsuka Pharmaceutical Development & Commercialization, Inc., 2014- A Randomized,Investigator-Blind, Multicenter Study to Compare the Efficacy and Tolerability of Once Daily, Monotherapy with Efudex®(fluorouracil) Topical Cream 5% versus Its Use in Combination with Three Topical Corticosteroid Products in Subjects with Scalp and/or Facial Actinic Keratosis, Promius Pharma, LLC., 2014- A Randomized, Parallel Group, Open Label, Multicenter Study to Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing with DFD06 Cream versus Temovate® Cream (clobetasol propionate 0.05%) in Subjects with Moderate to Severe Plaque Psoriasis, Promius Pharma, LLC., 2014- An Evaluation of the Efficacy of a Novel Topically Applied Advanced Hydration and Repair Treatment in the Improvement of Mild to Moderate Eczema. TPG (The Partnering Group), 2014- A Phase 2, Randomized, Double-Blind, Multicenter, Parallel-Group, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dose Levels of XP23829 in Subjects with Moderate-to-Severe Chronic Plaque-Type Psoriasis, XenoPort, 2014- Comedogenicity and Hypoallergenicity Evaluation of Theraplex Moisturizers, Theraplex, 2014- A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study, Comparing Tazarotene Cream 0.05% (Taro Pharmaceauticals, Inc.) to Tazorac® (Allergan, LLC, Tazarotene Cream 0.05%) and Both Active Treatments to a Placebo Control in the Treatment of Plaque Psoriasis, TARO Pharmaceuticals U.S.A., Inc., 2014- A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study, Comparing Adapalene Gel 0.3% (TARO Pharmaceuticals, Inc.) To Differin® (Galderma Laboratories, LP US, Adapalene Gel 0.3%) and Both Active Treatments to a Placebo Control in the Treatment of Acne Vulgaris, Taro Pharmaceuticals USA, Inc., 2014- A Long–term Safety and Efficacy Study of Oxymetazoline HCl Cream 1.0% in Patients with Persistent Erythema Associated with Rosacea, Allergan, 2014- A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design Study to Evaluate the Safety and Therapeutic Equivalence of Brimonidone Topical Gel. 0.33% (Watson Laboratories, Inc., USA) to reference Product Mirvaso®

(brimonidine) topical gel, 0.33% (Gladerma Laboratories, L.P., USA) in Patients with Moderate to Severe Facial Erythema Associated with Rosacea, Watson Laboratories Inc., 2014- Efficacy and Safety of Oxymetazoline HCl Cream 1.0% for the Treatment of Persistent Erythema Associated with Rosacea, Allergan, 2014- A Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Comparison Study To Determine The Therapeutic Equivalence Of A Generic Ingenol Mebutate Gel, 0.05% And Picato Gel, 0.05% In Subjects With Actinic Keratosis On The Trunk Or Extremities, Actavis, 2014 - Dermatological and Histological Evaluation of Skin Exposed to NBS-30, NBS-31, NBS-32, NBS-33 and NBS-34, NeoStem 2014- A Randomized, Double-Blind, Multiple-Center, Placebo-Controlled Study Comparing Clindamycin and Benzoyl Peroxide Gel 1%/5% (Taro Pharmaceuticals, INC) to Benzaclin (Clindamycin 1%/ Benzoyl Peroxide 5%) Topical Gel (Sanofi Acentis, U.S.) In The Treatment Of Acne Vulgaris, Taro Pharmaceuticals, 2014-A Randomized, Double-Blind, Vehicle-Controlled, Multicenter, Parallel Group Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate Plaque Psoriasis for 14 Days, Promius Pharma, LLC, 2014

-A Phase 2 Multi-center, Randomized, Doubleblind, Vehicle-controlled, Four-arm, Parallel Group Study to Assess the Safety, Tolerability, and Efficacy of Topical OPA-15406 Ointment, in Subjects With Mild/Moderate Atopic Dermatitis, Otsuka, 2014

-A Double-blind, Randomized, Parallel-group, Vehicle-controlled, Multicenter Study Comparing TOLMAR Calcipotriene Ointment, 0.005% to Reference Listed Drug in the Treatment of Plaque Psoriasis, Tolmar, 2014

- A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety and Efficacy of PF-04965842 in Subjetcs With Moderate to Severe Psoriasis, Pfizer, 2014- A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study, Comparing Tazarotene Cream 0.05% (Taro Pharmaceuticlas, Inc.) to Tazorac® (Allergan, LLC, Tazarotene Cream 0.05%) and Both Active Treatments to A Placebo Control in the Treatment of Plaque Psoriasis, Taro Pharmaceuticals U.S.A., Inc., 2014- A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study to Compare Perrigo UK FINCO Ingenol Mebutate Topical Gel 0.015% to Leo Pharma Inc. Picato® Topical Gel 0.015% (Ingenol Mebutate Topical Gel 0.015%), and Both Active Treatments to a Vehicle Control in the Treatment of Actinic Keratosis on the Head Region (Face orScalp), Perrigo, 2015



- A Multicenter, Randomized, Double-Blind, Parallel Group Complarison of Halobetasol Propionate Foam 0.05% Versus Vehicle Foam in Subjects With Plaque Psoriasis, Therapeutics, 2015-A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle-Controlled Clinical Study to Assess the Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis.

Dow Pharmaceutical Sciences, 2015 - A Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Comparison Study To Determine The Therapeutic Equivalence of Generic Fluorouracil Cream, 0.5% And Carac® (Fluorouracil) Cream, 0.5% in Subjects With Actinic Keratoses, Watson Laboratories, 2015

- A multi-center, open label, multiple dose, phase II trial to demonstrate the safety of DWP-450 in adult subjects for treatment of moderate-to-severe glabellar lines, Evolus, 2015

- A Multi-Center, Double-Blind, Randomized, Placebo Controlled, Parallel-Group Study Comparing Adapalene and Benzoyl Peroxide Gel, 0.3%/205% (Taro Pharmaceuticals U.S.A., Inc.) To Epiduo® Forte (Adapalene and Benzoyl Peroxide) Gel, 0.3%/2.5%, (Gladerma Laboratories, L.P.) and Both Active Treatments To A Placebo Control In The Treatment Of Acne Vulgaris, Taro Pharmaceuticals, 2015

- A Phase 2, Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Multicenter Study to Evaluate the Safety and Efficacy of CLS001 Topical Gel versus Vehicle Applied Once Daily for 12 Weeks to Female Subjects with Moderate to Severe Acne Vulgaris, Cutanea Life Sciences, 2015

- A Long-Term Safety And Efficacy Study Of CD5789 50g/g Cream In Subjects With Acne Vulgaris, Galderma, 2015 - A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Site Study To Evaluate the Therapeutic Equivalence of a Generic Tacrolimus Ointment, 0.1% (Glenmark Pharmaceuticals, Ltd)to the Marketed Product Protopic (tacrolimus) ointment 0.1% (Astellas Pharma US, Inc.) in the Treatment of Moderate to Severe Atopic Dermatitis, Glenmark, 2015- A Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging, Multiple-Site, Phase II Clinical Study to Evaluate the Efficacy and Safety of Desoximetasone 0.25% Shampoo in Patients with Moderate to Severe Scalp Psoriasis, Taro, 2015- A Multi-Center,Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study to Compare Perrigo New York, Inc.'s Ingenol MebutateTopical Gel 0.05% to Leo Pharma Inc. Picato Topical Gel 0.05% (Ingenol Mebutate Topical Gel 0.05%), and Both Active Treatments to a Vehicle Control in the Treatment of Actinic Keratosis on the Trunk and Extremities, Perrigo, 2015- A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing Metronidazole Gel 1% to Metrogel (Metronidazole Gel) 1% In The Treatment Of Rosacea, SeegPharm, 2015- A Randomized, Double-Blind, Multiple-Site, Placebo-Controlled, Parallel-Design, Clinical Study to Evaluate the Therapeutic Equivalence of Imiquimod Cream 5% (Taro Pharmaceuticals, U.S.A., Inc.) to Aldara 5% Cream (Meda AB, Sweden) in Patients with Actinic Keratosis, Taro, 2015- A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Efficacy and Safety of Desoximetasone Topical Spray, 0.15% (Taro Pharmaceuticals, U.S.A.,Inc.) in Patients with Mild to Moderate Plaque Psoriasis, Taro, 2015- A Multi-Center, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled Bioequivalence Study to Evaluate the Bioequivalence of A Generic of Clindamcin 1.2% and Benzoyl Peroxide 3.75% Gel of Actavis Laboratory UT, LTD.and the Reference Listed Onexton® (Clindamycin 1.2% and Benzoyl Peroxide 3.75%) Gel of Valeant Pharmaceuticals North America LLC, In Treatment of Subjects With Acne Vulgaris, Actavis Laboratories UT, Inc., 2015- A Phase 4, Multicenter, Randomnized, Placebo-Controlled, Double-Blind, Study of the Efficacy and Safety of Apremilast (CC-10004), in Subjects With Moderate Plaque Psoriasis, Celgene Corporation, 2015- A multi-center, open label, multiple dose, phase II trial to demonstrate the safety of DWP-450 in adult subjects for treatment of moderate-to-severe glabellar lines, Evolus, Inc., 2015- An Examination of the Effect of Cleansing on Skin Health, Boots, 2015- A Comparison of OTC Topical Agents in Eczema and Atopic Dermatitis Improvement, Burts Bees, 2015- The Effect of Nitrate Esters on the Appearance of Aging Skin, Carolina's Medical Center, 2015- Assessment of Cutaneous Irritation Involving 7 Different Topical Agents: Kenalog Spray, Luxiq Foam, Clobex Spray, Triamcinolone 0.1% Cream, Cetaphil Lotion, Petrolatum, and Benzyl Alcohol 5% Lotion, Ranbaxy, 2015- Nu Skin’s Nutritional Supplement Efficacy on Cellular Protection and Skin Health in Generally Healthy Adults, NuSkin, 2015- A Demonstration of the Cutaneous Penetration of a Novel Hyaluronic Acid Serum, Nuvesse, 2015- A Pilot Study to Determine the Pruritus Reducing Ability of a HydroGel versus Cortisone 10 Anti-Itch Cream in Adult Subjects, Oculus, 2015



- A Phase 2, Randomized, Double-Blind, Vehicle-Controlled, Dose Ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris, Demira Cu-Tech 2015- Anti-Aging Clinical Research Study with Epsilon and Nu Skin Facial Spa, Nuskin 2015- A Clinical Demonstration of a Novel Anti-Aging Serum, Reginica, 2015- A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study to Compare Perrigo UK FINCO’s Brimonidine Topical Gel 0.33% to Mirvaso® (Brimonidine) Topical Gel 0.33%, and Both Active Treatments to a Vehicle Control in the Treatment of Persistent (nontransient) Facial Erythema of Rosacea, Perrigo, Symbio 2015- Epsilon Duo Production Prototypes Assessment, Nuskin 2015- The Effect of a Recombinant EGF Cosmetic Serum Compared to a Fibroblast Conditioned Media Serum on the Appearance of Aging Skin, Alpheaon, 2015- Efficacy Demonstration of a Facial Peptide Based Regimen on the Appearance of Aging Skin, Revision, 2015- Epsilon Sensitive Skin Tolerance Study: Interlinks, NuSkin, 2015- Epsilon Formative Usability Study, NuSkin, 2015- A Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Comparison Sutdy to Determine the Therapeutic Equivalence of a Generic Ingenol Mebutate Gel, 0.05% and Picato Gel, 0.05% in Subjects with Actinic Keratosis on the Trunk or Extremities, Actavis Mid Atlantic, 2015-A Randomized, Parallel Group, Open Label, Multicenter Study to Assess the Potential for Adrenal Suppression and Systemicdrug Absorption Following Multiple Dosing with DFD06 Cream versus Temovate® Cream (clobetasol propionate 0.05%) in Subjects with Moderate to Severe Plaque Psoriasis, Promius Pharma, 2015

-The Tolerability and Efficacy of a Novel Acne Regimen, Herbalife, 2015-The Ability of Several Sonicating Facial Cleansing Devices to Produce Sebum Plug Removal for Acne Treatment, Pacific Bioscience Laboratories, 2015

-An Open Label, Safety Study to Assess the Potential for Adrenal Suppression Following Maximal Use Treatment with Desoximetasone 015% Topical Spray (Taro Pharmaceuticals U.S.A., Inc.) in Patients with Atopic Dermatitis, Taro, 2015

-A Double-blind, Randomized, Parallel-group, Vehicle-controlled, Multicenter Study Comparing TOLMAR Calcipotriene Ointment, 0.005% to Reference Listed Drug in the Treatment of Plaque Psoriasis, TOLMAR Inc., 2015

-A Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Dose Ranging study to Determine the Efficacy of Topically AppliedMTC896 Gel in Subjects with Acne Vulgaris, Mimetica Pty Limited, 2015

-A Randomized, Double-Blind, Vehicle-Controlled, Multicenter, Parallel Group study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis for 14 Days, Promius Pharma, 2015

-A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study to compare Perrigo UK FINCO Clindamycin Phosphate and Benzoyl Peroxide Topical Gel 1.2%/3.75% to Valeant Pharmaceuticals North America, LLC Onexton™ topical Gel (Clindamycin Phosphate and Benzoyl Peroxide Gel 1.2%/3.75%), and Both Active Treatments to a Vehicle Control in the Treatment of Acne Vulgaris, Perrigo, 2015

-A Double-Blind, Randomized, Paralled-Group, Vehicle-Controlled, Multicenter study to Evaluate the Safety and Bioequivalence of a Generic Pimecrolimus Cream, 1% and Reference Listed Elidel® (Pimecrolimus Cream, 1%) and Compare Both Active Treatments to a Vehicle Control in the Treatment of Mild to Moderate Atopic Dermatitis, Watson Laboratories, 2015

-A Phase 3, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis, Dow Pharmaceutical Sciences, 2015

-A Randomized, Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of 1.5mg/kg per Dayof Sarecycline Compared to Placebo in the Treatment of Acne Vulgaris, Warner Chilcott, 2015


-An Evaluation of a Ceramide PC-104 Based Cream in Sensitive Skin, Exeltis, 2016-A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence and Safety of Adapalene and Benzoyl Peroxide Gel, 0.3%/2.5% (Actavis Laboratories UT, Inc.) to Epiduo® Forte (adapalene and benzoyl peroxide) gel 0.3%/2.5% (Galderma) in the Treatment of Acne Vulgaris, Actavis Laboratories UT, 2016

-An Evaluation of the Benefits of a Wet Moisturizer in Subjects With Mild to Moderate Eczema / Atopic Dermatitis, Kao USA, 2016

-Micro-Comedone Follicular Biopsy, Boots, 2016-A Clinical demonstration of a Novel Anti-Aging serum, Suneva Medical, 2016-Forearm Control Application Test, Boots, 2016



-A Single Center Evaluation of the Ability of Tensage with Stem Cells to Improve the Visible Signs of Aging, 2016-Micro-Comedone Folliccular Biopsy 2, Boots, 2016-Forearm Control Application Test 2, Boots, 2016-A Randomized, Controlled Evaluation of the Safety and Efficacy of Topical Treatments for Moderate-Severe Facial Acne Vulgaris, Braintree Laboratories, 2016

-A Multi-Center, Double-Blind, Randomized, Placebo controlled, Parallel-Group Study, Comparing Clindamycin and Benzoyl Peroxide Gel 1%/5% (Taro Pharmaceuticals, Inc.) to PRBenzaclin® (Clindamycin, as Phosphate, 1% and Benzoyl Peroxide 5%) Topical Gel (Valeant Canada LP) and Both Active Treatments to a Placebo Control in the Treatment of Acne Vulgaris, Taro Pharmaceuticals U.S.A., 2016

- A Randomized, Prospective, Multicenter, Double Blind, Parallel Assignment, Placebo Controlled Bioequivalence Study of Pimecrolimus Cream, 1% and Elidel® (Pimecrolimus) Cream, 1% in Patients with Mild to Moderate Atopic Dermatitis, Renaissance Pharma, 2016

-A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of the Safety and Effectiveness of A-101 Solution 40% in Subjects with Seborrheic Keratosis on the Trunk, Extremeities and Face (Study 1), Aclaris Therapeutics, 2016

-A Phase 2, Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Study to Compare the Safety and Efficacy of IDP-123 Lotion to Tazorac® (tazarotene) Cream, 0.1%, in the Treatment of Acne Vulgaris, Dow Pharmaceuticals Sciences, 2016

-A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Tradipitant in Treatment-Resistant Puritus Associated with Atopic Dermatitis, Vanda Pharmaceuticals, 2016

-A Phase 2, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group, Clinical Study Comparing the Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris, Dow Pharmaceuticals Sciences, 2016

-A Multi-center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group study to Compare Perrigo UK FINCO’s Ivermectin Cream, 1% to Galderma Laboratories, Soolantra® Cream (Ivermectin Cream, 1%), and Both Active Treatments toa Vehicle Control in the Treatment of Inflammatory Lesions of Rosacea, Perrigo, 2016

-A Phase 3 Multi-Center, Randomized, Double-Blinded, Vehicle-Controlled, Parallel Group Study Comparing the Efficacy,, Tolerability and Safety of SB204 and Vehicle Gel Once Daily in the Treatment of Acne Vulgaris, Novan, 2016

-A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to AcZone® (Allergans’s Dapsone 5% Gel) and Both Active Treatments Compared to Placebo (Vehicle) inthe Treatment of acne Vulgaris, SEEGPharm, 2016

-A Multicenter, Double-Blind, Randomized, Parallel-group, Vehicle-Controlled Study to Evaluate the Safety and Clinical Equivalence of a Generic Azelaic Acid Foam, 15% in Patients with Moderate Facial Rosacea, Actavis, 2016

-A Double-Blind, Randomized, Parallel-Group, Vehicle-Controlled, Multicenter Study to Evaluate the Safety and Bioequivalence of Par Pharmaceutical Inc.’s Pimecrolimus Cream, 1% and Reference Listed Elidel® (Pimecrolimus Cream, 1%) and Compare Both Active Treatments to a Vehicle Control in the Treatment of Mild to Moderate Atopic Dermatitis, Par Pharmaceutical, 2016

-A Randomized, Double-Blind, Placebo-Controlled, Paralled-Desogn, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence and Safety of Ivermectin Cream 1% (Actavis Laboratories UT, Inc) to Soolantra™ (Ivermectin) Cream 1% (Galderma) in the Treatment of Moderate to Severe Papulopustular Rosacea, Actavis Laboratories UT, 2016

-A Multi-Center, Double-Blind, Randomized, Placebo Controlled, Parallel-Group Study, Comparing Dapsone Gel, 7.5% (Taro Pharmaceuticals U.S.A., Inc.) to Aczone® (Dapsone) Gel, 7.5%, (Allergan, Inc.) and Both Active Treatments to a Placebo Control in the Treatment of Acne Vulgaris, Taro Pharmaceuticals U.S.A., 2016

-A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks, Sol-Gel Technologies, 2016

-A Multi-Center, Double-Blind, Randomized, Placebo Controlled, Parallel-Group Study, Comparing Azelaic Acid Topical Gel 15% (Taro Pharmaceuticals U.S.A., Inc.) to Finacea® Gel (Bayer Healthcare) and Both Active Treatments to a Placebo Control in the Treatment of Moderate Facial Rosacea, Taro Pharmaceuticals U.S.A., 2016

-A Phase 2, Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study to Compare the Safety and Efficacy of IDP-122 Lotion with Ultravate® (halonetasol propionate) Cream, 0.05% in the Treatment of Plaque Psoriasis, Dow Pharmaceutical Sciences, 2016

-A Phase 3, Randomized, Vehicle-Controlled, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle Administered for 12 Weeks to subjects with Papulopustular Rosacea with a 4 Week Follow-up Period, Cutanea Life Sciences, 2016

-A Phase 3, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical study to Assess the Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis, Dow Pharmaceutical Sciences, 2016

-BI655066 (risankizumab) Versus Ustekinumab and Placebo Comparators in a Randomized Double Blind TrIal for Maintenance us in Moderate to Severe Plaque Type Psoriasis- 2 (UltIMMa-2), Boehringer Ingelheim Pharmaceuticals, 2016



- A Single Center Evaluation of the Ability of Tensage with Stem Cells to Improve the Visible Signs of Aging, Biopelle, 2016-A Clinical Demonstration of a Novel Anti-Aging Serum, Suneva Medical, 2016-Epsilon Clinical Study with A2 Models for Anti-Aging and Tolerance, NuSkin, 2016-An Evaluation of the Benefits of a Wet Moisturizer in Subjects with Mild to Moderate Eczema/Atopic Dermatitis, Kao USA, 2016

-An Evaluation a Ceramide PC-104 Based Cream in Sensitive Skin, Exeltis, 2016-A Phase 2, Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study of DRM01B Topical Gel in Subjects with Acne Vulgaris, Dermira, 2016

-Efficacy And Safety Of Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel Plus Doxycycline In Severe Inflammatory Acne (Non-Nodulocystic) Subjects, Galderma Laboratories, Lp, 2016

-A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Of En3835in The Treatment Of Edematous Fibrosclerotic Panniculopathy, Endo Pharmaceuticals Inc., 2016

-Phase 2 Study of RVT-501 in Adult and Adolescent Subjects with Atopic Dermatitis, Dermavant Sciences GmbH, 2016 -A Randomized, Double-Blind Study To Compare The Efficacy, Safety And Long-Term Safety Of Topical Administration Of Fmx-101 For 1 Year In The Treatment Of Moderate-To-Severe Acne Vulgaris, Study Fx2014-04, Foamix Pharmaceuticals, Inc., 2016

-A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study Of Gsk2894512 Cream For The Treatment Of Plaque Psoriasis, Glaxosmithkline, 2016

-A Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults And Adolescents With A History Of Atopic Dermatitis, Menlo Therapeutics Inc., 2016

-A 64-Week, Phase 3, Randomized, Placebo-Controlled, Parallel Design Study to Evaluate the Efficacy and Safety/Tolerabilityof Subcutaneous Tildrakizumab (SCH 900222/MK-3222), Followed by an Optional Long-Term Safety Extension Study, in Subjects With Moderate-to-Severe Chronic Plaque Psoriasis, Merck Sharp & Dohme Corp., 2016

-A 52-Week, Multicenter, Randomized, Double-Blind Study Of Secukinumab (300 Mg) To Demonstrate Efficacy As Assessed By Psoriasis Area And Severity Index And Investigator’s Global Assessment After 12 Weeks Of Treatment, Compared To Ustekinumab, And To Assess Longterm Safety, Tolerability, And Efficacy In Subjects With Moderate To Severe Plaque Psoriasis, Novartis, 2016

-A Phase 3, Randomized, Double-Blind, Placebo Controlled, Multi-Center Trial to Evaluate the Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar Lines (SAKURA 2), Revance Therapeutics, Inc., 2016

-A Randomized, Blinded, No-Treatment Control, Multicenter, Prospective Clinical Study of TEOSYAL® RHA Redensity for the Treatment of Moderate to Severe Perioral Rhytids, TEOXANE SA, 2016


-A Long-Term Safety And Efficacy Study Of Cd5789 50μg/G Cream In Subjects With Acne Vulgaris, Galderma, 2016-A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Site Study to Evaluate the Therapeutic Equivalence of a Generic Pimecrolimus Cream, 1% (Glenmark Pharmaceuticals Ltd) to the Marketed Product ELIDEL® (pimecrolimus) Cream, 1% (Valeant Pharmaceuticals North America LLC) in the Treatment of Mild to Moderate Atopic Dermatitis (AD), Glenmark Pharmaceuticals Ltd, 2016

-A Multi-Center, Double-Blind, Randomized, Placebo Controlled, Parallel-Group Study, Comparing Dapsone Gel, 7.5% (Taro Pharmaceuticals U.S.A., Inc.) To Aczone® (Dapsone) Gel, 7.5% (Allergan, Inc.) And Both Active Treatments to a Placebo Control in the Treatment of Acne Vulgaris, Taro Pharmaceuticals U.S.A., Inc., 2016

-A Demonstration of the Artificial Barrier Release Characteristics of Halcinonide 0.1% in Plastibase, Sun Dermatology, 2016-A Multicenter, Double-blind, Randomized, Parallel-group, Vehicle-Controlled Study to Evaluate the Safety and Clinical Equivalence of a Generic Azelaic Acid Foam, 15% and the Reference Listed Finacea® (Azelaic acid) Foam, 15% in Patientswith Moderate Facial Rosacea, Actavis, 2016

-A Phase 3, Randomized, Double-Blind, Vehicle-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of CLS006 versus Vehicle in Subjects 12 years of age or older with Cutaneous Common Warts, Cutanea Life Sciences, Inc., 2016

-A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel Group Study Comparing Tazarotene Cream 0.1% to Tazaroc® (Tazarotene) Cream 0.1% and Both Active Treatments to a Vehicle Control in the Treatment of Acne Vulgaris, Fougera Pharmaceuticals, Inc., 2016

-A Randomized, Placebo-Controlled, Double-Blind Study To Assess The Efficacy And Safety Of LYC-30937-EC In Subjects With Moderate Chronic Plaque-Type Psoriasis, Lycera Corp, 2016

-A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study to Compare Perrigo UK FINCO’s Azelaic Acid Foam, 15%, to Bayer Healthcare Pharmaceutical Inc.’s, FINACEA ® (AZELAIC ACID) FOAM, 15%, and Both Active Treatments to a Vehicle Control in the Treatment of Inflammatory Lesions of Rosacea, Perrigo, 2016



-Clinical study to Assess Tolerability of Interlinks TCS, NuSkin, 2016-Double Blinded Comparative Evaluation of a Regimen for Reducing Scalp Itching and Flaking While Improving the Appearance of the Hair, Hair and Scalp Therapeutics, 2016

-A Single Center, Double Blind, Randomized Study Evaluating BioRestorin-A in Improving the Appearance of Facial Intrinsic Aging, Ferndale Pharma Group, 2016

-An Evaluation of Several Acne Facial Cleanser Formulations, Colgate-Palmolive Co., 2016-Clinical Tape Strip Sample Gene Expression Analysis Study, Rodan + Fields through Genemarkers, 2016-The Ability of a Novel Nutritional Supplement to Improve the Appearance of Skin Health, Aethern, 2016-An Open Label Case Series Trail to Determine Skin AGE Response to a Proprietary Nutritional Supplement Using Non-Invasive Tools, Pharmanex – NuSkin Enterprises, 2016

-Forearm Control Application Test 3, Boots, 2016-A Randomized, Double-Blind, Vehicle-Controlled Study to Assess the Safety and Efficacy of BPX-01 Minocycline Topical Gel in the Treatment of Moderate to Severe Inflammatory Acne Vulgaris, BioPharmX, 2016

-Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Comparison Study to Determine the Therapeutic Equivalence of a Generic Ingenol Mebutate Gel, 0.015% and Picato® Gel, 0.015% in Subjects with Actinic Keratosis on the Face or Scalp, Actavis Laboratories, UT, 2016

-A Randomized, Double-blind, Parallel-group, Vehicle-controlled, Multicenter Study Comparing TOLMAR Calcipotriene Hydrate and Betamethasone Dipropionate Topical Suspension 0.005%/0.064% to Reference Listed Drug in the Treatment ofScalp Psoriasis, TOLMAR Inc., 2017

-A Multicenter, Open Label Study To Assess The Safety And Efficacy Of Risankizumab For Maintenance In Moderate To Severe Plaque Type Psoriasis (Limmitless), Abbvie, 2017

-A Phase 3, Multicenter, Randomized, Double-blind Study Evaluating the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type Psoriasis, Janssen Research & Development, LLC, 2017

-VOLTAIRE-X: Pharmacokinetics, safety, immunogenicity and efficacy of BI 695501 versus Humira® in patients with moderate to severe chronic plaque psoriasis: a randomized, double-blind, parallel-arm, multiple-dose, active comparator trial, Boehringer Ingelheim, 2017

-B2b LumiSpa 4 Combinations Safety/Tolerance Study, Nu Skin, 2017-An Efficacy and Safety Evaluation of a Novel Regimen for Teen Acne, Rodan & Fields, LLC, 2017-A Clinical Demonstration of the Efficacy and Tolerance of Two Skincare Regiments for Stressed, Sensitive Skin, Rodan & Fields, LLC, 2017

-A Demonstration of the Superior Aesthetic Characteristics of Ultravate Lotion, Ranbaxy, A Division of Sun Pharma, 2017-A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study Of A-101 Topical Solution Applied Twice A Week In Subjects With Common Warts, Aclaris, 2017

-A Phase 2, Single-Center, Randomized, Double Blind, Parallel-Group, Vehicle-Controlled Study Evaluating the Efficacy and Safety of AM001 Cream in the Treatment of Actinic Keratosis (AK) Lesions, AmDerma Pharmaceuticals, LLC, 2017

-A Multi-Center, Double-Blind, Randomized, Placebo Controlled, Parallel Group Study, Comparing Tretinoin Cream, 0.05% (Taro Pharmaceuticals U.S.A., Inc.) To Retin-A® (Tretinoin) Cream, 0.05% (Valeant) and Both Active Treatments to a Placebo Control in the Treatment of Acne Vlgaris, Taro Pharmaceuticals U.S.A., Inc., 2017

-A Randomized, Multicenter, Double-blind, Vehicle controlled Study to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam Compared to Vehicle in the Treatment of Facial Papulopustular Rosacea (FX2016-12), Foamix Pharmaceuticals, Inc., 2017

-A Multicenter Study Of PsorX Lotion In Subjects With Moderate Plaque Psoriasis, Ferndale Laboratories, Inc., 2017-A Randomized, Double-Blind, Placebo-Controlled, Phase 2b, Multicenter Study to Evaluate the Safety, Efficacy, and Tolerability of SNA-120 (Pegcantratinib Ointment) in Subjects with Pruritus Associated with Psoriasis Vulgaris, Sienna Biopharmaceuticals, Inc., 2017

-A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream–Controlled Study to Evaluate the Safety and Efficacy of INCB018424 Phosphate Cream Applied Topically to Adults with Atopic Dermatitis, Incyte, 2017

-A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris), Nielsen BioScience Inc., 2017

-A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of a Generic Pimecrolimus Cream, 1% (Taro Pharmaceuticals USA, Inc.) to the Marketed Product ELIDEL® (Pimecrolimus) Cream, 1% (Valeant Pharmaceuticals North America LLC) in the Treatment of Mild to Moderate Atopic Dermatitis, Taro Pharmaceuticals USA, Inc., 2017

-A Demonstration of the Superior Aesthetic Characteristics of Ultravate Lotion, Ranbaxy, A Division of Sun Pharma, 2017



-The Suitability of Two Skin Care Regimens for Sensitive Skin, Burt’s Bees, 2017-The Effect of a Facial Lotion on Skin Moisturization, Colgate-Palmolive Co., 2017-B2b LumiSpa 4 Combination Safety/Tolerance Study, NuSkin, 2017-An Efficacy and Safety Evaluation of a Novel Regimen for Teen Acne, Rodan & Fields, LLC, 2017-An Evaluation of a Novel Acne Bar and Liquid Acne Facial Cleansers, Colgate-Palmolive, 2017-A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing Tazarotene Cream 0.05% toTAZORAC® (Tazarotene) Cream 0.05% and Both Active Treatments to Vehicle Control in the Treatment of Stable Plaque Psoriasis, Fougera, 2017

-A Randomized, Double-Blind, Vehicle Controlled Study To Evaluate The Safety, Tolerability, And Efficacy Of Dmt210 Gel In Adult Patients With Moderate To Severe Acne Rosacea, Dermata, 2017

-Micro-Comedone Follicular Biopsy 3, Walgreens Boots Alliance, 2017-The Effect of Cosmetic Face Peel Regimens on Skin Appearance, Mission Pharmacal, 2017-The Validation of a Smart Mirror on Skin Health Assessment, HiMirror, 2017-The Effect of Loyon on Moderate Scalp Seborrheic Dermatitis, Oculus, 2016-Lumity Nutritional Supplement Efficacy on Skin Heath, Lumity, 2016-The Effect of a Skin Care Regimen on Facial Dyspigmentation, MD Complete, 2017-Epsilon Clinical Study to Assess Tolerability of Mushroom TCS, NuSkin, 2017-The Effect of Several Ingredients on Facial Dyspigmentation, NuSkin, 2017-LumiSpa Pivotal Clinical Study for Anti-Aging and Tolerance, NuSkin, 2017-A Clinical Demonstration of the Additive Skin Benefits of Getting Skin Ready (GSR) Program and HydraFacial Basic Treatment Procedure, ZO Skin Health, Inc. and HydraFacial/Edge Systems, 2017

-The Clinical and Antioxidant Effects of an Essential Vitamin C&E Cream Formulation, PCA, 2017-Multicenter, Randomized, Investigator-Blind, Placebo-Controlled 12-Week Clinical Usage Study in Subjects With Moderate toSevere Facial Photodamage, SkinMedica, Inc., 2017

-The Effect of a Facial Cream, SOMCOS001 on Skin Health, Somahlution LLC, 2017-A Demonstration of the Barrier Enhancing Characteristics of Halog 0.1% Ointment in Plastibase, Sun Dermatology, 2017-A Demonstration of the Artificial Barrier Release Characteristics of Halcinonide 0.1% in Plastibase, Sun Dermatology, 2017-A Single Center Evaluation of the Ability of Tensage with Stem Cells to Improve the Visible Signs of Aging, Biopelle, Inc., 2017

-A Randomized, Blinded, No-Treatment Control, Multicenter, Prospective Clinical Study of TEOSYAL® RHA Redensity for the Treatment of Moderate to Severe Perioral Rhytids, Teoxane SA, 2017-An Open-Label, Multi-Center Trial to Assess the Safety of Single and Repeat Treatments of Daxibotulinum toxin A for Injection for Treatment of Moderate to SevereGlabellar Lines (Sakura Open-Label Safety), Revance Therapeutics, Inc., 2017-Phase 2 Study of RVT-501 in Adult and Adolescent Subjects with Atopic Dermatitis, Dermavant Sciences GmbH, 2017-Evaluation of the Microbiome Following Use of Kamedis Acne Spot Treatment in Subjects with Acne, Kamedis LTD, 2018-Forearm Control Application Test 4, Walgreens Boots Alliance, 2018-Skin Microbiome Changes in Pores of Acne Patients, NuSkin, 2018-A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects with Moderate-to-Severe Plaque Psoriasis, Dr. Reddy’s Laboratories, 2018-A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group, Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris, Dow Pharmaceutical Sciences, a Division of ValeantPharmaceuticals North America, LLC, 2018-A Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of 1% and 3% Topical Minocycline Gel (HY01) in Patients with Papulopustular Rosacea, Hovione Scientia Ltd. 2018-Randomized, Double-blind, Vehicle-Controlled, Multicenter, Parallel-Group, Phase 2a Study to Assess the Safety and Efficacy of PR022 Topical Gel in Adults with Mild-to-Moderate Atopic Dermatitis, Realm Therapeutics, Inc., 2018-A Multicenter, Randomized, Double-Blind, Secukinumab-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects with Moderate to Severe Chronic Plaque Psoriasis, UCB Biopharma SPRL, 2018-Clinical Evaluation of YA-MAN’s W-Circle RF Device, YA-MAN Ltd., 2018-A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Comparison study to Determine the Therapeutic Equivalence of GDC 268 and Clindamycin Phosphate Topical Lotion, 1% in Subjects with Acne Vulgaris, Gage Development Company, LLC, 2018- A Multicenter, Randomized, Open-label, Phase 3 Long-term Safety Study of Topically Applied Sofpironium Bromide (BBI-4000) Gel, 5% and 15% in Subjects with Axillary Hyperhidrosis, Brickell Biotech, Inc., 2018



-A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Site Study to Evaluate the Therapeutic Equivalence of a Generic Calcipotriene and Betamethasone Dipropionate Topical Suspension, 0.005%/0.064% (Glenmark Pharmaceuticals Ltd) to the Marketed Product Taclonex Topical Suspension (LEO Pharma Inc.) in the Treatment of Scalp Psoriasis, Glenmark Pharmaceuticals Ltd, 2018- A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing Clindamycin 1% Gel to Clindamycin 1% Gel (Greenstone LLC) and Both Active Treatments to a Vehicle Control in the Treatment of Acne Vulgaris, Akorn Pharmaceuticals. 2018- A Randomized, Double-Blind, Placebo-Controlled, Phase 2B Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of ASN002 in Subjects with Moderate to Severe Atopic Dermatitis, Asana BioSciences, LLC., 2018-A Multi-Center, Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Phase 3 Study with Randomized Withdrawal and Retreatment to Evaluate the Efficacy and Safety of BMS-986165 in Subjects with Moderate-to-Severe PlaquePsoriasis, Bristol-Myers Squibb Research and Development, 2018-A Multi-Center, Double-Blind, Randomized, Three-Arm, Placebo Controlled, Parallel-Group Study, Comparing Adapalene Gel0.3% (Aleordermaceuticals Limited, India) to Differin® (Adapalene) Gel 0.3% (Galderma Laboratories, LP USA) and Both Active Treatments to a Placebo Control in the Treatment of Acne Vulgaris, Aleor Dermaceuticals Limited C/O Orbicular Pharmaceutical Technologies Pvt Ltd, 2018-A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus in Adults With Prurigo Nodularis, Menlo Therapeutics Inc., 2018-A Phase 3 Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study of S5G4T-1 in the Treatment of PapulopustularRosacea, Sol-Gel Technologies Ltd., 2018-A Randomized, Double-Blind, Placebo-Controlled, Efficacy Study of the Neurokinin-1 Receptor Antagonist VLY-686 in Patients With Atopic Dermatitis, Vanda Pharmaceuticals Inc., 2018-A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study to Compare Perrigo UK FINCO’s Limited Partnership Adapalene and Benzoyl Peroxide Topical Gel 0.3%/2.5%, and Both Active Treatments to a Vehicle Control in the Treatment of Acne Vulgaris, Perrigo, 2018-A MultiCenter, Double-Blind, Randomized, Placebo Controlled, Parallel-Group Study, Comparing Azelic Acid Foam 15% (Taro Pharmaceuticals U.S.A., Inc.) to Finacea® (Bayer Healthcare Pharmaceuticals Inc.) and Both Active Treatments to a Placebo Control in the Treatment of Moderate Facial Rosacea, Taro Pharmaceuticals U.S.A., Inc., 2018-A Phase 2b fl-Week Parallel Group, Double Blind, Vehide-Controlled Study of the Safety, Efficacy and Pharmacokinetics of ARQ-151 Cream 03% and ARQ-151 Cream 0.15% QD in Subjects with Chronic Plaque Psoriasis, Arcutis, Inc., 2018-A double-blind, randomized, vehicle-controlled Phase 2 study to assess the safety and efficacy of BPX-04 Minocycline topical gel in the treatment of inflammatory lesions of papulopustular rosacea, BioPharmX, Inc., 2018-A Double-Blind, Randomized, Multicenter, Vehicle-Controlled, Parallel Group Comparison Study to Determine the Efficacy and Safety of Halobetasol Propionate Spray, 0.05% Versus Vehicle Spray in Subjects with Plaque Psoriasis Receiving Up to Four Weeks of Twice-Daily Treatment, Therapeutics, Inc., 2018- A Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Study to Evaluate the Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects, Dow Pharmaceutical Sciences, a division of Valeant Pharmaceuticals North America, LLC, 2018-A Study of Tolerability, Safety, and Efficacy, of DMT310 in Patients with Acne Vulgaris, Dermata Therapeutics, 2018-The Effect of Azelaic Acid Foam on Folliculitis, Bayer, 2018-The Efficacy of Prebiotic Combination Therapy in Acne, NV Perricone, 2018-Effectiveness of a Topical Product on Hair Growth and Pigmentation, Miri Seiberg, 2018-AgeLOC LumiSpa Accent Clinical Study, NuSkin, 2018-An Evaluation of the Hair Removal and Skin Beauty Benefits of a Facial Dermaplaning Device, when used with and without Facial Oil, Reckitt Benckiser, LLC, 2018-The Benefits of a Nail Product in Improving Nail Appearance, Kramer Laboratories, 2018-A Clinical Demostration of the Antioxidant Abilities of a Facial Oil, Burt’s Bees, 2018-The Clinical Effectiveness of Novel Therapeutic Moisturizers, Vizuri, 2018-The Clinical Effectiveness of Novel Therapeutic Moisturizers in Environmental Protection, Vizuri, 2018-Efficacy and Safety of Kamedis Eczema Treatment in Children and Adults with Atopic Dermatitis, Kamedis Ltd., 2018-An Evaluation of the Comparative Skin Vitality Benefits of Three Different Hair Removal Methods, Reckitt Benckiser LLC, 2018-The Suitability of Two Skin Care Regimens in Moderate to Severe Facial Rosacea, Burt’s Bees, 2018-A Comparison of the Topical Antioxidant Capabilities of Two Skin Care Products, SkinMedica, 2018-Instant Pore Refiner, ZOSkinHealth, 2018



-A Clinical Trial to Evaluate the Safety, Tolerance, and Efficacy of an Acne Treatment in Females with Moderate to Severe Acne, SmartPhage, 2018-Effectiveness of a Topical Body Product on Legs, L’Oreal, 2018-LumiSpa Clinical Study to Assess Tolerability of the LumiSpa Small Area Treatment Device, NuSkin, 2018-A Clinical Evaluation of a Cosmeceutical for Facial Redness Reduction, Cynova, 2018-The Safety and Odor Blocking Properties of an Overall Body Feminine Spray, WellSpring, 2018-The Ability of a Hair Care Regimen to Improve Hair Health and Appearance, LifeVantage, 2018-A Phase 2B Open-Label Study to Evaluate the Efficacy, Safety, and Tolerability of Topical VDA-1102 Ointment in Subjects with Actinic Keratosis, Vidac Pharma Ltd., 2018-A Multicenter, Randomized, Double-Blind, Sham-Controlled, Efficacy and Safety Study of Autonomic Nerve Modulation (ANM) in Subjects With Moderate Plaque Psoriasis, Thync Global, Inc., 2018

WEB SITE DEVELOPMENT-AAD Spot Skin Cancer Web Development 2012-AAD Dermatology A-Z, 2011 – present-AAD Website, 2010 – present-Dermatology Consulting Services, 2009 - present-Institute for Fine and Thinning Hair, Pharmacia, 2000 - 2003-Olay Beauty, Procter & Gamble, 1999 - 2011-Skin Care Institute, Somme Institute, 2000 - 2002-Society of Cosmetic Chemists, 2000 - 2005-Cetaphil Ask Your Doctor, 2002 – 2004-Rosacea Website, Intendis, 2005 - 2011

EXPERT OPINION CONSULTANT-YourEncore Consultant (Engineering/Medical Interdisciplinary Consultant)-Pfizer (Women’s Health Initiative, Dermatology Division Protocol Design)-Phillips (Home Electronics Division)-Whitehall-Robins/Wyeth/Pfizer (Chapstick, Denorex, Preparation H)-Bayer Consumer Products (Camphophenique, Bactine, One-A-Day Vitamins)-Bayer Dermatology (Phase IV Development)-Procter & Gamble (Olay, Thermacare, Gillette)-TEVA Pharmaceuticals (Research and Development Division)-Novartis (Research and Development Division)-Allergan (Botox Consensus Expert Opinion Group, Research Protocol Development)-Pfizer (Dermatologic Consultant on New Product Development)-Chattem (Dermatologic Consultant on New Product Formulation and Development)-Avon (Dermatologic Consultant)-Milliken (Dermatologic Consultant on New Product Opportunities)-Johnson & Johnson (New Discovery Technology)

-Perrigo (FDA and Regulatory Issues) -Reckitt Benkiser (Skin Cleansing Product Discovery) -NuSkin (Product Conception and Development)

-SunPharma (Research Design)-Ranbaxy, Divison of SunPharma (Phase IV Development)

-Lumity Vitamins (Dermatologic Consultant) -MD Complete Skin Care (Dermatologic Consultant) -Scalp and Hair Therapeutics (Dermatologic Consultant) -Suneva (Dermatologic Consultant) -Exeltiis (Dermatologic Consultant) -Boots (Dermatologic Consultant)

-Amderma (Dermatologic Consultant)-Asana (Atopic Dermatitis Consultant)-Amirall (Project Development and Prioritization Consultant)



PATENTS-Draelos, ZD: A method of examining dry skin. Colgate-Palmolive, 2004.-Draelos, ZD, et al: A device for application of Strateris. Living Proof, 2014.

ABSTRACTS-Draelos, Z, Goldberg SJ: A clinical study of transducer beam characteristics. World Congress of Pediatric Cardiology,

1980.-Draelos, Z, Goldberg SJ, Areias J, Sahn DJ: Echo doppler demonstration of the series effect and vortex shed distance in

flow models and clinical echo-doppler studies. Circulation 62:332, 1980. -Draelos, Z, Goldberg, SJ, Sahn DJ: How accurate is the ultrasonically imaged size of a ventricular septal defect?

Circulation 62: 164, 1980.-Draelos, Z, Goldberg SJ: Effects of tissue, frequency, crystal size and focus on ultrasonic beams. American Academy of

Pediatrics, 1980. -Kececioglu Z, Goldberg SJ, Allen HD, Sahn DJ: Cardiac Doppler Ultrasound Slide/tape presentation), American Chest

Meeting, 1981. -Draelos, Z, Goldberg SJ, Valdes-Cruz LM, Allen HD: An M-mode echocardiographic assessment of severe dilated

cardiomyopathy. American College of Cardiology, 1981. -Draelos, Z, Levine N: Hyperthermic treatment of human squamous cell skin cancer in a nude mouse model. Clinical

Research 33:154A, 1985. -Draelos, Z, Levine N: Radiofrequency hyperthermia in the treatment of cutaneous tumors in a mouse model system.

American Academy of Dermatology, 1985. -Draelos, Z, Levine N: Radiofrequency hyperthermia in the treatment of melanoma in a mouse model. Journal of

Investigative Dermatology 86:472, 1986. -Draelos, Z, Levine N: Retinoic acid and fractionated radiofrequency hyperthermia in the treatment of murine melanoma.

Journal of Investigative Dermatology 88:486, 1987. -Draelos, ZD: A dermatologic evaluation of testing methodologies for sensitive skin. Journal of the Society of Cosmetic

Chemists, December 1996. -Draelos, ZD: Cosmetic intolerance syndrome. American Journal of Contact Dermatitis, March 1997. -Draelos, ZD: Formulating for Mature Skin. Journal of Cosmetic Science, April/May 1999. -Draelos, ZD: Barrier Creams in the Treatment of Irritant Contact Dermatitis. American Journal of Contact Dermatitis, 1999.-Draelos, ZD: Cosmetic Remedies for Hair Loss in Pediatric Patients. Pediatric Dermatology, 1999.-Draelos, ZD (and others): A Novel Nitrone-Based Free Radical Trap Blocks UV-Induced Cytokine Production in Human

Fibroblasts and Keratinocytes and Inhibits UV-Induced Erythema in Human Skin In Vivo, Journal of the Society of Investigative Dermatology, 2001.

-Draelos, ZD; Evaluation of Rosacea Severity and Facial Stinging Following Topical Application of Azelaic 15% Gel. Supplement to the Journal of the American Academy of Dermatology, 2004 March; 50(3).

-Draelos, ZD: Cosmeceutical Update Evidence-Based. American Academy of Dermatology, 2005. -Draelos, ZD: Psychometirc Validation of the Oily Skin Self Assessment Scale (OSSAS) and the Oily Skin Impact Scale

(OSIS), ISPOR 10th Annual European Congress, 2007.

ORAL PRESENTATIONS (UNITED STATES)-Draelos, ZD: Hair Care in the Elderly: Basic Concepts and New Ideas. American Academy of Dermatology, 1987. -Draelos, ZD: Cosmetic Solutions to Common Dermatologic Problems. American Academy of Dermatology, 1987. -Draelos, ZD: Cosmetic Solutions to Common Dermatologic Problems. American Academy of Dermatology, 1988. -Draelos, ZD: Cosmetic Remedies. American Academy of Dermatology, 1989, 1990, 1992. -Draelos, ZD: Cosmetic Camouflaging. American Academy of Dermatology, 1989. -Draelos, ZD: Cosmetic Camouflaging. American Academy of Dermatology, 1990. -Draelos, ZD: Cosmetics. Grand Rounds, Duke Medical Center, 1988. -Draelos, ZD: The Eyes Have It. American Academy of Dermatology, 1988. -Draelos, ZD: Past and Present Methods of Hair Replacement. Upjohn Hair Seminar, 1988. -Draelos, ZD: Hair Replacement. National Association of Retail Druggists, 1988. -Draelos, ZD: Hair Care and Hair Replacement. Hair America Branch of National Cosmetologists Association, 1988.



-Draelos, ZD: What's New in Cosmetics. Cosmetic Symposium, Beth Israel Medical Center, 1988. -Draelos, ZD: Remedies for Cosmetically Induced Dermatoses. International Symposium on Dermatologic Therapy.

University of British Columbia, 1988. -Draelos, ZD: Cosmetics and Medical Skin Conditions. International Symposium and Dermatological Therapy, University of

British Columbia, 1988. -Draelos, ZD: Medical Fountain of Youth, Randolph County Medical Society, 1988. -Draelos, ZD: Cosmetics and the Art of Illusion. Women's Forum, High Point Regional Hospital, 1988. -Draelos, ZD: Hair Care. Women's Forum, High Point Regional Hospital, 1989. -Draelos, ZD: Cosmetics for the Professional Woman. Triad Professional Women's Forum, 1989. -Draelos, ZD: Shampooing and Conditioning Your Hair. Triad Professional Women's Forum, 1990. -Draelos, ZD: Eye Cosmetics. Women's Dermatologic Society, 1990. -Draelos, ZD: Facial Cosmetics. Women's Dermatologic Society, 1990. -Draelos, ZD: Facial and Eye Cosmetics. North Carolina Medical Society, 1990. -Draelos, ZD: Camouflaging Cosmetics. Harvard Cosmetics Symposium, 1990. -Draelos, ZD: Wound Care and Dressing Materials. High Point Regional Hospital, 1990. -Draelos, ZD: Urticaria. High Point Regional Hospital, 1990. -Draelos, ZD: Facial Cosmetics. Valley of the Sun Dermatology Meeting, 1991. -Draelos, ZD: Eye Cosmetics. Valley of the Sun Dermatology Meeting, 1991. -Draelos, ZD: Cosmetic Remedies. California Dermatology Society, 1991. -Draelos, ZD: Cosmetics, an Overview. American Academy of Dermatology, 1993. -Draelos, ZD: Moisturizers. American Academy of Dermatology, 1994. -Draelos, ZD: Hair Prostheses. American Academy of Dermatology, 1992. -Draelos, ZD: Estheticians. American Academy of Dermatology, 1993. -Draelos, ZD: Hair Cosmetics. Dialogues in Cosmetic Dermatology, 1993. -Draelos, ZD: Facial Cosmetics for Men and Women. Dialogues in Cosmetic Dermatology, 1993. -Draelos, ZD: What's New in Cosmetics. Dialogues in Cosmetic Dermatology, 1994 and 1995. -Draelos, ZD: Estheticians and Dermatology. Dialogues in Cosmetic Dermatology, 1994 and 1995. -Draelos, ZD: Cosmetic Camouflaging. Hawaiian Dermatology Seminar, 1994. -Draelos, ZD: Moisturizer Formulation. Hawaiian Dermatology Seminar, 1995. -Draelos, ZD: Cosmetic Camouflaging. Valley of the Sun Dermatology Meeting, 1995. -Draelos, ZD: What's New in Cosmetics. Valley of the Sun Dermatology Meeting, 1995. -Draelos, ZD: Facial Cosmetics. North Carolina Medical Society, 1993. -Draelos, ZD: Fungal Infections of the Skin and Their Treatment. Triad Medical Professionals, 1994. -Draelos, ZD: Cosmeceuticals. Skin Symposium, 1994. -Draelos, ZD: Cosmetics. American College of Osteopathic Medicine Annual Meeting, 1994. -Draelos, ZD: Sun Protection. Women's Professional Golf Association Annual Tournament, 1994. -Draelos, ZD: Caring for Your Skin. High Point Regional Hospital Nurses Association, 1994. -Draelos, Z. Great Looking Skin. Healthy Habits Forum, High Point Regional Hospital, 1994. -Draelos, Z: Cosmetics. Tucson Dermatologic Society, 1994. -Draelos, Z: Moisturizers. Miami Dermatologic Society, 1995. -Draelos, Z: Skin Care Products in the Dermatologic Practice. Dermik Laboratories Sales Force, 1993. -Draelos, ZD: Maintaining Healthy Skin. North Carolina Dermatology Nurses Association, 1993. -Draelos, ZD: Facial Foundations. American Academy of Dermatology, 1996. -Draelos, ZD: Skin Care in the Elderly. American Academy of Dermatology, 1996. -Draelos, ZD: Skin Care Product Selection. Johnson and Johnson Worldwide Consumer Products International Division,

London, England, 1996. -Draelos, ZD: Evaluating Sensitive Skin. Colgate-Palmolive Skin Care Division, 1995. -Draelos, ZD : Dermatologic Concerns in Skin Care Product Formulation. S. C. Johnson and Sons Personal Care Products

Division, 1995. -Draelos, ZD: BHA vs. AHA. International Symposium on Aging Skin, 1997. -Draelos, ZD: Sensitive Skin: A New Dermatologic Enigma. American Academy of Dermatology, March 1997. -Draelos, ZD: Innovation in Cosmetic and Skin Care Product Formulation from a Dermatologist's Perspective. International

Society for Colloidal Chemistry, March 1997. -Draelos, ZD: Nail Cosmetics. American Academy of Dermatology, August 1997. -Draelos, ZD: What's New in Cosmetic Dermatology. American Academy of Dermatology, February 1998. -Draelos, ZD: Nail Cosmetics and Nail Disease. American Academy of Dermatology, February 1998.



-Draelos, ZD: Caring for Your Skin. Wonderful Program for Women, High Point, NC, 1998. -Draelos, ZD: Cosmetics for Hair Loss Patients, University of Minnesota Conference on Hair Loss, 1998. -Draelos, ZD: What's New in Cosmetic Dermatology, Dialogues in Cosmetic Dermatology, 1998. -Draelos, ZD: The Hydroxy Acids in Dermatology, Dialogues in Cosmetic Dermatology, 1998. -Draelos, ZD: Sun Protection, High Point Regional Hospital, 1998. -Draelos, ZD: Skin Care and Dermatology, North Carolina Medical Society Annual Meeting, 1998. -Draelos, ZD: Sensitive Skin. American Contact Dermatitis Society Meeting, 1998. -Draelos, ZD: Nail Cosmetics. American Academy of Dermatology Summer Meeting, 1998. -Draelos, ZD: Cosmetics in the Surgical Patient. American Society for Dermatologic Surgery, 1999. -Draelos, ZD: What's New in Cosmetic Dermatology. American Academy of Dermatology, 1999.-Draelos, ZD: Skin Care for All Seasons. Roche Vitamins Presentation, 1999.-Draelos, ZD: Cosmetic Onychodilemmas. Council for Nail Disorders Meeting, 1999. -Draelos, ZD: Barrier Creams in the Treatment of Irritant Contact Dermatitis, American Contact Dermatitis Society, 1999. -Draelos, ZD: Vitamins and the Skin. International Cosmetics Exposition, 1999. -Draelos, ZD: Skin Care in the Perimenopausal Woman. Estee Lauder Media Event, 1999. -Draelos, ZD: Cosmetics in Dermatology, American Academy of Dermatology, 1999. -Draelos, ZD: Vitamins and Their Effect on the Skin, Southeastern Meeting of the Society of Cosmetic Chemists, 1999. -Draelos, ZD: Formulating for the Unique Attributes of Mature Skin. Scientific Meeting of the Society of Cosmetic Chemists,

1999. -Draelos, ZD: Alpha, Beta, and Polyhydroxy Acids for Aging Skin. International Symposium on Aging Skin, 1999. -Draelos, ZD: New Developments in Skin Care. Health and Beauty Aids Global Expo, 1999. -Draelos, ZD: What’s New in Cosmetic Dermatology, Dialogues in Cosmetic Dermatology, 1999.-Draelos, ZD: Vitamins and Their Use in Topical Agents, Dialogues in Cosmetic Dermatology, 1999.

-Draelos, ZD: Sensitive Skin: Perceptions, Evaluation, and Treatment, Society of Cosmetic Chemists-The Carolina Chapter, October meeting, 1999.

-Draelos, ZD: Cosmetics Help Rosacea and Acne Patients Feel and Look Better. Acne and Rosacea Academy, 1999. -Draelos, ZD, Simion A, Abrutyn E. Abililty of Creams to Reduce Erythea, Stratum Corneum Barrier Damage, and

Subjective Itching. Annual Scientific Meeting, 2000.-Draelos, ZD: Camouflage Techniques for Children, Society for Pediatric Dermatology Annual Meeting 2000.-Draelos, ZD: Skin Care Management and Cosmetics for Adolescents. Society for Pediatric Dermatology Annual Meeting

2000.-Draelos, ZD: Cosmetics in Dermatology Expert Discussion Leader, American Academy of Dermatology, 2000.-Draelos, ZD: Hair Cosmetics. Colorado Dermatology Society, 2000.-Draelos, ZD: Cosmetics in Sensitive Skin, Dickey Speaker, Geisinger Clinic, 2000.-Draelos, ZD: The Use of Hydroxy Acids in Skin Care, American Academy of Dermatology, 2000.-Draelos, ZD: Hydroxy Acids as Peeling Agents, American Academy of Dermatology, 2000.-Draelos, ZD: Dermatologic Research, Carolinas Chapter Society of Cosmetic Chemists, 2000.-Draelos, ZD: Practical Solutions for Dermatologic Problems. North Carolina Dermatology Association Meeting, 2000.-Draelos, ZD: Symposium on Hair and Nail Diseases. University of Minnesota, 2000.

-Simion FA, Abrutyn ES, Draelos ZD: Ability of Moisturizers to Reduce Dry Skin and Irritation and to Prevent their Return, 58th Annual Meeting of the American Academy of Dermatology, 2000 and the Society of Cosmetic Chemistry National Meeting, 2000

-Simion FA, Abrutyn ES, Draelos ZD: Ability of Creams to Reduce Erythema, Stratum Corneum Barrier Damage, and Subjective Itching. Society of Cosmetic Chemists Annual Scientific Meeting, 2000.

-Draelos ZD, McBurney E, Mandy SH. ASDS Session: Spotlight on Cutting Edge Research and Cosmetic Dermatology, ASDS-ACMMSCO Combined Annual Meeting, 2001

-Draelos, ZD: Topical Retinoids, Vitamins & Others, Cosmetic Dermatology Seminar sponsored by the Skin Disease Foundation, 2001

-Draelos, ZD: Speaking of Women Keynote Speaker, 5 National Presentations, 2001.-Draelos, ZD: Assessing Chemical Skin Irritants, Society of Cosmetic Chemists Southeastern Division, 2001.-Draelos, ZD: What’s New in Cosmetic Dermatology 2001? Dialogues in Cosmetic Dermatology, 2001.-Draelos, ZD: Topical Cosmeceuticals. Dialogues in Cosmetic Dermatology, 2001.

-Draelos, ZD: Epidermal Rejuvenating Agents, ASDS-ACMMSCO Combined Annual Meeting, 2002 -Draelos, ZD: Great Skin for Life, Green Street Baptist Church Women’s Conference, 2003

-Draelos, ZD: The Impact of Cosmetic Dermatology on Skin Care and Cosmetics, National Meeting Society of Cosmetic Chemists, 2003.



-Draelos, ZD: Topical Cosmeceuticals in Active Cosmetics, Annual Meeting of the American Society for Dermatologic Surgery, 2003.

-Draelos, ZD: Topical Cosmeceuticals, Defining Active Cosmetics and Cosmeceuticals, Where is the Future?, Annual Meeting of the American Society for Dermatologic Surgery, 2003.

-Draelos, ZD: Cosmeceuticals 2003, AAD Academy 2003. -Draelos, ZD: Clinical Benefits of Natural Ingredients in Aging Skin and Pigmentation Disorders, The Role of Natural

Ingredients in Dermatology, Academy ’03 CME Symposia, 2003 -Draelos, ZD: Topics in…208 Hair & Skin Cosmetics. American Academy of Dermatology meeting, 2003. -Draelos, ZD: Skin Care & Cosmetics in the Rosacea Patient, 27th Annual Hawaii Dermatology Seminar, 2003. -Draelos, ZD: Cosmeceuticals, 27th Annual Hawaii Dermatology Seminar, 2003. -Draelos, ZD: The Facial Aesthetic Consensus Conference for Botox Cosmetic, 2004 -Draelos, ZD: Emerging Cosmeceuticals & What’s New in Skin Care Techniques, Southeastern Consortium for

Dermatology Meeting, 2004. -Draelos, ZD: Topical Agents and Peeling Agents, Cosmetic Dermatology Seminar, 2004 -Draelos, ZD: New Cosmetic Agents & Procedures, Cosmetic Dermatology Seminar, 2004 -Draelos, ZD: Cosmeceuticals: What’s Real and What’s Not, 7th Annual Winter Symposium at Mount Sinai, 2004

-Draelos, ZD: Rosacea and the Skin Barrier, Rosacea Nosology Symposium, Galderma, 2004.-Draelos, ZD: Sunscreens, Fall Clinical Dermatology Conference, 2004.-Draelos, ZD: Evidence-based Cosmeceuticals, American Academy of Dermatology meeting, 2005.-Draelos, ZD: Novel Cosmeceutical Technologies, American Academy of Dermatology meeting, 2005.-Draelos, ZD: Noninvasive Topical Treatment & Integration with Cosmetic Practice, American Academy of Dermatology

meeting, 2005.-Draelos, ZD: Cosmeceutical Update: Evidence Based, American Academy of Dermatology meeting, 2005.-Draelos, ZD: Antiaging Cosmetics, American Academy of Dermatology meeting, 2005.-Draelos, ZD: Cosmeceuticals: The First Step in Resurfacing, American Academy of Dermatology meeting, 2005.-Draelos, ZD: Update on Cleansers & Cleansing Devices, American Academy of Dermatology meeting, 2005.-Draelos, ZD: Novel Use of Topical Agents for Anti-Aging, American Academy of Dermatology meeting, 2005.-Draelos, ZD: Photoprotection, American Academy of Dermatology meeting, 2005.-Draelos, ZD: Skin Care & Topical Management of Rosacea, 2005.-Draelos, ZD: Moisturizers Update, Summer American Academy of Dermatology meeting, 2005.-Draelos, ZD: Maintaining Healthy Hair for Life Summer American Academy of Dermatology meeting, 2005.-Draelos, ZD: Cosmeceuticals, Summer American Academy of Dermatology meeting, 2005.-Draelos, ZD: The Importance of Vehicles in Skin Care, Summer American Academy of Dermatology meeting, 2005.

-Draelos, ZD: Clinical Symposia-Advances in Dermatology, Dermatology Foundation, 2005 -Draelos, ZD: The Impact of Formulations in Topical Therapies, Improving Efficacy in Psoriasis and Otsacea: New

Formulations, 2005 -Draelos, ZD: A Review of Evidence-Based Rosacea Cosmeceutical Research, American Dermatological Association 125 th

Annual Meeting, 2005 -Draelos, ZD: A Moisturizing Cream that helps preserve the skin barrier, enhace hydration and reduce desquamation in

untreated psoriasis patients, 64th Annual Meeting of the American Academy of Dermatology, 2005 -Draelos, ZD: Hair Cosmetics: What Every Dermatologist Needs to Know, 64th Annual Meeting American Academy of

Dermtology, 2006, San Francisco. -Draelos, ZD: Treating Beyond the Diagnosis. 64th Annual Meeting American Acadmey of Dermatology, 2006. -Draelos, ZD: Cosmeceuticals & Products within the Cosmetic Dermatologic Practice, 64th Annual Academy of

Dermatology, 2006. -Draelos, ZD: Brittle Nails. 64th Annual Meeting American Acadmey of Dermtology, 2006. -Draelos, ZD: New Innovations in Topical Ingredients. The 2006 South Beach Symposium, Miami Beach. -Draelos, ZD: Rosacea and the Skin Barrier. 2006 Winter Conference of the North Carolina Dermatology Association.

-Draelos, ZD: Practical Solutions to Nail Cosmetic Problems. 65th Annual Meeting American Academy of Dermatology, 2007.

-Draelos, ZD: Cosmetic Intolerance Syndrome, 65th Annual Meeting American Academy of Dermatology, 2007. -Draelos, ZD: Treating Beyond the Diagnosis, 65th Annual Meeting American Academy of Dermatology, 2007. -Draelos, ZD: Cosmeceuticals-The First Step in Resurfacing, 65th Annual Meeting American Academy of Dermatology,

2007. -Draelos, ZD: Cosmetic Dermatology, 65th Annual Meeting American Academy of Dermatology, 2007.



-Draelos, ZD: Aesthetic Innovations: Scars. 2007 South Beach Symposium, 2007. -Draelos, ZD: Beauty as a Concept, Summer Academy of Dermatology meeting, 2007. -Draelos, ZD: Nails. Summer American Academy of Dermatology meeting, 2007. -Draelos, ZD: Women’s Dermatology. Summer American Academy of Dermatology meeting, 2007. -Draelos, ZD: Cosmeceuticals Old and New: The Cleansers of the Skin & Hair and The Latest Advances in Fillers.

Summer American Academy of Dermatology meeting, 2007. -Draelos, ZD: New Therapies. Summer American Academy of Dermatology meeting, 2007. -Draelos, ZD: Evidence-Based Cosmeceuticals. Summer American Academy of Dermatology meeting, 2007. -Draelos, ZD: Perspectives on Comprehensive Skin Care and Sustaining Skin Barrier Function, CME Symposium:

Evolving Therapeutics and Changing Faces in Rosacea, 2007. -Draelos, ZD: Natural Ingredients in Dermatology-Emollients & Other Uses. Fall Clinical Dermatology Conference, 2007. -Draelos, ZD: International Congress of Cosmetic Dermatologists, visiting professor, 2007. -Draelos, ZD: What’s Hot & What’s Not: Aging Gracefully. Summer American Academy of Dermatology meeting, 2008. -Draelos, ZD: Futuristic Dermatologic Innovations, Ingredient & Technology Conference, 2008. -Draelos, ZD: New Ideas in Dermatologic Well-Being, HBA Spring Conference, 2008. -Draelos, ZD: Evidence-Based Cosmeceuticals. Summer American Academy of Dermatology meeting, 2008 -Draelos, ZD: Nails. Summer American Academy of Dermatology meeting, 2008. -Draelos, ZD: What’s Hot & What’s Not: Women’s Dermatology. Summer American Acadmey of Dermatology meeting,

2008. -Draelos, ZD: The Benzoyl Peroxide Molecule in Acne Treatment: New Perspectives on History, Chemistry and Efficacy.

Industry Supported Symposia, 2008. -Draelos, ZD: Office Drug Dispensing: Is it Good for the Patients? American Dermatological Association 128 th Annual

Meeting, 2008. -Draelos, ZD: Preventing Unnecessary Female Hair Loss. ISHRS 16th Annual Scientific Meeting, 2008. -Draelos, ZD: Hair Cosmetics. ISHRS 16th Annual Scientific Meeting, 2008. -Draelos, ZD: Natural ingredients and new dermatolgic frontiers. Ingredient & Technology Conference & Exhibition, 2008. -Draelos, ZD: Surgical Pearls, 66th Annual Meeting American Academy of Dermatology, 2008. -Draelos, ZD: Cosmeceuticals for Skin Rejuvenation, 66th Annual Meeting American Academy of Dermatology, 2008. -Draelos, ZD: Treating Beyond the Diagnosis, 66th Annual Meeting American Academy of Dermatology, 2008. -Draelos, ZD: Cosmeceuticals: The First Step in Cosmesis, 66th Annual Meeting American Academy of Dermatology, 2008. -Draelos, ZD: Managing Common Cosmetic Nail Concerns: Brittle, Peeling, Ridging, Splitting, Chipping and Soft Nails.

66th Annual Meeting American Academy of Dermatology, 2008. -Draelos, ZD: How to Add Lioposuction Procedures to Your Practice. American Society for Dermatologic Surgery, 2008. -Draelos, ZD: Clinical Research in Dermatologic Surgery: How I Actually Do It. American Society for Dermatologic

Surgery, 2008. -Draelos, ZD: OTCS, Anti-aging and skin cancer. Orlando Dermatology Aesthetic and Clinical Conference, 2009. -Draelos, ZD: Kits, Washes, Toners: Combination Treatment for Acne I. South Beach Symposium, 2009. -Draelos, ZD: Anti-Inflammatory Molecules. South Beach Symposium, 2009. -Draelos, ZD: Aging Skin. Society of Cosmetic Chemists Annual Scientific Seminar, 2009. -Cornelison R, Daniel CR, Draelos ZD. Nails. American Academy of Dermatology Summer meeting, 2009 -Draelos ZD: What’s Hot and What’s Not: Aging Gracefully. American Academy of Dermatology Summer meeting, 2009 -Draelos ZD: Evidence-Based Cosmeceuticals. American Academy of Dermatology Summer meeting, 2009 -Draelos ZD: Treatment of Xerosis: How to Distinguish One Emollient from Another. Fall Clinical Dermatology

Conference, 2009 -Draelos ZD: Botulinum Toxin (Plenary Workshop). Fall Clinical Dermatology Conference, 2009 -Draelos ZD: Fillers III. Fall Clinical Dermatology Conference, 2009 -Draelos ZD:The Nutraceutical/Cosmeceutical Connection in Dermtologic Surgery. American Society for Dermatologic

Surgery, 2009 -Draelos, ZD: State of the Art in Cosmeceuticals. American Society for Dermatologic Surgery, 2009 -Draelos, ZD: The Efficacy of Cosmeceuticals. 12th Annual Mount Sinai Winter Symposium, 2009 -Draelos, ZD: New Compounds: The Science of Cosmeceuticals. The 2010 South Beach Symposium, 2010 -Draelos, ZD. Keynote Speaker. Society of Cosmetics Chemists, Winter 2010 -Draelos, ZD. Hair Loss in Women. 68th Annual Meeting, American Academy of Dermatology, 2010 -Draelos, ZD. Cosmeceuticals for Skin Rejuvenation. 68th Annual Meeting American Academy of Dermatology, 2010 -Draelos, ZD. Moving line of Drug Activity. Society of Scientific Chemists. 2010 Annual Meeting.



-Draelos, ZD. Aging and the Nutraceutical/Cosmeceutical Connection. Hamption University Skin of Color Research Institute Symposium, 2010

-Draelos, ZD. Nails. AAD Summer Academy Meeting, Chicago, 2010.-Draelos, ZD. Do Cosmeceuticals Really Work? AAD Summer Academy Meeting, Chicago, 2010.-Draelos, ZD. Evolving Concepts in Skin Care. AAD Summer Academy Meeting, Chicago, 2010.-Draelos, ZD. Exploring Evidence Based Cosmeceuticals. AAD Summer Academy Meeting, Chicago, 2010.-Draelos, ZD, Lupo, MP. Nutraceuticals and cosmeceuticals for the Dermatologic Surgeon. ASDS/ASCDAS Annual

meeting, Chicago, 2010-Draelos Z. Physiology of the Skin. Face & Body Spa Conference & Expo, Chicago, 2011-Draelos Z. Nanotechnology hlds promise for future imaging of the skin. AAD Annual Meeting, New Orleans, 2011-Draelos Z. Generational Dermatology Summit. New York, 2011.-Spa and Resort/Medical Aesthetics Expo and Conference. New York, 2011.-Draelos Z. AAD Update. North Carolina Dermatology Association Summer Meeting, 2011.-Draelos Z. The Impact of Nanotechnology in photoprotection? Summer Academy Meeting, American Acadmey of

Dermatology, New York, 2011.-Draelos Z. Exploring Evidence-Based Cosmeceuticals. Summer Academy Meeting, American Acadmey of Dermatology,

New York, 2011.-Draelos Z. Moderator: The Dermatology-Cosmeceutical Interface: A Provocative Inquiry, Part 1. HBA Global Expo, New

York, 2011. -Draelos Z. Moderator: The Dermatology-Cosmeceutical Interface: A Provocative Inquiry, Part 2. HBA Global Expo, New

York, 2011-Draelos, Z. Clinical and Therapeutic Challeges in Appearance Procedures. Clinical Dermatology Conference, Hawaii,

winter, 2012-Draelos, Z. Emollients and Wound Healing. Clinical Dermatology Conference, Hawaii, 2012-Draelos, Z. Cosmeceuticals in Dermatology. Clinical Dermatology Conference, Hawaii, 2012-Draelos, Z. Special Symposium on the Science of Cosmeceuticals. 10th Annual 2012 South Beach Symposium. Miami,

2012-Draelos, Z. The Science of Cosmeceuticals. 10th Annual 2012 South Beach Symposium. Miami, 2012-Draelos, Z. Cosmetic Formulations for Dermatological Conditions. AAD 70 th Annual Meeting, San Deigo, 2012-Draelos, Z. The Science of Cosmeceuticals and Neutraceuticals. AAD 70 th Annual Meeting, San Deigo, 2012-Draelos, Z. Therapeutic Hotline. AAD 70th Annual Meeting, San Deigo, 2012-Draelos, Z. Melasma Therapeutics. AAD 70th Annual Meeting, San Deigo, 2012-Draelos, Z. What’s New and Emerging Therapeutics. AAD 70th Annual Meeting, San Deigo, 2012-Draelos, Z. Cosmeceuticals-The Consumer (and Physician) Challenge. Mastering Advances in Dermatology, 2012.-Draelos, Z. Emollients and Aquaporins. Clinical Dermatology Conference, Hawaii, 2013.-Draelos, Z. Understanding Personal Care Needs in Ethnic and Emerging Markets. Society of Cosmetic Chemists Annual

Scientific Seminar. 2013-Draelos, Z. Sugars and Skin Signaling. Induchem Cosmetic Chemist Seminar, New York, 2013.-Draelos, Z. Ethnic Skin Care. Society of Cosmetic Chemists, St. Louis, 2013.-Draelos, Z. Nail Cosmetics. AAD, Annual Meeting, Miami, 2013-Draelos, Z. Cosmeceuticals and Nutraceuticals. AAD, Annual Meeting, Miami, 2013-Draeos, Z. Aging Theories. AAD, Annual Meeting, Miami, 2013-Draelos, Z. Cosmetics Fact and Fancy. AAD, Annual Meeting, Miami, 2013-Draelos, Z. Evidence Based Cosmeceuticals. Summer AAD, New York, 2013-Draelos, Z. Factual Cosmetics. Harvard Dermatology Symposium, Boston, 2013-Draelos, Z. Hand Rejuvenation. International Society for Cosmetic Surgery, Orlando, 2013-Draelos, Z. Cosmeceuticals: What Effects Can We Really Demonstrate, Boston, 2013-Draelos, Z. Skin, Hair, and Nail Care for the Dermatologist, Summer AAD, New York, 2013-Draelos, Z. The Science of Cosmeceuticals, 12th Annual South Beach Symposium, Miami Beach, 2014-Draelos, Z. Treating Hyperpigmentation, 12th Annual South Beach Symposium, Miami Beach, 2014-Draelos, Z. The Science of Cosmeceuticals and Nutraceuticals, AAD Annual Meeting, Denver, CO, 2014-Draelos, Z. et al. Medical and Surgical Management of Nail Disorders, AAD Annual Meeting, Denver, CO, 2014-Draelos, Z. et al. Superficial Mycotic Infections: An Update, AAD Annual Meeting, Denver, CO, 2014-Draelos, Z. et al. Aging Gracefully, AAD Annual Meeting, Denver, CO, 2014-Draelos, Z. Anti-Aging Platforms and Clinical Studies, Anti-Aging Conference and Tabletop Exhibition, New Brunswick, NJ

2014



-Draelos, Z. et al. Soft Tissue Augmentation: The Nasolabial Fold and Beyond, AAD Annual Meeting, Denver, CO, 2014-Draelos, Z. Skin, Hair, and Nail Care for the Dermatologist, Summer AAD meeting, Chicago, 2014-Draelos, ZD. Growth Factors, Maui Dermatology, January 2015-Draelos, ZD. Hot Topics-Cosmeceuticals: Fact or Fancy. 73 Annual Meeting American Academy of Dermatology, San Francisco, March 20-24, 2015.-Draelos, ZD. Nail Cosmetics and Esthetics. 73 Annual Meeting American Academy of Dermatology, San Francisco, March 20-24, 2015-Draelos, ZD. Science and the Cutaneous Benefits of Nutraceuticals. 73 Annual Meeting American Academy of Dermatology, San Francisco, March 20-24, 2015-Draleos, ZD. Science and the Damaging Effects of Nutraceuticals. 73 Annual Meeting American Academy of Dermatology, San Francisco, March 20-24, 2015-Draelos, ZD. Dermatology Review. 73 Annual Meeting American Academy of Dermatology, San Francisco, March 20-24, 2015-Draelos, ZD. Skin, Hair, and Nail Care for the Dermatologist. Summer Academy Meeting, AAD, New York, August 19-23, 2015-Draelos, ZD. What's New in Rosacea Therapy. 73 Annual Meeting American Academy of Dermatology, San Francisco, March 20-24, 2015-Draelos, ZD. The Science of Skin, Hair, and Nail Care. Summer Meeting American Academy of Dermatology, New York, 2015-Draelos, ZD. The Disease of Aging. North Carolina Dermatology Association, Pinehurst, North Carolina, January 2016-Draelos, ZD. South Beach Symposium Cosmetic Dermatology Chair, South Beach, Florida, February 2016-Draelos, ZD. Aging and IR Radiation. Virgin Dermatology. St. Thomas, January 2016-Draelos, ZD. Science and Eating for Health. 74 Annual Meeting American Academy of Dermatology, Washington, DC, 2016-Draleos, ZD. Science and Eating for Disease. 74 Annual Meeting American Academy of Dermatology, Washington, DC, 2016-Draelos, ZD. Dermatology Review. 74 Annual Meeting American Academy of Dermatology, Washington, DC, 2016-Draelos, ZD. What's New in Rosacea Therapy. 74 Annual Meeting American Academy of Dermatology, Washington, DC, 2016-Draelos, ZD. Skin, Hair, and Nail Care for the Dermatologist. Summer Academy Meeting, AAD, Boston, 2016-Draelos, ZD. Massachusetts Dermatology Society, Portsmouth, NH, 2016-Draelos, ZD. Emollients and Moisturizers. Las Vegas Fall Clinical Meeting, 2016-Draelos, ZD. Industry Symposium Speaker, Moisturizers, Las Vegas Fall Clinical Meeting, 2016-Draelos, ZD. Aging and Dermatology. North Carolina Dermatology Association Meeting, 2016-Draelos, ZD. Acne Treatment Controversies, American Academy of Dermatology, 2016-Draelos, ZD. Cosmeceuticals, Dermatology Review. American Academy of Dermatology, 2016-Draelos, ZD. The Science of Cosmeceuticals and Nutraceuticals. American Academy of Dermatology, 2016-Draelos, ZD. Functional Cosmetics, Cosmetics Symposium, 2016-Draelos, ZD. What’s New In Rosacea Therapy, Rosacea Symposium. American Academy of Dermatology, 2016-Draelos, ZD. Cosmeceuticals, Dermatology Review. American Academy of Dermatology, 2017-Draelos, ZD. The Science of Cosmeceuticals and Nutraceuticals. American Academy of Dermatology, 2017-Draelos, ZD. Functional Cosmetics, Cosmetics Symposium, 2017-Draelos, ZD. What’s New in Rosacea Therapy, Rosacea Symposium, American Academy of Dermatology, 2017-Draelos, ZD. Skin Care Update, Society of Cosmetic Chemists, Irvine, CA, 2017-Draelos, ZD. The Latest in Skin Care, American Society for Dermatologic Surgery, 2017-Draelos, ZD. Stem Cell Ingredients, South Beach Symposium, 2017-Draelos, ZD. What’s New in Skin Care, South Beach Symposium, 2017-Draelos, ZD. Cosmeceuticals and Nutraceuticals. American Academy of Dermatology, 2018-Draelos, ZD. Cosmeceuticals: Fact or Fancy. American Academy of Dermatology, 2018.-Draelos, ZD. Natural Cosmeceuticals. American Academy of Dermatology, 2018.-Draelos, ZD. New Delivery Systems, American Academy of Dermatology, 2018.-Draelos, ZD. Dermatology Review: Cosmeceutical Update, American Academy of Dermatology, 2018.-Draelos, ZD. Skin, Hair, and Nail Cosmetics. Summer Meeting American Academy of Dermatology, 2018.

ORAL PRESENTATIONS (INTERNATIONAL)



-Draelos, ZD: Facial Cosmetics. University of Vancouver, British Columbia, 1988. -Draelos, ZD: Developing Products for Skin Care. Johnson & Johnson, London, England, 1997. -Draelos, ZD: Moisturizers in Mature Skin, Oil of Olay, Procter & Gamble, Toronto, Canada, 1998. -Draelos, ZD: The Role of Anti-Aging Therapies in the Prevention of Non-melanoma Skin Cancers, The 7th World

Congress on Cancers of the Skin. Rome, Italy, 1998. -Draelos, ZD: Beta Hydroxy Acids in Skin Care, Oily of Olay, Procter & Gamble, Sydney, Australia, 1999. -Draelos, ZD: Anti-Aging Moisturizer Technology, SinoAsian Congress of Dermatology, Xian, China, 2000.

-Draelos, ZD: Clinical Situations Conducive to Proactive Barrier Enhancement. 20th World Congress of Dermatology, Paris,2002.

-Draelos, ZD: Compliance in the Acne Patient, International Congress of Dermatology, Paris, France, 2003.-Draelos, ZD: Topical Niacinamide in Skin Care, International Congress of Dermatology, Paris, France, 2003.-Draelos, ZD: Clinical Situations Conducive to Proactive Scalp Skin and Hair Shaft Improvement, Berlin, Germany, 2004.-Draelos, ZD: The Dry Skin Cycle, Stratum Corneum IV Meeting, Paris, France, June, 2004.-Draelos, ZD: Approaches to Aging Skin, European Academy of Dermatology and Venerology, Florence, Italy, 2004.-Draelos, ZD: Skin in the Female Patient, European Academy of Dermatology and Venerology, Florence, Italy, 2004.-Draelos, ZD: Novel Approaches to Topical Formulation, Novartis, Basil, Switzerland, 2004.

-Draelos, ZD: Antiageing moisturizers. European Society for the Cosmetic & Aesthetic Dermatology, 2005 -Draelos, ZD: The Best and New in Cosmeceuticals. 62nd Congress of the Brazilian Society of Dermatology, 2007. -Draelos, ZD: Cosmetic Drug Use in Aging. 62nd Congress of the Brazilian Society of Dermatology, 2007. -Draelos, ZD: Cosmeceuticals: The Right Choice. 62nd Congress of the Brazilian Society of Dermatology, 2007. -Draelos, ZD: Novel treatments for geriatric xerosis. 21st World Congress of Dermatology, Buenos Aires, Argentina, 2007. -Draelos, ZD: Cosmeceuticals: practical solutions for common problems. 21st World Congress of Dermatology, Buenos

Aires, Argentina, 2007. -Draelos, ZD: Expanding realm of medical cosmetics. 21st World Congress of Dermatology, Buenos Aires, Argentina. -Draelos, ZD: Cosmeceuticals and advances in the treatment of scarring. 21st World Congress of Dermatology, Buenos

Aires, Argentina, 2007. -Draelos, ZD: Clinical situations conducive to proactive skin health and anti-aging improvement. 21st World Congress of

Dermatology, Buenos Aires, Argentina, 2007.-Draelos Z. 16th Annual Scientific Meeting of the ISHRS, featured guest speaker, 2008.

-Draelos ZD: Cosmeceuticals for skin rejuvenation. VI World Congress of the International Academy of Cosmetic Dermatology, Lisbon, Portugal, 2008.

-Draelos Z: Corrective Make Up-A true help for patients. 18th Congress EADV, Berlin, Germany, 2009 -Draelos Z: The cosmeceutical/nutrition connection. Ageing Skin Meeting, Manchester, England, 2010 -Draelos Z. Skin care products in skin of colour and controversies in skin care. South African Society for Dermatology

Surgery Conference, Durban, 2010.-Draelos Z. Nail cosmetics adverse events. 1st International Summit for Nail Diseases, Athens, 2010.-Draelos Z. Nail Disorders due to drug reactions. 1st International Summit for Nail Diseases, Athens, 2010.-Draelos Z. Treating ingrowing nail and other nail disorders with anchor taping and acrylic gutter splint. . 1st International

Summit for Nail Diseases, Athens, 2010.-Draelos Z. Congress of the Brazilian Society of Dermatology. 2010.-Draelos Z. Cellulite and striae, what works and what is the hype. Laser and Esthetic Theriapy in Ethnic Skin, College of

Medicine, King Saud University, Saudia Arabia, 2010.-Draelos Z. Cosmecuticals and skin care products. Laser and Esthetic Theriapy in Ethnic Skin, College of Medicine, King

Saud University, Saudia Arabia, 2010.-Draelos Z. Anti oxidants and skin ageing. Laser and Esthetic Theriapy in Ethnic Skin, College of Medicine, King Saud

University, Saudia Arabia, 2010.-Draelos Z. Male Skin and Ingredients Relevant to Male Skin Care. 22nd World Congress of Dermatology, Seoul, 2011.-Draelos Z. Cosmeceuticals and Nutraceuticals Relevant to Dermatology. 22nd World Congress of Dermatology, Seoul,

2011.-Draelos Z. Topical and Oral Interventions for Postmenopausal Skin. 22nd World Congress of Dermatology, Seoul, 2011.-Draelos Z. Anti-Aging and Oral Antioxidants. 22nd World Congress of Dermatology, Seoul, 2011.-Draelos Z, Elsner P, Swaile D, Cowley K, Wu Yan. Man in the Mirror. 22nd World Congress of Dermatology, Seoul, 2011.-Draelos, Z. Dermocosmetics in Acne. European Academy of Dermatology, Lisbon, 2011.-Draelos, Z. Cosmeceuticals. European Academy of Dermatology, Lisbon, 2011.-Draelos, Z. New Treatments for Aging, San Paulo, 2012.-Draelos, Z. Acne Treatment. RADLA, San Paulo, 2012.



-Draelos, Z. Nutrition and the Skin. RADLA, San Paulo, 2012.-Draelos, Z. Evaluation of a hydroquinone alternative in pigmentary disease. 21st EADV Congress in Prague, Czech

Republic, 2012-Draelos, Z. Acne Treatments. Reckitt-Benckiser Global Advisory Board. Geneva, 2013-Draelos, Z. Aging. International Federation of the Society of Cosmetic Chemists. Rio, 2013.-Draelos, Z. Redefining Masseters. Gender Aesthetic Conference. Singapore, 2013.-Draelos, Z. Environmental Insults and Skin Aging. European Academy of Dermatology, Istanbul, 2013.-Draelos, Z. 4 presentations on Cosmetic Dermatology. Austalian Society of Facial Aesthetics. Sydney, 2013.-Draelos, Z. Dermocosmetics: the adaptation of nutritionals into skin care for potential appearance enhancement, Brazil,

2013-Draelos, Z. Peels: What is the safe option for periorbital rejuvenation? 12 th Anit-Aging Medicine World Congress, Monte

Carlo, 2014-Draelos, Z. Chemical peels: superficial and medium depth, 12 th Anit-Aging Medicine World Congress, Monte Carlo, 2014-Draelos, Z. What’s new in topical skin care? 12th Anit-Aging Medicine World Congress, Monte Carlo, 2014-Draelos, Z. The Science and Utility of HUD in Dermatology and Cosmetic Dermatology. 12 th Anit-Aging Medicine World

Congress, Monte Carlo, 2014-Draelos, ZD. Cosmetic Dermatology for the General Dermatologist. 23Rd World Congress of Dermatology, Vancouver, 2015.-Draelos, ZD. Esthetics-Medical Approaches. 23Rd World Congress of Dermatology, Vancouver, 2015.-Draelos, ZD, et al. New Frontiers in Antioxidant Research. 23Rd World Congress of Dermatology, Vancouver, 2015.-Draelos, ZD, et al. Improve total patient outcome and optimize your practice with advanced cleansing technology. 23Rd World Congress of Dermatology, Vancouver, 2015.-Draelos, ZD. Active ingredients, vehicles and other substances. Xth World Congress of the International Academy of Cosmetic Dermatology. Rio de Janeiro, Brazil, Nov 14-16, 2015.-Draelos, ZD. Insights Regarding the Skin Barrier, Paris, October 2018.

AUDIOVISUAL AND AUDIO PRODUCTIONS-Kececioglu Z, Goldberg SJ, Allen HD, Sahn DJ. Introduction to Cardiac Doppler Ultrasound. Slide- tape presentation for

library distribution, 1978. -Draelos, ZD and others: New Perspectives on Acne, Cleveland Clinic Foundation, Slide Lecture Kit, 1994. -Draelos, ZD: Satellite media tour on dry skin. Procter & Gamble, 1997. -Draelos, ZD: Satellite media tour on beta hydroxy acids. Procter & Gamble, 1997. -Draelos, ZD: Satellite media tour on UVA photoprotection. Procter & Gamble, 1998. -Draelos, ZD: Video news release on Resilience Lift, Estee Lauder, 1998. -Draelos, ZD: Video news release on Azelex, Allergan, 1999. -Draelos, ZD: Video news release on UVA photoprotection, Procter & Gamble, 1999. -Draelos, ZD: Video news release on skin care, Allergan, 1999. -Draelos, ZD: Video news release on colored cosmetics and the skin, Procter & Gamble, 1999. -Draelos, ZD: Satellite media tour on occupational hand care, Healthpoint, 2000.-Draelos, ZD: Video news release on sun protection, Ciba and Skin Cancer Foundation, 2000.-Draelos, ZD: Video news release on acne and sebum production, Ferndale Laboratories, 2000.-Draelos, ZD: Unique and Effective Combination Treatment for Moderate to Severe Melasma, Galderma, 2002.-Draelos, ZD: Cosmeceuticals, Dialogues in Dermatology, July 2003-Draelos, ZD: Stiefel Acne Slide Physician Education Kit, July 2005-Draelos, ZD: Topical Anti-Aging Cosmeceuticals, January 2005-Draelos, ZD: Advances in Rosacea, Webcast, October 2004

-Draelos, ZD, Chung J. Food for Thought. Women’s Dermtologic Society. Skin Stories to Go, 2009 -Draelos, ZD: Cosmeceuticals, 2nd ed. Procedures in Cosmetic Dermatology Series, 2009.

-Draelos, ZD. Cosmetic Chemists Dermatology Training Series, 8 parts, 2012-Draelos, ZD. Skin Inc. Estheticians Skin Care Training Series, 4 parts, 2012

-Draelos, ZD. Investigator Meeting Training Session Scalp Psoriasis, 2016 -Draelos, ZD. Investigator Meeting Training Session Acne, 2016

BOOKS



-Draelos, ZK: Cosmetics in Dermatology. Edinburgh, Churchill-Livingstone, 1990. (Translated in Portugese) -Draelos, ZK: Cosmetics in Dermatology. Edinburgh, Churchill-Livingstone, Second edition, 1996. (Translated in Portugese,

Chinese, Japanese) -Draelos, ZD: Atlas of Cosmetics Dermatology. WB Saunders, Philadelphia, 2000.

-Draelos, ZD: The Therapeutic Use of Salicylic Acid, Supplement to Cosmetic Dermatology, September 1997. -Draelos, ZD: Dermatologic Aspects of Cosmetics. Dermatologic Clinics, WB Saunders, 2000.-Draelos, ZD: Atlas of Dermatologic Cosmetic Office Procedures, WB Saunders, 2002.-Draelos, ZD: Hair Care. Taylor & Francis, 2005.-Draelos, ZD: Cosmeceuticals. Elsevier, 2005. (Translated in Portugese, Chinese, Polish, Italian, Spanish)-Draelos, ZD, Thaman, L: Dermatologic Formulation. Informa, 2006.-Draelos, ZD: Cosmeceuticals (second edition). Elsevier, 2008. (Translated into Portugese, Chinese)

-Lim, H, Draelos, ZD: Sunscreens, Informa, 2008. -Draelos, ZD: Cosmetic Dermatology-Products and Procedures. Wiley-Blackwell, 2010. (Book translated into Spanish for

Spain, Spanish for Mexico, French, Portugese) (Versions developed for Southern India, Pakistan, Africa, Thailand)-Draelos, ZD: Cosmetics in Dermatology (third edition), Informa, 2011

-Draelos, ZD (editor): Cosmetic Dermatology: Products and Procedures (second edition). Wiley-Blackwell, 2015.-Draelos, ZD (editor): Cosmeceuticals (third edition). Elsevier, 2015.

BOOK CHAPTER CONTRIBUTIONS-Draelos, ZK: Use of Cosmetics in Cutaneous Surgery. Cutaneous Surgery. Wheeland RG (Ed), WB Saunders, 1994.

Kececioglu, Z: Pediatric and Adolescent Echocardiography: A Handbook. Goldberg SJ, Allen HD, Sahn D. Chicago, Yearbook Publishers, Inc., 1975. Chapters 1, 2 and 4.

-Draelos, ZK: Post-surgical Cosmetics. Dermatologic Surgery. Roenigk, RK(ed) and Roenigk HH, second edition, Marcel Dekker, 1996.

-Draelos, ZK: Cosmetic Treatment. Pediatric Dermatology. Schachner LA and Hansen RC (eds), second edition, Churchill Livingstone, 1996.

-Draelos, ZK: Cosmetics in the Treatment of Pigmentary Disorders. Pigmentation and Pigmentary Disorders. CRC Press, 1993.

-Draelos, ZK: Hair Care Products. Hair Replacement. Stough DB and Haber RS (eds) Mosby, 1996. -Draelos, ZD: Facial Cosmetics, Skin Care Products, and the Dermatologic Patient. Principles and Practice of Dermatology.

Sams WM, Lynch PJ (eds), Churchill Livingstone, 1996. -Draelos, ZD: New Developments in Cosmetics and Skin Care Products. Advances in Dermatology, Mosby-Year Book,

1997. -Draelos, ZD: Skin and Hair Biology and Conditioning. Conditioning Agents. Romanowski P, Marcel Dekker, 1999. -Draelos, ZD: Cosmetics in the Post Operative Patient. Skin Resurfacing. Coleman WM, Lawrence N, Williams & Wilkins,

1998. -Draelos, ZD: Cosmetics and Skin Care Products for the Dermatologist. Clinical Dermatology. Demis DJ (ed), Lippincott-

Raven Publishers, 1999. -Draelos, ZD: Topical Skin Care. Atlas of Aesthetic Cutaneous Surgery. MS Kaminer, KA Arndt, JS Dover(eds), WV

Saunders, 1999. -Draelos, ZD: Acne Vulgaris and Rosacea. Conn's Current Therapy. Rakel RE (ed), WB Saunders, 1999. -Draelos, ZD: Ancillary Skin Care. Cosmetic Dermatology Baran R, Maibach H (eds), Martin Dunitz, 1998. -Draelos, ZD: Cosmetic Safety and Testing. Harry's Cosmeticology. Reiger M(ed), Chemical Publishing, 2000. -Draelos, ZD: Vitamins and the Skin. The Chemistry and Manufacture of Cosmetics. Schlossman M (ed), Allured

Publishing, 2000. -Draelos, ZD: The Use and Role of Cosmetics. The Dermatology of Girls and Women. Parrish LC, Brenner S, Ramos-e-

Silva M (eds), Parthenon Publishing Group, 2000. -Draelos, ZD: The Clinical Toxicology of Cosmetics and Skin Care Products. Hazardous Materials Toxicology: Clinical

Principles of Environmental Health, Sullivan JB, Krieger G (eds), Williams and Wilkins, in press. -Draelos, ZD: Ancillary Esthetic Dermatologic Treatments and Procedures. Cosmetic Dermatologic Surgery. Narins RS

(ed), Marcel Dekker, 2000. -Draelos, ZD: Cosmetic Therapy. Comprehensive Dermatologic Drug Therapy. Wolverton SE (ed), WB Saunders, 2000.-Draelos, ZD: Emedicine Textbook Chapters on Moisturizers and Nail Care, on line 2000.-Draelos, ZD: Anti-Cellulite Creams, Endermologic and Other Non-Surgical Methods for Treating Excess Adipose Tissue.

Safe Liposuction. Narins RS (eds), Marcel Dekker, Inc., 2000.



-Draelos, ZD: Cosmetic Treatment. Pediatric Dermatology. Schachner LA and Hansen RC (eds), third edition, WB Saunders, 2007.

-Draelos, ZD: Topical Skin Care. Atlas of Aesthetic Cutaneous Surgery, Kaminer MS, ed, 2000-Draelos, ZD: Cosmetics and Cosmeceuticals. Dermatology. Bolognia JL, Jorizzo JL, Rapini RP, Horn TD, Mascaro JM,

Salasche SJ, Saurat JH, Siegfried E, Stingl G (eds), Harcourt, 2000.-Draelos, ZD: Topical Skin Care. Atlas of Cosmetic Surgery. Kaminer MS, Dover JS, Arndt KA (eds), WB Saunders, 2001.

-Draelos, ZD: Ancillary Aesthetic Dermatologic Treatments and Procedures. Cosmetic Surgery. RS Narins, ed, 2001 -Draelos, ZD: Other Topical Agents for the Aging Face. In Lowe N, Carruthers A, Carruthers J, Coghlan B, Draelos ZD,

Glogau R, Griffiths C, Klein A, Lask G (eds), Facial Rejuvenation. Martin Dunitz, 2002. -Draelos, ZD: Ancillary skin care products. Textbook of Cosmetic Dermatology. H Maibach, R Baran(eds), 2003

-Draelos, ZD: Topical Treatments for Benign Photodamage. Goldberg DJ (ed), Marcel Dekker, 2004.-Shapiro S, Draelos, ZD, Mallin K: Eczema Management, Physicians Continuing Medical Education, 2004.-Draelos, ZD. Dermatology Section Editor, Skin Care Chapter, Lifestyle Medicine, 2nd edition, pages 991-1002.

-Draelos, ZD. Modalities for Increasing Penetration. Cosmeceuticals and Cosmetic Practice. Patricia K. Farris, ed., Wiley Blackwell, 2014, pages 37-44.

-Draelos, ZD. Acne Mechanica. Acneiform Eruptions in Dermatology. Joshua A. Zeichner, ed. Springer, 2014, pages.125-128.

-Draelos, ZD. Cosmeceuticals-Efficacy and Influence on Skin Tone. African Skin and Hair Disorders. Nonhlanhla P. Khumalo, ed., Elsevier, 2014, pages 137-143.

-Draelos, ZD. Skin Care Products, Cosmetics, and Cosmeceuticals. Text Atlas of Obstetric Dermatology. George Kroumpouzos, ed., Lippincott Williams and Wilkins, 2014, pages 251-257.

-Draelos, ZD: Cosmetics in Rosacea. Pathogenesis and Treatment of Acne and Rosacea. Zouboulis, Christos C., Katsambas, Andreas D., and Kligman, Albert M. (eds), Springer, 2014.-Draelos, ZD: Hair Care and Dyeing. Alopecias. Ioannides, D. and Tosti A. (eds), Karger, 2015.-Draelos, ZD: Cosmeceuticals 3rd Edition. Expert Consult eBook version. Publish date 2015.-Draelos, ZD: Sauers Textbook of Dermatology. Cosmetics for the Physician, Chapter 7, 2016.-Draelos, ZD: Evidence-Based Procedural Dermatology. Second Edition, Springer, 2016.-Draelos ZD. Cosmetic camouflage for pigmentation issues. Ch 28, pp257-282, Hyperpigmentation, edited by Dimitris

Rigopoulos, Alexander C. Katoulis. CRC press, 2018

AUDIO PRESENTATIONS-Draelos, ZD: Sunscreens and Hair. Dialogues in Dermatology, 1997.-Draelos, ZD: Cosmetics and Sensitive Skin. Dialogues in Dermatology, 1998. -Draelos, ZD: Vitamins in Skin Care. Dialogues in Dermatology, 1999.-Draelos, ZD and others: Combination Treatment for Melasma, 2004.

-Draelos, ZD: Hydroxy Acids. Dialogues in Dermatology, 2003.-Draelos, ZD: Tips for Thinning Hair. Dialogues in Dermatology, 2008.

-Draelos ZD, Lawrence N. Antioxidants. Dialogues in Dermatology, 2010.-Draelos, ZD. Cosmeceuticals in Skin of Color. Dialogues in Dermatology, 2011.-Draelos, ZD. Vitamins and the Skin. Dialogues in Dermatology, 2013.

VIDEO PRESENTATIONS-Draelos, Z: Hair Care in the Female Androgenetic Alopecia Patient, Discovery International Productions, Upjohn Co.,

1990.-Draelos, ZD: Oil Absorbing Polymers and Facial Acne, Ferndale Laboratories, 2000.-Draelos, ZD: Women’s Health, Sun Protection and Skin Aging. National Syndicated Cable Series purchased by national

network, 2000. -Draelos, ZD: Science Update, “Hair Conditioner”, 2002 -Draelos, ZD: Web-Based CME program American Academy of Dermatology, 2003 -Draelos, ZD: Bikowski J. Webcast for Berlex and Collagenex, 2004 -Draelos, ZD: Maintaining Beautiful Hair Through Thick and Thin. American Academy of Dermatology’s ACADEMY 2005 -Draelos, ZD: Elewski B. Looking at Seborrheic Dermatitis from every angle. 2005 Dermatologist Webcast.



-Draelos, ZD: Advances in Facial Rejuvenation: Botulinum Toxin Type A, Hyaluranoic Acid Dermal Fillers, and CombinationTherapies—Consensus Recommendations: Pocket Guide and Slide Presentation, 2008

-Draelos, ZD: Cosmeceuticals, 2nd ed, 2008 -Draelos, ZD: and other members of the Facial Aesthetics Consensus Group: Plastic and Reconstructive Surgery. Pocket

Guide and Slide Presentation, 2009 -Draelos, ZD: Cosmetic Dermatology Teaching Series for Aestheticians, Skin, Inc. (Allured Publishing Company), 2014 -Draelos, ZD: Skin Physiology for the Cosmetic Chemist, Cosmetics & Toiletries (Allured Publishing Company), 2014 -Draelos, ZD: Investigator Meeting presentations on Acne and Scalp Psoriasis, Catawba Research, 2016 -Draelos, ZD: Investigator Meeting presentations on Rosacea, Catawba Research, 2017

INSTRUCTIONAL MANUALS-Draelos, Z: Hair Replacement Techniques. Upjohn Co., 1988. -Draelos, Z: Hair Loss and Hair Care in Women. Upjohn Co., 1991. -Draelos, Z: Skin Care Manual. Johnson and Johnson Worldwide Consumer Products, 1995. -Draelos, ZD: Skin Care Guide for Pharmacists, Procter & Gamble, 1999.-Draelos, ZD: Acne Workbook, Galderma, 2000.

PAMPHLETS-Draelos, ZK and others: Depakote and Hair Loss in Your Child, 1992. -Draelos, ZK: Cosmetics, American Academy of Dermatology, 1994. -Draelos, ZK: You and Your Dermatologist, American Academy of Dermatology, 1997. -Draelos, ZK and others: Teen Health, American Academy of Dermatology, 1995. -Draelos, ZD: Nails, American Academy of Dermatology, 1997.

-Draelos, ZD: Going Under Cover, Best Face Forward. Galderma Laboratories, 1998 -Draelos, ZD: A Novel Topical Oil-Imbibing Technology For the Control of Excessive Facial Oil, Cosmetic Dermatology

Supplement, 1999. -Draelos, ZD: Cosmetic compatibility: Another reason AZELEX adds more. Allergan, 1999.

-Draelos, ZD: Skin Care. The Partnership for Women’s Health at Columbia, 2000.-Draelos, ZD: Acne Briefs, Cosmetics for the Acne Patient, 2000.-Draelos, ZD: The Use of Cosmetics and Skin Care Products, American Academy of Dermatology, 2001.-Draelos, ZD: Rosacea Briefs, Cosmetic Camouflage and Skin Care for Rosacea Patients, 2001.

-Draelos, ZD: ACNEBRIEFS. Galderma, 2000; 2(4).-Draelos, ZD: Cosmetics and Skin Reactions, American Academy of Dermatology, 2012, updated 2014.

TELEVISION APPEARANCES-"Good Morning America, ABC, representing the Skin Cancer Foundation on "Sunscreen Protection," 1994. -WGHP, Greensboro, North Carolina, discussing moisturizers, sunscreens, hair care, tanning booths, and chemical

peeling, 1992, 1994, 1995, 1996, 1998. -"20/20", ABC, Segment discussing "Hirsutism in Women," 1996. -Television series "Women at Risk," presentation on how to care for maturing skin, 1999.-Morning News, NBC, representiong the American Academy of Dermatology on “Hormonal Hair Loss,” 2008.-Fox News Greensboro, WGHP, “Deal or Dud: Cosmetics in Action,” 2006, 2007, 2008, 2010, 2011, 2014, 2016.

VISITING PROFESSORSHIPS-Draelos, ZD: Hyperthermia in Dermatology. University of Minnesota, Peter Lynch MD, 1987. -Draelos, ZD: Hair and Facial Cosmetics. University of Cincinnati, Cincinnati, Ohio, James Nordlund, MD, 1989. -Draelos, ZD: Cosmetic Camouflaging, University of Arizona, Tucson, Arizona, Norman Levine, MD, 1994. -Draelos, ZD: Hair and Facial Cosmetics. University of Miami, Miami, Florida, William Eaglestein, MD, 1995. -Draelos, ZD: Mechanisms of Cutaneous Aging, John Hopkin's School of Medicine, Baltimore, Maryland, Thomas Provost,

MD, 1997. -Draelos, ZD: The Cutaneous Effects of Alpha and Beta Hydroxy Acids, University of Pennsylvania, Philadelphia,

Pennsylvania, Richard Odom, MD, 1997.



-Draelos, ZD: The Hydroxy Acids, University of Colorado Health Sciences, Denver, Colorado, 1997. -Draelos, ZD: The Hydroxy Acids, Pennsylvania State College of Medicine, Harrisburg, Pennsylvania, James Marks, MD,

1997. -Draelos, ZD: Hydroxy Acid Creams and Peels, Mt. Sinai Dermatology Program, New York, New York, Mark Lebwohl, MD,

1997. -Draelos, ZD: Alpha and Beta Hydroxy Acids, SUNY, New York, New York, Alan Shalita, MD, 1997. -Draelos, ZD: Antiaging Therapies. University of Oklahoma Medical School, Oklahoma City, Oklahoma, Lynn Drake, 1997. -Draelos, ZD: Moisturizers. Columbia Dermatology Program, New York, New York, Vincent DeLeo, 1997. -Draelos, ZD: Skin and Hair Care Products. Jefferson Dermatology Program, Philadelphia, Pennsylvania, Joni Uitto, 1997. -Draelos, ZD: Reaching Beyond the Diagnosis. University of Arizona Dermatology Section, Tucson, Arizona, Norman

Levine, 1998. -Draelos, ZD: Reaching Beyond the Diagnosis. University of Chicago Department of Dermatology and combined programs,

Chicago, Illinois, 1998. -Draelos, ZD: Reaching Beyond the Diagnosis. University of Minnesota Department of Dermatology, Minneapolis,

Minnesota, Mark Dahl, 1998. -Draelos, ZD: Reaching Beyond the Diagnosis. Northwestern Department of Dermatology, Chicago, Illinois, Henry Roenigk,

1999. -Draelos, ZD: Reaching Beyond the Diagnosis. Duke University Section of Dermatology, Durham, North Carolina, John

Murray, 1999. -Draelos, ZD: Reaching Beyond the Diagnosis. Chapel Hill Department of Dermatology, Chapel Hill, North Carolina, 1999.-Draelos, ZD: Cosmetic Dermatology. Emory Department of Dermatology, Atlanta, Georgia, 2000.-Draelos, ZD: Cosmetic Dermatology. Henry Ford Hospital and Multiple University Dermatology Programs, Detroit,

Michigan, 2000.-Draelos, ZD: Cosmetic Dermatology. University of Colorado Department of Dermatology, Denver, Colorado, 2000.-Draelos, ZD: Cosmetic Vignettes. Chapel Hill Department of Dermatology, Chapel Hill, North Carolina, 2001.-Draelos, ZD: Cosmetic Vignettes. University of Utah Department of Dermatology, Salt Lake City, Utah, 2001.-Draelos, ZD: Cosmetic Vignettes. Medical College of Wisconsin Department of Dermatology, Milwaukee, Wisconsin, 2001.-Draelos, ZD: Cosmetic Vignettes. University of Chicago Department of Dermatology, Chicago, Illinois, 2001.-Draelos, ZD: Cosmetic Vignettes. University of Pennsylvania Joint Dermatology Programs, Philadelphia, Pennsylvania,

2001.-Draelos, ZD: Cosmetic Vignettes. University of Arizona Section of Dermatology, Tucson, Arizona, 2001.

I have visited 5 university dermatology programs annually from 2001-2013 to present resident lectures on cosmetic dermatology and related topics. These lectures are not listed as individual programs to conserve space.

MONOGRAPHS-Draelos, ZK: Compliance in the Acne Patient. SynerMed Publication, 1994. -Draelos, ZK: Hypoallergenicity Consensus Forum Proceedings, Ted Thomas Publications, 1994. -Draelos, ZK: Cosmetics: An Overview. Current Problems in Dermatology, March/April 1995. -Draelos, ZD: Emollients. Supplement to Skin and Aging, 1999. -Draelos, ZD: Safe Shaving. Schick, 2000.-Draelos, ZD: Managing Unwanted Facial Hair, Bristol Myers Squibb, 2000.-Draelos, ZD: Acne Briefs, Volume 2, Number 4, 2001.-Draelos, ZD: Dyschromia Rounds, 2001.-Draelos, ZD: Skin Care: Over-the-Counter Options, Galderma, 2002.-Draelos, ZD: Examination of a New Photodamage Formula, Dyschromia Rounds, 2002.-Draelos, ZD: Several Active Naturals Aid in the Prevention of Photoaging. Skin and Allergy News, 2003.-Draelos, ZD and Consensus Conference Members: Consensus Recommendations on the Use of Botulinum Toxin Type A

in Facial Aesthetics, Plastic and Reconstructive Surgery Supplement, 2004.-Draelos, ZD: Rosacea Roadmap, 2004.-Draelos, ZD: Dealing with Scalp Flaking, Procter & Gamble Educational Brochure, 2005.

POSTER EXHIBITS-Draelos, ZK: Hyperthermia in the treatment of a murine model of melanoma. Society of Investigative Dermatology, 1986. -Draelos, ZD: Dermatologic characterization of sensitive skin. American Academy of Dermatology, 1998.



-Draelos, ZD: The Use of Zinc Oxide as a Broad Spectrum Photoprotectant in Females With Sensitive Skin. American Academy of Dermatology, 1999.

-Draelos, ZD: Dermatologic Criteria for Assessing Cosmetic Compatibility: A Clinical Trial With Azelaic Acid 20% Azelaic Acid Cream. American Academy of Dermatology, 1999.

-Simion FA, Abrutyn E, Draelos ZD: Ability of Creams to Reduce Erythema, Stratum Corneum Barrier Damage, and Subjective Itching. American Academy of Dermatology Meeting, Winter 2000.

-Draelos, ZD: The Tazarotene CLEAR Trial A Multicenter, Investigator-Masked Comparison of the Efficacy and Tolerability of Treating Acne Vulgaris with Tazarotene qd, Clindamycin bid, or Combination Therapy with Tazarotene. American Academy of Dermatology Meeting, Summer 2000.

-Ogbogu P, Feldman SR, Fleischer AB Jr, Brodell RT, Draelos ZD: Differences Between Physicians’ and Patients’ Perspectives on Office-Based Dispensing. American Academy of Dermatology, Summer, 2000

-Lowe N, Anderson N, Draelos Z, Eisen D: Comparing the Efficacy and Tolerability of Tazarotene 0.1% Gel and Tretinoin 0.025% Gel in the Treatment of Facial Acne Vulgaris: A Second Multicenter, Double-Blind, Randomized Trial. American Academy of Dermatology Meeting, Summer 2001.

-Fuller BB, Smith DR, Spaulding DT, Pilcher BK, Draelos ZD: A Novel Nitrone-based Free Radical Trap Blocks UV-induced Cytokine Production in Human Fibroblasts and Keratinocytes and Inhibits UV-induced Erythema in Human Skin in vivo. Society of Investigative Dermatology, Annual Meeting 2001.

-Draelos ZD, Ertel K, Berge C, Amburgey M: A Facial Moisturizing Product As An Adjunct in the Treatment of Rosacea. American Academy of Dermatology Annual Meeting, 2003.

-Ling G, Lebwohl M, Pariser D, Draelos Z, et al: Efficacy and Safety of Pimecrolimus Cream 1% in the Treament of Intertgrinous Psoriasis: A Double-blind Study. American Academy of Dermatology Annual Meeting, 2003.

-Draelos ZD, Kempers S, Hauffe S, Chon K: Skin Selectivity: Comparison of Pharmacokinetics, Local Tolerability, and Efficacy of Pimecrolimus and Tacrolimus in Adult and Pediatric Patients with Atopic Dermatitis. American Academy of Dermatology Annual Meeting, 2003.

-Draelos ZD: Development of a New Aqueous Gel Formulation of Azelaic Acid 15% as Topical Therapy for Moderate Papulopustular Rosacea, Society of Investigative Dermatology Annual Meeting, 2003.

-Draelos ZD, Graupe, K: A New Topical Formulation for the Treatment of Mild to Moderate Papululopustular Rosacea: Azelaic Acid 15% Gel. American Academy of Dermatology Annual Meeting, 2003.

-Draelos ZD, Pilcher BK,Smith DR, Fuller BB: Clincial Efficacy of a Novel Non-steroidal Anti-inflammatory Molecule in Treating Symptoms of Rosacea: Identificiation of Inflammatory Mediators Inhibited by CX-452. Society of Investigative Dermatology Annual Meeting, 2003.

-Draelos, ZD: Evaluation of Rosacea Severity and Facial Stinging Following Topical Application of Azelaic Acid 15% Gel. American Academy of Dermatology Annual Meeting, 2004.

-Draelos ZD, Tofte S, Hanifin J, Chon K: Systemic Exposure of Pimecrolimus Cream 1% and Tacrolimus Ointment 0.1% in Adult Patients with Moderate to Severe Atopic Dermatitis. American Academy of Dermatology Annual Meeting, 2004.

-Draelos ZD: The Rosacea Patient’s Skin. Hawaii Dermatology Seminar, 2004.-Draelos ZD: Cosmetic Sunscreen Technologies. DF: Clinical Symosia, 2005.-Draelos ZD, Pillai R, Cargill I: Clocortolone pivalate cream in combination with a barrier cream on the control of irritant

contact hand dermatitis. American Academy of Dermatology Annual Meeting, 2005.-Draelos ZD: Importance of tolerability and skin barrier function in rosacea treatment selection. American Academy of

Dermatology Annual Meeting, 2005.-Lowe N, Horwitz S, Tanghetti E, Draelos Z: Tazarotene versus tazarotene plus hydroquinone in the treatment of

photodamaged facial skin: a multicenter, double-blind randomized study. American Academy of Dermatology Annual Meeting, 2005.

-Kenneally D, Draelos ZD: Cosmetic Benefits Improve Compliance in Dandruff/Seborrheic Dermatitis Shampoo Treatment, American Academy of Dermatology Annual Meeting, 2005.

-Cosmetic Benefits Improve Compliance in Dandruff/Seborrheic Dermatitis Shampoo Treatment. Zoe Draelos, Dianna Kenneally, Ward Billhimer, Megan Copas, Laura Lebda. Proctor & Gamble, 2005

-Facilitating Accommodation to Topical Tretinoin With an SPF 15?UV Facial Moisturizer Containing Niacinamide, Panthenol, and Tocopheryl Acetate. Zoe Draelos, Cynthia Berge, Mary Amburgey. Proctor & Gamble, 2005

-Corneocyte Scrapings as a Parameter for the Assessment of Ashen Skin, Zoe Draelos, Perveen Kazmi, Elizabeth Volz, Thomas Polefka, Colgate-Palmolive Co., 2005

-Dapsone Topical Gel 5% in Combination with Vehicle Gel, Benzoyl Peroxide Gel 4%, or Adapalene Gel 1.1%: Results of a Randomized, Double-blind Study for the Treatment of Acne Vulgaris. Alan B Fleischer Jr, David Pariser, Zoe Draelos, 2006

-Oil of Olay Ribbons Body Wash-Atopic Dermatitis Home Use Study. Draelos, ZD, and Ertel, K., 2006



-Age related NADH oxidase (arNOX) activity of epidermal punch biopsies correlate witht subject age and arNOX activities of serum and saliva. Dale Kern, Zoe Draelos, Dorothy M. Morre and D. James Morre. NuSkin Enterprises, Dermatolgy Consulting Serives, and Purdue University, 2006

-The effect of a non-alkaline skin cleanser on the skin barrier of rosacea patients, Galderma Laboratories, 2006-The effect of a daily facial cleanser formulated for normal to oily skin on the skin barrier of acne patients, Galderma

Laboratories, 2006-A moisturizing cream that helps preserve the skin barrier, enhance hydration and reduce desquamation in untreated

psoriasis patients, Galderma Laboratories, 2006-A Double-blind, Randomized, Vehicle-controlled Trial To Dertermine the Efficacy and Safety of Hydrocortisone Butyrate

Lotions 0.1% in the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Subjects Aged 3 months to Less Than 18 years. Scott Checketts, David Fivenson, Daniel Grossier, Regina Hamlin, Adelaide Hebert, Daniel Hogan, Candice Johnson, Steven Kempers, Robert Loss, Robert Matheson, Robert Schoenfield, Judith Williams, Debra Breneman, Zoe Draelos, Leon Kircik; Ferndale Laboratories, 2007

-Dapsone gell, 5% in combinations with adapalene gel, 0.1%, benzoyl peroxide gel, 4%, or vehicle gel for the treatment of acne vulgaris: a randomized , double-blind study. Alan B Fleischer, Jr, William Abramovits, David M Pariser, Zoe Draelos, for the Dapsone Gel in Combination Therapy Study Group, 2007

-An Open Label Adrenal Suppresion Study of Hydorcoritsone Butyrate Lotion 0.1% used 3x Daily in Pediatric Subjects Aged 3 months to Less than 18 years With Moderate to Severe Atopic Dermatitis, Ferndale Laboratories

-Draelos ZD. Clindamycin/Benzoyl Peroxide in the Treatment of Perioral Dermatitis: A Double-Blind, Randomized, Vehicle-Controlled Study, 64th Annual Meeting of the American Meeting of the American Academy of Dermatology, 2006

-Draelos ZD. The Role of MultiVesicular Emulsions in Dermatology, 64th Annual Meeting of the American Academy of Dermatology, 2006

-Draelos ZD. Tolerability and preference of two benzoyl peroxide/clindamycin gels in combination with tretinoin 0.025% cream in adult acne patients. 64th Annual Meeting of the American Academy of Dermatololgy, 2006

-Draelos ZD, Hensby C, Cargill I. The role of multivesicular emulsions in dermatology. . 64 th Annual Meeting of the American Academy of Dermatololgy, 2006

-Draelos ZD. A Moisturizing Cream That Helps Preserve the Skin Barrier, Enhance Hydrations and Reduce Desquamations in Untreated Psoriasis Patients,64th Meeting of the American Academy of Dermatology, 2006

-Draelos ZD: The Effect of a Daily Facial Cleanser Formulated for Normal to Oily skin on the Skin Barrier of Acne Patients. 64th Annual Meeting of the American Academy of Dermatololgy, 2006

-Draelos ZD. The Effect of a Gentle Moisturizing Cream on the Skin Barrier and Flaking of Patients with Mild Plaque Psoriasis. 64th Annual Meeting of the American Academy of Dermatology, 2006

-Draelos ZD. The Effect of a Gentle Daily Facial Cleanser for Oily Skin on the Skin Barrier of Acne Patients. 64 th Annual Meeting of the American Academy of Dermatology, 2006

-Draelos ZD. The Effect of a Gentle Non-Alkaline Skin Cleaser on the skin Barrier of Rosacea Patients. 64 th Annula Meeting of the American Academy of Dermatology, 2006

-Draelos ZD, Callender VD, Dhawan SS, Young C. Tolerability and Preference of Two Benzoyl Peroxide/Clindamycin Gels in Combination with Tretinoin 0.025% Cream in Adult Female Acne Patients

-Draelos ZD, Spreen K. Phase 4 Trial Findings on the Safety and Tolerability of Combination Solution of Mequinol 2%/ Tretinion 0.01% in Dark Skin Types. Am Acad of Derm Summer Meeting, 2006

-Fleischer AB, Draelos ZD, Abramovits W, Pariser DM. Dapsone gel 5% in combination with adapalene gel 0.1%, benzoyl peroxide gel 4%, or vehicle gel for the treatment of acne vulgaris: A randomized, double –blind study. Am Acad of Dermatology, 2007.

-Draelos ZD, Akridge R. An efficacy assessment of a novel skin cleansing device in seborrheic dermatitis. Am Acad of Dermatology, 2007.

-Oresajo C, Yatskayer M, Fares H, Draelos Z, Hansenne I. A Twenty Four-Week, Dermatologic Eveluation of The Efficacy and Tolerance of a Topical Antioxidant Product Containing Vitamins C, E, and Ferulic Acid for Photodamaged Skin, 21st World Congress of Dermatology, 2007.

-Oresajo C, Yatskayer M, Galdi A, Trokman N, Rizer R, Draelos Z, Hansenne I. Multi-center, Clinical Evaluation of a Broad Spectrum Sunsceen Moisturizer containing a New Photostable UVA/UBV Complex for Treatment of Photodamage facial Skin, 21st World Congress of Dermatology, 2007.

-Draelos Z. Psychometric Validation of the Oily Skin Self Assessment Scale (OSSAS) and the Oily Skin Impact Scale (OSIS). ISPOR 10th Annual European Congress, 2007

-Draelos Z. A dermatologic evealuation of the tolerance and efficacy of a topical antioxidant composition containing vitamins C, E, and Ferulic acid. EADV, 2007



-Draelos Z. The Ability of onion extract gel to improve healing and cosmetic appearance in postsurgical wounds. 17 th AnnualWound Healing Society Meeting, 2007

-Tanghetti E, Draelos Z, Grimes P, Dhawan S, Gold M. Moisturizer Use Enhances Facial Tolerability of Tazarotene ) 1% cream without Compromising Efficacy in Patients with Acne Vulgaris, 32nd Hawaii Dermatology Serminar

-Draelos Z, Kayne A: Implications of azelaic acid’s multiple mechanisms of action: Therapeutic versatility, American Academy of Dermatology Annual meeting, 2008.

-Draelos Z. A double-blind, randomized clinical trial evaluating the dermatologic benefits of coffee berry extract, American Academy of Dermatology Annual meeting, 2008.

-Draelos Z, Ertel K, Watson D, Bacon R. High-petroleum depositing body wash benefits mild to moderate active atopic dermatitis, American Academy of Dermatology Annual meeting, 2008.

-Gollnick HP, Guericke OV, Kaszuba A, Kaszuba A, Rosoph L, Draelos Z. Adapalene-benzoyl peroxide: A trans-Atlantic, randomized, double-blind, controlled study in 1670 acne vulgaris patients, American Academy of Dermatology, 2010

-Draelos Z, Hardas B, Pappert E, Kaur M, Murray W. Evaluation of the clinical efficacy of onion extract cream in the treatment of new stretch marks. American Academy of Dermatology, 2010

-Draelos Z. Moisturing benefits of a novel serum containing low and high molecular weight bylauronic acid. AAD Summer Academy meeting, 2010.

-Draelos Z. A Clinical Demonstration of the spreadability of a Non-Steroidal Hyaluronic Acid Emollient Foam in Atopic Dermatitis. AAD Summer Academy meeting, 2010.

-Draelos Z. The Efficacy of Hyaluronic Acid Foam in the Treament of Mild to Moderate Atopic Dermatitis, AAD Summer meeting, 2010.

-Draelos Z, Koutatsu B, Butcher D, Billhimer W. Delivery of a pseudoceramide to atopic skin is related to objective and subjective improvement, AAD Annual Meeting, 2011.

-Draelos Z, Glenn MJ, Rosoph LA, Kaszuba A, Cornelison R, Soto P, Gore B, Liu Y, Graeber M. Adapalene-Benzoyl Peroxide: A Transatlantic, Randomized, Double-Blind, controlled Studyin 1670 Acne Vulgaris Patients. E-poster: 22nd World Congress of Dermatology, Seoul, 2011

-Draelos Z, Colon LE, Johnson LA. An Evaluation of the Appearance of Facial Cosmetics Following Daily Application of Metronidazole Gel, 1%. E-poster: 22nd World Congress of Dermatology, Seoul, 2011.

-Draelos Z, Puissegur L, Gold M, Goldman M. Hydriquinone-free brightening complex: A multicenter study for skin aging. 70th AAD Meeting, San Diego, CA, 2012.

- Gold Linda S.,Draelos, Z, et al., Long-Term Safety of Ivermectin 1% Cream vs. Azelaic Acid 15% Gel In Treating Subjects with Papulo-Pustular Rosacea. European Academy of Dermatology and Venerology, 2014.

- Reich, K, Puig, L, Draelos, Z, et al. Sustainability of Response With Secukinumab to 52 Weeks in Moderate-to-Severe Plaque Psoriasis: Data From the Full Year Investigative Examination of Secukinumab vs. Etanercept Using 2 Dosing Regimens to Determine Efficacy In Psoriasis (FIXTURE) Study, European Academy of Dermatology and Venerology, 2014.

-Draelos, Z. An Investigator Blinded Assessment of the Efficacy of Triamcinolone Acetonide 0.2% Spray When Applied Without Rubbing. Fall Clinical Dermatology Meeting, 2014.

-Draelos, Z. Demonstration of the Biphasic Release of Halcinonide Cream (0.1%), Fall Clinical Dermatology Meeting, 2014.-Draelos, ZD. et al.: Maximal use systemic exposure (MUSE) study evaluating AN2728, a novel boron-based small molecule, for the treatment of pediatric and adolescent subjects with mild-to-moderate atopic dermatitis.Seminars in Cutaneous Medicine and Surgery (Supplement 5). 2014, December, v 33.-Draelos, ZD. et al.: Secukinumab sustainability of response in subjects with moderate-to-severe plaque psoriasis over 52 weeks: a subanalysis from the fixture study. Seminars in Cutaneous Medicine and Surgery(Supplement 5). 2014 December, v 33.-Draelos, ZD. et al.: Innovation in papulopustular rosacea treatment: efficacy and safety of invermectin 1% cream. Seminars in Cutaneous Medicine and Surgery(supplement 2). 2015 March, v 34, S20.-Draelos, ZD. et al.: Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea. Seminars in Cutaneous Medicine and Surgery(supplement 2). 2015 March, v 34, S20.-Draelos, ZD. et al.: Post-hoc Analyses of the Effect of AN2728 Topical Ointment, 2% on Atopic Dermatitis-associated Pruritus in Four Clinical Studies. ASDR 2015.-Draelos, ZD. et al.: Bimatoprost 0.03% for the Treatment of Eyebrow Hypotrichosis. AAO 2015 Annual Meeting of the American Academy of Ophthalmology, Las Vegas, Nov 14-17, 2015.-Draelos, ZD. Post-hoc analyses of the effect of AN2728 topical ointment, 2% on atopic dermatitis-associated pruritus. Journal of Investigative Dermatology, Fall 2015.-Draelos, ZD. et al.: Changes in Skin Laxity Among Responders to Deoxycholic Acid Injection (ATX-101) in the REFINE Trials. ASDS 2015.



-Draelos, ZD. Age and Gender as Predictors of Treatment Outcomes with Once-Daily Dapsone 7.5% Topical Gel for Acne Vulgaris. Maui Derm 2016.-Fabi, S, Draelos ZD, Dayan SH, Gross TM, Lizzul PF Beddington FC, Somogyi C. Changes in Skin Laxity Among Responders to ATX-101 in the REFINE Trials. Maui Derm 2016-Bucko A, Draelos ZD, Duboid JC, Jones TM. A Double-Blind, Randomized Study to Compare Microcyn Scar Management HydroGel, K103163, and Kelo-cote Scar Gel for Hypertrophic or Keloid Scars. Maui 2016.-Wood SM, Gray R, Hester SN, Mastaloudis AF, Kern D, Namkoong J, Draelos ZD. Novel Nutritional Formula Protects Against Cellular Damage. Experimental Biology 2016.-Stein-Gold L, Kircik LH, Draelos ZD, Werschler P, DuBois J, Lain E, Baumann L, Goldberg DJ, Kaufman J, Tanghetti EA, Weng E, Berk DR, Ahluwalia G. American Academy of Dermatology Annual Meeting Poster 2017. Efficacy and Safety of Topical Oxymetazoline Cream 1.0% for Treatment of Facial Erythema Associated With Rosacea: Findings From Two Pivotal Phase 3 REVEAL Studies-Kircik LH, DuBois J, Draelos ZD, Werschler P, Grande K, Cook-Bolden FE, Berk DR, Ahluwalia G. American Academy of Dermatology Annual Meeting Poster 2017. Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Facial Erythema Associated With Rosacea: REVEAL Study-Draelos ZD, Estes E, Kempers SE, Powala C,, Shanler S, Smith SR, Wilson DC, Bradshaw M. American Society for Dermatologic Surgery Poster 2017. Efficacy and Safety of A-101 Hydrogen Peroxide Topical Solution 40% in Adult Subjectswith Seborrheic Keratosis: Results from the Phase 3, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study-Kern D, Namkong J, Riggs M, Cook B, Draelos Z, Knaggs H. European Society for Dermatologic Research Poster 2017. A Novel Device for Skin Type Based Treatment While Cleansing-Stein-Gold L, Dhawan S, Weiss J, Draelos ZD, Ellman H. Fall Clinical Poster 2017. The Efficacy and Safety of FMX101, Minocycline Foam 4%, for the Treatment of Acne Vulgaris: A Pooled Analysis of 2 Phase 3 Studies-Kern DG, Draelos ZD, Namkoong J, Riggs M, Knaggs H. American Academy of Dermatology Annual Meeting Poster 2017. A Unique Sensitive Skin Cleansing Technology-Blume-Peytravi U, Tanghetti E, Kremeny L, Draelos Z, et al. EADV Poster 2018. A Long-Term Safety and Efficacy Study of Trifarotene 50 micrograms/gram Cream in Subjects with Facial and Truncal Acne Vulgaris-Draelos ZD, Sugarman J, Jackson M. Maui Derm Poster 2018. DFD-01, A Novel Emollient Spray Formulation of Betamethasone Dipropionate, Demonstrates Maximum Usage Safety in Moderate to Severe Plaque Psoriasis-Kircik L, Draelos, ZD, Lin T, Pillai R. Fall Clinical Poster 2018. Transepidermal Water Loss and Skin Hydration Assessment of a Novel Lotion Formulation-Stein Gold L, Dhawan S; Weiss J, Draelos ZD, Ellman H. American Academy of Dermatology Annual Meeting Poster 2018. FMX101 4% Minocycline Foam for the Treatment of Acne Vulgaris: Safety and Patient Satisfaction From the Open-Label Extension of 2 Phase 3 Studies-DG Kern, ZD Draelos, J Namkoong, M Riggs, HE Knaggs. American Academy of Dermatology Annual Meeting Poster 2018. Sensitive Skin Tolerance to Cleansing Tool Topographies and Cleansers-Gunt HB, Draelos ZD, Levy SB, Lutrario CA. American Academy of Dermatology Annual Meeting 2018. Effectiveness of a

Nature-based Sensitive Skin Regimen (NBSSR) Compared with Synthetic Dermatologist-recommended Control Regimen (CR) in Subjects with Sensitive Skin Related to Atopic Dermatitis/Eczema, Rosacea, or Cosmetic Intolerance

SYMPOSIUMS-Draelos, ZD: Cosmetics Symposium Director, American Academy of Dermatology, 1994-1998. -Draelos, ZD: Perspectives on Skin Care Products, Director, Hawaiian Dermatology PostMeeting Seminar, 1994. -Draelos, ZD: Hypoallergenicity Consensus Forum, Panelist, RoC SA, 1994.-Draelos, ZD: International Consensus on the Signs of Aging Skin, 1999.-Draelos, ZD: Forum on Skin Barrier Function, Whitehall-Robins, 2001.

-Draelos, ZD: Sixth Annual International Symposium of Aging Skin, 2002.-Draelos, ZD: Forum on Skin Care Consensus, Coria, 2004.

-Draelos, ZD: International Stratum Corneum IV Symposium, P & G Beauty, 2004. -Draelos, ZD: Consensus Conference of Standard Rosacea Treatment Algorithms, National Rosacea Society, 2005 -Draelos, ZD: International Stratum Corneum IV Symposium, 2005 -Draelos, ZD: Leadership Development Team, American Society for Dermatologic Surgery, 2005 -Draelos, ZD: Reduction of skin hyperpigmentation—cosmetic considerations, P& G Beauty, 2006. -Draelos, ZD: Suncare 2020: Challenges and Future Imperatives for Improving Suncare for American Consumers,

Coppertone Solar Research Center, 2010.



PRESS CONFERENCES-Draelos, ZD: Cosmetic Treatment of Aging Skin. Neutrogena, 1991. -Draelos, ZD: Selecting the Proper Moisturizer. Dermik, 1993. -Draelos, ZD: Hair Removal in Women. Schick and Lane and Coady, 1995, 1996. -Draelos, ZD: Dry Skin and Cleansing of the Skin. Procter & Gamble, 1997. -Draelos, ZD: Hydroxy Acid Formulation. Procter & Gamble, 1997. -Draelos, ZD: Healthy Nails for Life. American Academy of Dermatology, 1997. -Draelos, ZD: Moisturizing Mature Skin. Procter & Gamble, 1998. -Draelos, ZD: Hair Cosmetics. American Academy of Dermatology, 1999. -Draelos, ZD: Melanoma Skin Cancer Detection Press Conference, American Academy of Dermatology, Sunscreens 101,

2004.I have participated in at least 3 national press conference type events annually since 2004. These conferences are not listed

to conserve space. The themes for the press conference activities range from hair to skin to nail care topics discussing the science of new developments in technology.

MONTHLY BRIEF COLUMN CONTRIBUTIONS-Draelos, ZD: Your Cosmetics Practice. Skin and Aging , 1997-1998. Monthly 2-page articles submitted for 12 issues on a

variety of cosmetic related topics.

ELECTRONIC PUBLICATIONS-Draelos ZD: Skin Cleansers. eMedicine Textbook, posted 2002, updated 2005, 2007, 2009.-Draelos ZD: Hair Cleansers. eMedicine Textbook, posted 2002, updated 2005, 2007, 2009.-Draelos ZD: Nail Cosmetics. eMedicine Textbook, posted 2002, updated 2005, 2007, 2009.-Draelos ZD: DermQuest.com, 2005

-Draelos ZD: online article: Two Randomized Studies Demonstrate the Efficacy and Safety of Dapsone Gel, 5% for the Treatment of Acne Vulgaris. Elsevier.com, 2006.

-Draelos ZD: Medscape Reference. Updated May 22, 2013. Available at: http:/emedicine.medscape.com/article/1067572-overview

-Draelos ZD: Cosmetics. Medscape Reference. Updated May 22, 2013. Available at: http:/emedicine.medscape.com/article/1066966-overview

-Draelos, ZD: A split-face evaluation of a novel pigment-lightneing agent compared with no treatment and hydroquinone. Journal of the American Academy of Dermatology. Available on-line 16 October 2014

JOURNAL ARTICLE PUBLICATIONS-Kececioglu Z, Goldberg SJ, Allen HD, Sahn DJ: Range-grated Doppler ultrasound: Review of its utility. Arizona Medicine

36:359, 1979. -Draelos Z, Goldberg SJ, Areias J, Sahn DJ: Verification and clinical demonstration of the echo-Doppler series effect and

vortex shed distance. Circulation 63:1422-1428, 1981. -Draelos Z, Goldberg SJ: Role of M-mode echocardiography in congenital aortic stenosis. American Journal of Cardiology

47:1267-1272, 1981. -Draelos Z, Goldberg SJ, Sahn DJ: How accurate is the ultrasonically imaged size of the ventricular septal defect?

Pediatric Cardiology 3:189-195, 1982. -Goldberg SJ, Draelos Z, Sahn DJ, Valdez-Cruz LM: Rangegated echo-Doppler velocity and turbulence mapping in

patients with valvular aortic stenosis. American Heart Journal 103:858-863, 1982. -Draelos Z, Levine N: Hyperthermic treatment of cutaneous malignancies. Journal of the American Academy of

Dermatology 9:623-628, 1983. -Draelos Z, Hansen R, Hays S: Symmetric progressive telangiectatic nevi with hemorrhagic angiokeratomas. Pediatric

Dermatology 3:212-214, 1986. -Draelos Z, Hansen R: Polymorphic light eruption in childhood. Clinical Pediatrics 24:692-695, 1985. -Draelos Z, Hansen R: Sehamberg's purpura in children: Case study and literature review. Clinical Pediatrics 26:659, 1987.-Draelos Z, Hansen R: Polymorphic light eruption in pediatric patients with American Indian ancestry. Pediatric

Dermatology 3 :384-389, 1986.



-Draelos Z, Hansen R, and James W: Gianotti-Crosti syndrome associated with infections other than hepatitis B. JAMA 4 256:2386-2388, 1986.

-Draelos Z, Hansen R: Hemorrhagic bullae in an anemic female. Archives of Dermatology 122:1325-1330, 1986. -Draelos Z, Hansen R: Trunk tumor resembling a congenital nevus. Archives of Dermatology 122:1065, 1986. -Draelos Z, Levine N: Capacitive radiofrequeney hyperthermia in the treatment of cutaneous murine melanoma. Journal of

Investigative Dermatology 89:518-521, 1987. -Draelos Z: Hair Care: Five Part Series. Asheboro Courier Tribune, May, 1988. -Draelos Z: Cosmetics for the teenager. American Academy of Dermatology School Monograph, July, 1988. -Draelos Z: Safe use of hair additions. American Hair Loss Journal, 1989. -Draelos, ZD: Adverse reactions to cosmetics. Cosmetic Dermatology 1:37-38, 1989. -Draelos, ZD: Artificial and sculptured nails. Cosmetic Dermatology 1:12-13, 1989. -Draelos, ZD: Hair care in the elderly. Cosmetic Dermatology 8:12-14,1989. -Draelos, ZD: Hair cleansing: Part 1. What's in a shampoo? Cosmetic Dermatology 6:12-14, 1989. -Draelos, ZD: Hair cleansing: Part 2. Specialty shampoos. Cosmetic Dermatology 7:12-14, 1989. -Draelos, ZD: Hair coloring in the elderly: Part 1. Gradual and temporary hair coloring agents. Cosmetic Dermatology 9:10-

12, 1989. -Draelos, ZD: Hair coloring in the elderly: Part 2. Semipermanent and permanent hair coloring agents. Cosmetic

Dermatology 10:10-13,1989. -Draelos, ZD: Hair conditioners: Mechanism and function. Cosmetic Dermatology 2:10-12, 1989. -Draelos, ZD: Skin Cleansers: A review. Cosmetic Dermatology 4:10-13, 1989. -Draelos, ZD: Skin lubrication and moisturizers. Cosmetic Dermatology 1:12-14, 1989. -Draelos, ZD: Sunscreen agents and skin protection. Cosmetic Dermatology 3:14-16, 1989. -Draelos, ZD: Use of cover cosmetics for permanent abnormalities. Cosmetic Dermatology 5:14-16, 1989. -Draelos, ZD: Caution: Eyebrow dyeing may be illegal. Cosmetic Dermatology 10:39-40, 1990. -Draelos, ZD: Cosmetics to imitate a summer tan. Cosmetic Dermatology 12:8-10, 1990. -Draelos, ZD: Description and proper use of lip cosmetics. Cosmetic Dermatology 9:12-14, 1990. -Draelos, ZD: Evaluating the patient with diffuse, nonscarring hair loss: Part 1. Cosmetic Dermatology 2:10-14, 1990. -Draelos, ZD: Evaluating the patient with diffuse, nonscarring hair loss: Part 2. Cosmetic Dermatology 3:12-14, 1990. -Draelos, ZD: Evaluating the patient with diffuse, nonscarring hair loss: Part 3. Cosmetic Dermatology 4:10-13, 1990. -Draelos, ZD: Eyebrows: A cosmetically important facial feature. Cosmetic Dermatology 8:8-9, 1990. -Draelos, ZD: Eyelash cosmetics dramatize and provide camouflage. Cosmetic Dermatology 6:8-10, 1990. -Draelos, ZD: Eyelid cosmetics dramatize and recontour eyes. Cosmetic Dermatology 7:12-14, 1990. -Draelos, ZD: Hair removal techniques: Part one. Cosmetic Dermatology 10:10-12, 1990. -Draelos, ZD: Hair removal techniques: Part two. Cosmetic Dermatology 11:12-14, 1990. -Draelos, ZD: Selecting cosmetics for the patient using topical tretinoin. Cosmetic Dermatology 5:12-14, 1990. -Draelos, ZD: The augmentation of hair through artificial and natural hair additions. Cosmetic Dermatology 1:12-17, 1990. -Draelos, Z: Camouflaging cosmetics. Skin Cancer Foundation Journal, 1990. -Draelos, Z: Hair loss in the chemotherapy patient. American Hair Loss Journal, 1990. -Draelos, ZD: Eye cosmetics. Dermatologic Clinics 9:1-7, 1991. -Draelos, ZD: Hair cosmetics. Dermatologic Clinics 9:19-27, 1991. -Draelos, ZD: Cosmetics for the Acne Patient - Part 1: Acne Specialty Cosmetics. Cosmetic Dermatology 4(l):ls-l7, 1991. -Draelos, ZD: Cosmetics for the Acne Patient - Part 2: Facial Foundation Selection. Cosmetic Dermatology 4(2):l2-l4' 1991.-Draelos, ZD: Cosmetics for the Acne Patient - Part 3: Cosmetic Camouflage of Acne Blemishes. Cosmetic Dermatology

4(3):14-15, 1991. -Draelos, ZD: Grooming Implements Useful in the Dermatologic Practice. Cosmetic Dermatology 4(4):14-16, 1991. -Draelos, ZD: Cosmetic Camouflage in Female Androgenetic Alopecia Patients. Cosmetic Dermatology 4(5):13-15, 1991. -Draelos, ZD: Cosmetics Have a Positive Effect on the Postsurgical Patient. Cosmetic Dermatology 4(6):11-13, 1991. -Draelos, ZD: Aging Skin Requires Special Cosmetics. Cosmetic Dermatology 4(7):11-14, 1991. -Draelos, ZD: Cosmetics for the Black Patient. Cosmetic Dermatology 4(8):12-15, 1991. -Draelos, ZD: Hair Cosmetics for the Black Patient - Part 1: Hair Care. Cosmetic Dermatology 4(9):12-14, 1991. -Draelos, ZD: Hair Cosmetics for the Black Patient - Part 2: Hair Straighteners. Cosmetic Dermatology 4(10):17-21, 1991. -Draelos, ZD: Hair Cosmetics for the Black Patient - Part 3: Hairstyling. Cosmetic Dermatology 4(11):12-14, 1991. -Draelos, ZK, Yeatts RP: Eyebrow Loss, Eyelash Loss, and Dermatochalasis. Derm Clinics 10(4):793- 798, 1992. -Draelos, ZD: Cosmetics Designed for Men. Cosmetic Dermatology 11:14-16, 1992. -Draelos, ZD: A Dermatologic Evaluation of Facial Treatment Salons. Cosmetic Dermatology 1:24-26, 1992. -Draelos, ZD: Evaluating Cosmetic Counter Advice. Cosmetic Dermatology 2:12-13, 1992.



-Draelos, ZD: Evaluation of Cosmetic Marketing Claims - Part 1: What Do They Really Mean? Cosmetic Dermatology 9:14-16,1992.

-Draelos, ZD: Evaluation of Cosmetic Marketing Claims - Part 2: What Do They Really Mean? Cosmetic Dermatology 10:16-18, 1992.

-Draelos, ZD: Preadolescent Cosmetics May Cause Dermatologic Problems and Misconceptions. Cosmetic Dermatology 12:14-19, 1992.

-Draelos, ZD: Specialty Additives in Cosmetics May Cause Confusion Among Dermatologists. Cosmetic Dermatology 3:24-27, 1992.

-Draelos, ZK: Cosmetic Camouflaging Techniques. Cutis 52:362-364, 1993. Draelos ZD: Black Individuals Require Special Products for Hair Care. Cosmetic Dermatology 12:19-20, 1993.

-Draelos, ZD: Cold Permanent Hair Waving Knowledge: An Aid to the Dermatologist - Part 1. Cosmetic Dermatology 6:31-34, 1993.

-Draelos, ZD: Cold Permanent Hair Waving Knowledge: An Aid to the Dermatologist - Part 2. Cosmetic Dermatology 7:22-26, 1993.

-Draelos, ZD: Four Common Problematic Cosmetics Discussed. Cosmetic Dermatology 4:15-19, 1993. -Draelos, ZD: Recognizing Problems Associated with Permanent Waving Procedures. Cosmetic Dermatology 2:14-16,

1993. -Draelos, ZD: The Importance of Preservative Selection in Cosmetics. Cosmetic Dermatology 8:48-50, 1993. -Draelos, ZD: The Mechanisms of Shaving: A Complex Interaction Between the Blade and the Skin. Cosmetic Dermatology

10:54-55, 1993. -Draelos, ZD: The Potential Risks of Manicures and Pedicures. Cosmetic Dermatology 5:14-16, 1993. -Draelos, ZD: Tips to Identify and Advise Patients with Poor Hair Coloring Results. Cosmetic Dermatology 1:16-18, 1993. -Draelos, ZD: Understanding the Difference Between Antiperspirants and Deodorants. Cosmetic Dermatology 9:18-

19,1993. -Draelos, ZD: Various Camouflage Techniques are Available to Improve Nail Pigmentation. Cosmetic Dermatology 3:19-22,

1993. -Draelos, ZD: Various Considerations Important in Recommending Skin Care Products. Cosmetic Dermatology 11 :23-24,

1993. -Draelos, ZD: Camouflage Cosmetics and Techniques. Cosmetics and Toiletries 109:75-84, 1994. -Draelos, ZD: Assessing the Complexity of Cosmetic Ingredients. Cosmetic Dermatology 7:17-18, 1994. -Draelos, ZD: Dermatologists Should Understand Nail Polish Versatility. Cosmetic Dermatology 1:13- 14, 1994. -Draelos, ZD: Liposomes in Dermatology. Cosmetic Dermatology 2:12-14, 1994. Draelos ZD: Understanding Electrolysis:

Part l-Principles and Theory. Cosmetic Dermatology 10:11- 14, 1994.-Draelos, ZD: Understanding Electrolysis: Part 2 - The Practice. Cosmetic Dermatology 11:13-16, 1994. -Draelos, ZD: Understanding the Esthetic and Therapeutic Benefits of Face Masks. Cosmetic Dermatology 6:19-22, 1994. -Draelos, ZD: Understanding the Techniques of the Esthetician: Part 1. Cosmetic Dermatology 4:15-18, 1994. -Draelos, ZD: Understanding the Techniques of the Esthetician: Part 2. Cosmetic Dermatology 5:16-18, 1994. -Draelos, ZD: The Use of Biological Additives in Cosmetic Products: Part 1. Cosmetic Dermatology 2:16-17, 1994. -Draelos, ZD: The Use of Biological Additives in Cosmetic Products: Part 2. Cosmetic Dermatology 3:15-18, 1994. -Draelos, ZD: The Uses and Formulations of Facial Foundations: Part l. Cosmetic Dermatology 8:14-18, 1994. -Draelos, ZD: The Uses and Formulations of Facial Foundations: Part 2. Cosmetic Dermatology 9:16-20, 1994. -Draelos, ZK: Post-surgical Cosmetics. Derm Clinics 13(2):461-465, 1995. Draelos ZK: Hair Sun Protection. Skin Cancer

Foundation Journal, 1995. -Draelos ZK, Reitschel RL: A Dermatologist's Perception of Hypoallergenicity. Journal of the American Academy of

Dermatology 35:248, 1996. -Draelos, ZD: Skin Care. Clinics of Plastic Surgery 24:369, 1997. -Draelos, ZD: Acne Medication Selection Important for Patient Compliance. Cosmetic Dermatology 11:13, 1995. -Draelos, ZD: AHAs and the Skin. Cosmetic Dermatology 9:15, 1995. -Draelos, ZD: Alternative Skin Treatments Often Queried by the Consumer. Cosmetic Dermatology 4:13, 1995. -Draelos, ZD: Keeping Abreast of Various Soap Formulations. Cosmetic Dermatology 6:13, 1995. -Draelos, ZD: Photoprotection for the Hair. Cosmetic Dermatology 8:16, 1995. -Draelos, ZD: Questions and Answers About Hair Care for the Black Patient: Part 1. Cosmetic Dermatology 1:14, 1995. -Draelos, ZD: Questions and Answers About Hair Care for the Black Patient: Part 2. Cosmetic Dermatology 2:12, 1995. -Draelos, ZD: The Dermatologic Concerns of Aromatherapy and Skin Care. Cosmetic Dermatology 3:15, 1995. -Draelos, ZD: The History, Formulation and Safety of Color Additives in Cosmetics. Cosmetic Dermatology 12:11, 1995. -Draelos, ZD: The Value of Vitamins on the Skin. Cosmetic Dermatology 7:17, 1995.



-Draelos, ZD: Therapeutic Skin Moisturization. Cosmetic Dermatology 10:10, 1995. -Draelos, ZD: Understanding Noninvasive Cutaneous Testing Methods. Cosmetic Dermatology 5:16, 1995. 108. -Draelos, ZD: Fragrances in Cosmetics Part 1. Cosmetic Dermatology 1:16, 1996. -Draelos, ZD: Fragrances in Cosmetics Part 2. Cosmetic Dermatology 2:26, 1996. -Draelos, ZD: Dermatologic Micropigmentation Part 1. Cosmetic Dermatology 3:16, 1996. -Draelos, ZD: Dermatologic Micropigmentation Part 2. Cosmetic Dermatology 4:16, 1996. -Draelos, ZD: Cosmetic Safety Testing Part 1. Cosmetic Dermatology 5:22, 1996. -Draelos, ZD: Cosmetic Safety Testing Part 2. Cosmetic Dermatology 6:22, 1996. -Draelos, ZD: Cosmetic Safety Testing Part 3. Cosmetic Dermatology 7:19, 1996. -Draelos, ZD: Cosmetic Compatibility. Cosmetic Dermatology 8:16, 1996. -Draelos, ZD: Dermatologists Should Be Aware of Latest Cosmetics from the Earth Trend. Cosmetic Dermatology 9:15,

1996. -Draelos, ZD: Topical Cellulite Treatments. Cosmetic Dermatology 10:16, 1996. -Draelos, ZD: Re-evaluating the Mechanics of Shaving. Cosmetic Dermatology 11:11, 1996. -Draelos, ZD: Understanding the Dermatologic Unspeakables: Bad Breath and Body Odor. Cosmetic Dermatology 12:9,

1996. -Draelos, ZD: Skin Care in the Elderly. Journal of Geriatric Dermatology, 5(3), 1997. -Draelos, ZD: Camouflaging Techniques and Dermatologic Surgery. Journal of Dermatologic Surgery 12:1029, 1996. -Draelos, ZD: Sensitive Skin. American Journal of Contact Dermatitis, 8(2):67-78, 1997. -Draelos, ZD: Skin Lightening Agents Provide Dermatologists with Various Treatment Options. Cosmetic Dermatology 1:13,

1997. -Draelos, ZD: Dermatologic Implications of Three New Cosmetic Ingredients. Cosmetic Dermatology 2:15, 1997. -Draelos, ZD: Understanding African-American Hair and Chemical Relaxers. Cosmetic Dermatology 4:23, 1997. -Draelos, ZD: The Mechanisms of Hair Damage. Cosmetic Dermatology 5:19, 1997. -Draelos, ZD: Color and Cosmetic Selection. Cosmetic Dermatology 6:19, 1997. -Draelos, ZD: The Cosmetic Compatibility of a Novel Topical 6% Benzoyl Peroxide Acne Medication. Cosmetic

Dermatology 6:35, 1997. -Draelos, ZD: Encountering Skin Changes. Cosmetic Dermatology 7:14, 1997. -Draelos, ZD: Understanding Cutaneous Aging. Cosmetic Dermatology 8:12, 1997. -Draelos, ZD: The Relationship Between Hair Biology and Cosmetic Treatments. Cosmetic Dermatology 9:14, 1997. -Draelos, ZD: Evaluating and Treating Sensitive Skin. Cosmetic Dermatology 10;13, 1997. -Draelos, ZD: Performing the Dermatologic Cosmetic Consultation. Cosmetic Dermatology 11:15, 1997. -Draelos, ZD: What's New in Nail Cosmetics. Cosmetic Dermatology 12:12, 1997. -Draelos, ZD: Hydroxy Acids for the Treatment of Aging Skin. Journal of Geriatric Dermatology 5(5):236-240, 1997. -Draelos, ZD: Hair Care in the Elderly. Journal of Geriatric Dermatology 5(4):176-180, 1997. -Draelos, ZD: Understanding African-American Hair. Dermatology Nursing 9(4):227-231, 1997. -Draelos, ZD: Hair Under the Sun. Women's Health Digest 3(2):86-87, 1997. -Draelos, ZD, Marenus K: The Etiology of Cellulite, Journal of Dermatologic Surgery 23:1177, 1997. -Draelos, ZD: Hair Under the Sun. Women's Health Digest, 1997. -Draelos, ZD: Sensitive Skin: Perceptions, Evaluation, and Treatment. American Journal of Contact Dermatitis, 8:67, 1997. -Draelos, ZD: Cosmetics, Skin Care Products, and the Dermatologic Surgeon: Postsurgical Selection of Cleansing

Products. Dermatologic Surgery 24:543, 1998. -Draelos, ZD: Basic Tenets in the Evaluation of Cosmetics and Skin Care Products. The Journal of Clinical Dermatology,

Winter 1998. -Draelos, ZD: 25 Years of Skin Aging Treatments, Journal de Medecine Esthetique et de Chirurgie Dermatologique, 1998 -Draelos, ZD: Controversies in In-office Dispensing. Journal of Dermatologic Surgery 24:781, 1998. -Draelos, ZD: Diagnostic Tips for Cosmetically Induced Nail Disorders. Cosmetic Dermatology 1:16, 1998. -Draelos, ZD: Cosmetics in Children. Cosmetic Dermatology 2:15, 1998. -Draelos, ZD: Hair Biology for the Dermatologist. Cosmetic Dermatology 3:15, 1998. -Draelos, ZD: Evaluating Cosmeceuticals for Efficacy. Cosmetic Dermatology 4:12, 1998. -Draelos, ZD: Cosmetic Techniques for Damaged Hair. Cosmetic Dermatology 5:17, 1998. -Draelos, ZD: What's New in Cosmetic Dermatology 1998? Cosmetic Dermatology 6:16, 1998. -Draelos, ZD: What is an Emollient. Cosmetic Dermatology 7:17, 1998. -Draelos, ZD: Hydroxy Acid Update. Cosmetic Dermatology 7:27, 1998. -Draelos, ZD: Cigarette Smoking, Sun Exposure and Aging. Cosmetic Dermatology 8:15, 1998. -Draelos, ZD: What About the Bottle? Cosmetic Dermatology 9:15, 1998.



-Draelos, ZD: Development of Cosmeceuticals. Cosmetic Dermatology 10:15, 1998. -Draelos, ZD: Antibacterial Ingredients: Issues and Answers. Cosmetic Dermatology 11:11, 1998. -Draelos, ZD: Barrier Creams: Efficacy and Evaluation. Cosmetic Dermatology 12:13, 1998. -Draelos, ZD: Topical Agents used in Association with Cosmetic Surgery. Seminars in Curtaneous Medicine and Surgery.

Arndt KA, LeBoit PE, Robinson JK, Wintroub BU (eds), WB Saunders, 18:112-118, 1999. -Draelos, ZD: A Mysterious Case of Swollen Lips, Corlandt Forum, March 1999. -Draelos, ZD (as one of a multiauthored manuscript): Finasteride in the Treatment of Men with Frontal Male Pattern Hair

Loss, Journal of the American Academy of Dermatology 40:930, 1999. -Draelos, ZD: Photoprotection of the Skin and Hair. Cosmetic Dermatology 1:15, 1999. -Draelos, ZD: Where Do Facial Cosmetics Go? Cosmetic Dermatology 2:11, 1999. -Draelos, ZD: Preventing Hair Damage. Cosmetic Dermatology 3:13, 1999. -Draelos, ZD: Common Dermatologic Myths: Cleansing of the Skin and Hair. Cosmetic Dermatology 4:13, 1999. -Draelos, ZD: Current Issues Regarding Fragrance. Cosmetic Dermatology 5:21, 1999. -Draelos, ZD: New Insights into Hair Damage. Cosmetic Dermatology 6:17, 1999. -Draelos, ZD: Novel Topical Therapies in Dermatology. Current Problems in Dermatology, 1999.

-Draelos, ZD: The Cosmetic Compatibility of 20% Azeleic Acid Cream, Cosmetic Dermatology, 1999. -Draelos, ZD: Smoke Gets in Your Eyes. Healthy Skin & Hair, 1999. -Draelos, ZD: Research and Development in Cosmetics and Skin Care Products. Cosmetic Dermatology 7:15-17, 1999. -Draelos, ZD: Dermatologic Criteria for Assessing Cosmetic Compatibility: A Clinical Trial with Azelaic Acid 20% Cream.

Cosmetic Dermatology 8:44-49, 1999. -Draelos, ZD: Variability in Skin Parameters and Sensitive Skin. Cosmetic Dermatology 8:11-13, 1999. -Draelos, ZD: Vitamins and their Cutaneous Effects. Cosmetic Dermatology 9:17-20, 1999. -Draelos, ZD: Expanded Concepts of Photoprotection. Cosmetic Dermatology 10:13-15, 1999. -Draelos, ZD: Cosmetics and Marketing: A Dermatologic Perspective. Cosmetic Dermatology 11:13-14, 1999. -Draelos, ZD: Skin Cleansing, Moisturization, and pH. Cosmetic Dermatology 12:10-11, 1999.-Draelos, ZD: Evaluating Vitamin Formulations. Journal of Aesthetic Dermatology and Cosmetic Surgery 1:103-108, 1999.-Draelos, ZD: Formulating for Sensitive Skin, Cosmeticos Nuevos, 1999.-Draelos, ZD, Berson D, Webster G: Saving Face: a treatment update for acne. Patient Care June 15, 1999, pp 257-278.-Draelos, ZD: A Novel Topical Oil-Imbibing Technology for the Control of Excessive Facial Oil. Cosmetic Dermatology

Supplement, October 1999.-Draelos, ZD: Rosacea. Gender Specific Medicine Digest 2: Summer 1999.-Draelos, ZD: The Treatment of Rosacea. Gender-Specific Medicine Digest, 2:4, 1999.

-Draelos, ZD: What accounts for the increased incidence of flushing and facial redness in mature women? Gender-Specific Medicine Digest. Summer 1999; 2(2): 4.

-Draelos, ZD: Cosmetic Considerations in the Treatment of Acne and Rosacea. Perspectives July 1999.-Draelos, ZD: Cosmetics to Imitate a Summer Tan. Skin Therapy Letter 6:3, 2000.-Draelos, ZD: Alpha hydroxy acids, Beta hydroxy acids, and other topical agents. Dermatologic Therapy 13:154-158, 2000.-Draelos, ZD: Approach to the Patient with Diffuse, Nonscarring Hair Loss. The Journal of Cosmetic Dermatology

(India)1:3-7, 2000.-Draelos, ZD: Silicones in Topical Dermatologic Preparations Cosmetic Dermatology 1:35-36, 2000.-Draelos, ZD: Tattoos to Body Piercing to Antiperspirants: Metals and the Skin. Cosmetic Dermatology 2:37-39, 2000.-Draelos, ZD: Cosmetics for the Mature Patient. Cosmetic Dermatology 3:40-43, 2000.-Draelos, ZD: Understanding Sunscreens Part 1. Cosmetic Dermatology 4:43-45, 2000.-Draelos, ZD: Understanding Sunscreens Part 2. Cosmetic Dermatology 5:39-41, 2000.-Draelos, ZD: Polymer in Dermatology: The Future of Skin Care. Cosmetic Dermatology 6:39-41, 2000.-Draelos, ZD: Botanicals and Skin Care. Cosmetic Dermatology 7:45-47, 2000.-Draelos, ZD: Dermatologic Problems Caused by Cosmetics. Cosmetic Dermatology 8:51-52, 2000.-Draelos, ZD: Petrolatum in Dermatology. Cosmetic Dermatology 9:44-46, 2000.-Draelos, ZD: The Development of Enhanced Efficacy Antiperspirants for the Treatment of Hyperhidrosis. Cosmetic

Dermatology 10:19-22, 2000.-Draelos, ZD: Cutaneous Exfoliation 2000. Cosmetic Dermatology 10:51-57, 2000.-Draelos, ZD: Who Sees the Dermatologist? Cosmetic Dermatology 11:36-39, 2000.-Draelos, ZD: Insight into Dermatologic Problems of the Eye Area. Cosmetic Dermatology 12:43-48, 2000.-Draelos, ZD: Hydrogel Barrier/Repair Creams and Contact Dermatitis. American Journal of Contact Dermatitis 11:222-225,

2000.-Draelos, ZD: Treating the Patient with Multiple Cosmetic Allergies. Postgraduate Medicine 107:70-77, 2000.



-Draelos, ZD and others: Cosmetics, Educational Review Manual in Dermatology, 8 th edition, 2000.-Draelos, ZD: The Dry Facts About Wet Perspiration. Cosmetics and Toiletries 115:87-90, 2000.-Draelos, ZD: Formulation for Sensitive Skin (Spanish). Cosmeticos Nuevos. March 2000.-Draelos, ZD: Cosmetics for the Acne Patient. Acne Briefs 2:1-8, 2000.-Draelos ZD: Managing Unwanted Facial Hair. Cosmetic Dermatology Supplement, 2000.-Draelos, ZD: A Dermatologist’s Perspective on the Final Sunscreen Monograph. Journal of the American Academy of

Dermatology 4:109-110, 2001.-Draelos, ZD: Pigmentation, Swelling and Wrinkling in the Eye Area. Cosmetics and Toiletries 116:41-50, 2001.-Ogbogu P, Fleischer AB, Brodell RT, Bhalla G, Draelos ZD, Feldman SR: Physicians’ and Patients’ Perspectives on Office-

Based Dispensing. Archives of Dermatology 137:151-154, 2001.-Leyden J, Lowe N, Kakita L, Draelos Z: Comparison of Treatment of Acne Vulgaris with Alternate-Day Application of

Tazartone Gel and Daily Application of Adapalene Gel: A Randomized Trial. Cutis 67(6S):10-16, 2001.-Draelos, ZD: Special Considerations in Eye Cosmetics. Clinics in Dermatology 19, 2001.-Draelos, ZD: Hydroquinone: Optimizing Therapeutic Outcomes in the Clinical Setting. Today’s Therapeutic Trends, May

2001.-Draelos, ZD: Cosmetics in Acne and Rosacea, Seminars in Cutaneous Medicine and Surgery, 2001.-Draelos, ZD: Botanicals as Topical Agents. Clinics in Dermatology 19: 2001.-Draelos, ZD: Surface Characteristics of Facial Foundation and the Skin. Journal of the American Academy of Dermatology,

45:542-543, 2001.-Draelos, ZD: Cosmetics in Acne and Rosacea. Seminars in Cutaneous Medicine and Surgery, 20:209-213, 2001.-Draelos, ZD: Self Tanning Lotions. American Journal of Clinical Dermatology.-Draelos, ZD: Novel Topical Therapies in Cosmetic Dermatology, Current Problems in Dermatology.-Draelos, ZD: A Global Perspective on Skin and Hair Care. Cosmetic Dermatology 1:35-36, 2001.-Draelos, ZD: Insights for Eyes: Part One. Cosmetic Dermatology 2:57-62, 2001.-Draelos, ZD: Insights for Eyes: Part Two. Cosmetic Dermatology 3:57-62, 2001.-Draelos, ZD: Can Intact Hand Skin Barrier Function Be Maintained in an Occupational Setting? Cosmetic Dermatology

4:31-33, 2001.-Draelos, ZD: Looking for Hidden Answers to Obvious Questions- Part 1. Cosmetic Dermatology 4:55-59, 2001.-Draelos, ZD: Looking for Hidden Answers to Obvious Questions- Part 2. Cosmetic Dermatology 5:55-59, 2001.-Draelos, ZD: Looking for Hidden Answers to Obvious Questions- Part 3. Cosmetic Dermatology 6:55-58, 2001.-Draelos, ZD: An Algorithm for the Cosmetic Patient: Part 1. Cosmetic Dermatology 7:51-52, 2001.-Draelos, ZD: Cosmetics and the Acne Patient. Cosmetic Dermatology 8:59-62, 2001.-Draelos, ZD: An Algorithm for the Cosmetic Patient: Part 2. Cosmetic Dermatology 9:69-76, 2001.-Draelos, ZD: An Algorithm for the Cosmetic Patient: Part 3. Cosmetic Dermatology 10:65-72, 2001.-Draelos, ZD: In Search of Answers Regarding Cellulite. Cosmetic Dermatology 11:55-58, 2001.-Draelos, ZD: Bovine Spongiform Encephalopathy and Dermatology. Cosmetic Dermatology 12:43-47, 2001.-Draelos, ZD: Educating the Cosmetic Patient. Dermatologic Therapy 14, 2001.-Draelos, ZD: Cosmetic Selection in the Sensitive-skin Patient. Dermatologic Therapy 14: 2001.-Draelos, ZD: Overview: Cosmetics and the Art of Adornment. Dermatologic Therapy 14: 2001.-Draelos, ZD: Antiperspirants and the Hyperhidrosis Patient. Dermatologic Therapy 14: 2001.

-Draelos, ZD: Self-Tanning Lotions. Are They a Healthy Way to Achieve a Tan? Am J Clin Dermatol 2002; 3(5): 317-318.-Draelos, ZD: Book Review for Cosmeceuticals: Drugs vs. Cosmetics. Archives of Dermatology 137:1339, 20

-Draelos, ZD: A Dermatologist’s perspective on the Final Sunscreen Monograph. J Am Acad of Dermatol, 2001.-Draelos, ZD: Understanding Self-Tanning Preperations. Cosmetic Dermatology 1:47-48, 2002.-Draelos, ZD: Cosmeceuticals in the Rosacea Patient. Cosmetic Dermatology 2:48-50,56, 2002. -Draelos, ZD: Hair Coloring 2002. Cosmetic Dermatology 3:39-42, 2002.-Draelos, ZD: Wipes, Cloths, and Wraps: Fibered Paper Products and Dermatology. Cosmetic Dermatology 4:42-45,

2002.-Draelos, ZD: Clinical Situations Conducive to Proactive Barrier Enhancement. Cutis Supplement, Cutis, 2002.-Draelos, ZD: Skin in the Tropics: Sunscreens and Hyperpigmentations, by Vermen M. Verallo-Rowell, MD. Cosmetic

Dermatology 5:34, 2002.-Draelos, ZD: Increasing the Longevity of Hair? Part One: Hair Styling and Drying Tips. Cosmetic Dermatology 5:47-48,

2002.-Draelos, ZD: Increasing the Longevity of Hair? Part Two: Hair Shampooing and Conditioning Tips. Cosmetic Dermatology

6:69-71, 2002.-Draelos, ZD: Pigment Sunscreens, Photoprotection, and Hair. Cosmetic Dermatology 7:45-46, 2002.



-Draelos, ZD: Is the Product Designed for Sensitive Skin? Cosmetic Dermatology 8:71-78, 2002.-Draelos, ZD: Is All Skin Alike? Cosmetic Dermatology 9:81-84, 2002.-Draelos, ZD: Broken Nails: To Mend or Not to Mend: Part One. Cosmetic Dermatology 11:41-42, 2002.-Draelos, ZD: Targeting Eye Area Problems. Skin May:42-34, 2002.-Draelos, ZD, Tanghetti EA: Optimizing the Use of Tazarotene for the Treatment of Facial Acne Vulgaris Through

Combination Therapy. Cosmetic Dermatology 69:20-29, 2002.-Draelos, ZD: Self-Tanning Lotions: Are They a Safe Way to Achieve a Tan? American Journal of Clinical Dermatology

3:317-318, 2002. -Draelos, ZD: Handbook of Cosmetic Science and Technology (Book Review). Arch Dermatol. 2002 Dec; 138:1262. -Draelos, ZD: Clinical Situations Conducive to Proactive Barrier Enhancement. Cutis. 2002. 70(6S): 17-20. -Draelos, ZD: Eyelid Dermatitis Caused by Cosmetics. Photo&Derm 2003; 1(5): 4-7.

-Draelos, ZD: Shampoo, Hair, and Technology: Part One. Cosmetic Dermatology 1:45-46,48,51, 2003.-Draelos, ZD: Shampoo, Hair, and Technology: Part Two. Cosmetic Dermatology 2:71-72,74,76, 2003.-Draelos, ZD: Conditioning Hair: Creams, Lotions, and Potions-Part I. Cosmetic Dermatology 4:61-64, 2003.-Draelos, ZD: Conditioning Hair: Creams, Lotions, and Potions-Part II. Cosmetic Dermatology 5:32, 35-36, 2003.-Draelos, ZD: Cutaneous UV Defense Mechanisms and the Role of Sunscreens. Cosmetic Dermatology 8:63-64, 66,

2003.-Draelos, ZD: Botanical Antioxidants. Cosmetic Dermatology 9:46, 49-50, 2003.-Draelos, ZD: Topical Anti-Inflammatory Agents. Cosmetic Dermatology 10: 41-42, 2003.-Draelos, ZD: What’s In a Formulation? Cosmetic Dermatology 11:56-58, 2003.-Draelos, ZD: Evaluating the Patient With Diffuse, Nonscarring Alopecia, Part I. Cosmetic Dermatology 12:48-51, 2003.-Draelos, ZD: Self Tanning Lotions. New Ethicals Journal (New Zealand) 5:59-61, 2003.

-Draelos, ZD: From the Bottle to the Brain. GCI. 2003 June; 19-22. -Draelos, ZD: Optimizing Patient Care through Therapeutic Cleansers and Moisturizers. 2003; vol 1:1.

-Draelos, ZD: Treating Beyond the Histology of Rosacea. Cutis 74(3S):28-31, 2004. -Del Rosso JQ, Dahl MV, Draelos ZD, Jones D, Murphy G, Odom R, Powell FC. Classification, Pathophysiology, and

Treatment of Rosacea. 2004 Cutis. Vol 4:32-34.-Draelos, ZD: The Impact of Cosmetic Dermatology on Skin Care and Cosmetics. Journal of Cosmetic Science 55:209-

210, 2004.-Draelos, ZD: From Proteins to Peptides: What Does It Mean to the Dermatologist? Cosmetic Dermatology 17(1):63-64,

66-67, 2004.-Draelos, ZD: Evaluating the Patient With Diffuse, Nonscarring Alopecia, Part II: Hair Loss Due to Cosmetic Practices.

Cosmetic Dermatology 17(2):123-126, 2004.-Draelos, ZD: The Chemistry of Permanent Hair Straightening, Part I. Cosmetic Dermatology 17(5):303-304, 306, 2004.-Draelos, ZD: The Basic Principles and Practice of Anti-Aging Medicine and Age Management for the Aesthetic Surgeon

and Physician (BOOK Review). 17(7):426, 2004.-Draelos, ZD: The Chemistry of Permanent Hair Straightening, Part II. Cosmetic Dermatology 17(7):453455, 2004.-Draelos, ZD: Acne Cosmetica Revisited. Cosmetic Dermatology 17(8):512-513, 2004.-Draelos, ZD: The Chemistry of Permanent Hair Straightening, Part III. Cosmetic Dermatology 17(9):601-602, 605, 2004.-Draelos, ZD: New Insights Into Dandruff. . Cosmetic Dermatology 17(10):671-672, 2004.-Draelos, ZD: Cosmeceutical Trends: The Multifunctional Cosmetic. Cosmetic Dermatology 17(11):735-736, 2004.-Draelos, ZD: The Development of Novel Cosmeceuticals. Cosmetic Dermatology 17(12):807-810, 2004.-Draelos, ZD: Expanding the Horizons of Cosmeceuticals. Global Cosmetic Industry (GCI) 5:32-34, 2004.-Draelos, ZD: Seborrheic Dermatitis, Supplement to Skin & Aging, December 2004.-Draelos, ZD: Noxious Sensory Perceptions in Patients with Mild to Moderate Rosacea Treated with Azelaic Acid 15% Gel,

Cutis 74:257-260, 2004.-Draelos, ZD, Ertel K, Hartwig P: The effect of two skin cleansing systems on moderate xerotic eczema. Journal of the

American Academy of Dermatology, 50:883-888, 2004.-Gribertz C, Ling M, Lebwohl M, Pariser D, Draelos ZD, et al: Pimecrolimus Cream 1% in the Treatment of Intertriginous

Psoriasis: A Double-blind Randomized Study. Journal of the American Academy of Dermatology, 51(5-738, 2004.-Draelos, ZD: Expanding the Horizons of Cosmeceuticals. Global Cosmetics Industry May, 32-34, 2004.

-Draelos ZD, Kenneally DC, Hodges LT, Billhimer W, Copas M, Margraf C. A Comparison of Hair Quality and Cosmetic Acceptance Following the Use of Two Anti-Dandruff Shampoos. Journal of Investigative Dermatology Symposium Proceedings. December 2005; 10(3): 201-204.

-Draelos ZD, Ertel K, Hartwig P, Rains G.: The Effect of Two Skin Cleansing Systems on Moderate Xerotic Eczema. Journal of the American Academy of Dermatology, 2004 June; 50(6) index issue: 883-888.



-Draelos, ZD: Noxious Sensory Perceptions in Patients With Mild to Moderate Rosacea Treated With Azelaic Acid 15% Gel. Therapeutics for the Clinician. 2004 Oct; 74: 257-260.

-Draelos, ZD; Facial Hygiene and Comprehensive Management of Rosacea. Cutis. 2004 March; 73(3): 183-186. -Draelos ZD, Ertel K, Hartwig P, Rains G. The effect of tow skin cleansing systems on moderate xerotic eczema. Journal

of the American Academy of Dermatology. 2004 June; 50(6); 883-888. -Kligman, DE, Draelos ZD: High-Strength Tretinoin for Rapid Retinization of Photoaged Facial Skin. Dermatologic Surgery.

June 2004; 30(6), 864-866. -Del Rosso JQ, Dahl MV, Draelos ZD, Jones D, Murphy G, Odom R Powell FC. Roundtable Discussion:Classification,

Pathophysiology, and Treatment of Rosacea. Cutis. Dec 2004; 74(suppl 3): 32-34. -Draelos, ZD: Facial Hygiene and Comprehensive Management of Rosacea. 2004 March; 73:183-187. -Draelos ZD, Ertel K, Hartwig P, Rains G. The Effect of Two Kin Cleansing Systems on Moderate Xerotic Eczema. Journal

of the American Academy of Dermatology. 2004 June; 50(6)index issue: 883-888.-Draelos, ZD: Searching for the Cosmeceutical Connection. Cosmetics and Toiletries 120(2):41-44, 2005.-Draelos, ZD: Maintaining the Barrier While Altering the Biofilm. Skin and Aging. January 2005, 7-8.-Draelos, ZD: Using Color Cosmetics. Skin and Aging. January 2005, 9.-Draelos, ZD: Are We Creating a Vanity Society? Global Cosmetics Industry, August 2005, 22.-Draelos, ZD: Commentary for Protease Therapy for Epidermal Ablation. Dermatologic Surgery 11(2):147. -Draelos, ZD: The dermatologic implications of novel delivery systems. G Ital Dermatol Venereol. 2005; 140: 467-8.

-Schwartz JR, Marsh RG, Draelos ZD: Zinc and Skin Health: Overview of Physiology and Pharmacology. Dermatol Surg 2005; 31: 837-847.

-Draelos ZD, Jacobson EL, Kim H, Kim M, Jacobson MK. A pilot study evaluating the efficacy of topically applied niacin derivatives for treatment of female pattern alopecia. Journal of Cosmetic Dermatology. 2005; 4: 257-260.

-Draelos, ZD. Commentary on: Review of Photorejuvenation: Devices, Cosmeceuticals, or Both? Dermatol Surg. 2005 Sept; 31: 9 Part 2, 1178.

-Draelos, ZD: Commentary on Topical Protease Therapy For Epidermal Ablation, Fein et al. Dermatol Surg. 2005 Feb; 31(2): 9.

-Draelos, ZD: Innovations in Dermatology: Rethinking the Aging Face.Cosmetics and Toilitries. 2005 Oct; 120(10): 75-78.-Draelos, ZD: Assessment of Skin Barrier Function in Rosacea Patients with a Novel 1% Metronidazole Gel. Drugs in

Dermatology 4:557-562, 2005.-Draelos ZD, Ertel K, Berge C: Niacinamide-Containing Facial Moisturizer Improves Skin Barrier and Benefits Subjects

with Rosacea. Cutis 76:135-141, 2005.-Draelos, ZD: Topical and Oral Estrogens Revisited for Antiaging Purposes. Fertility and Sterility 84:291-292, 2005.-Draelos, ZD: Retinoids in Cosmetics. Cosmetic Dermatology 18:3-5, 2005.-Draelos, ZD: Cosmetics and Skin Care, Giornale Italiano di Dermatologia e Venereologia, 2005.

-Draelos, ZD: Cosmetic dermatology: a review of skin care. Giornale Italiano di Dermatologia e Veneroligia, 2005; 140 ; 515-29.

-Simion FA, Abrutyn ES, Draelos ZD: The Ability of Moisturizers to Reduce Dry Skin and Irritation and to Prevent their Return. Journal of Cosmetic Science, 2005.

-Draelos ZD. Merging the Therapeutic and the Cosmeceutic to Treat Seborrheic Dermatitis. 18(1):43-44, 46, 2005.-Draelos ZD. Reexamining Methods of Facial Cleansing. 18(2):173-175, 2005.-Draelos ZD. Cosmeceuticals: The First Step in Resurfacing. 18(5):373-375, 2005.-Draelos ZD. Topical Cosmeceuticals Attempting to Mimic Injectable Botulinum Toxin-Is It Possible? 18(7):521-522, 524,

2005.-Draelos ZD. Evaluating a Novel Method of Topical Benzoyl Peroxide 6% Acne Medication Delivery. 18(8):567-569, 2005.-Draelos ZD. Helpful Ideas for Enhancing Patient Sunscreen Compliance. 18(9):638-640, 2005.-Draelos ZD. A Cosmetic Approach to Cheilitis. 18(10):709-710, 712, 2005.-Draelos ZD. Cosmeceuticals and Sensitive Skin. 18(11):764-767, 2005.

-Draelos ZD. Commentary to article: Rokhsar Et Al: Review of Photorejuvenation. Dermatol Surg. 2005 Sept; 31(9)part 2: 1166-1178.

-Draelos ZD. Mastering the ‘arts” of medicine and appearance. Dermatology Times. 2005 Nov; 26(11): 4. -Schwartz JR, Marsh RG, Draelos ZD. Zinc and Skin Health: Overview of Physiology and Pharmacology. Dermatol Surg.

2005 July; 31(7)Part 2: 837-847. -Draelos ZD. Novel Approach to the Treatment of Hyperpigmented Photodamaged Skin: 4% Hydroquinone/0.3% Retinol

versus Tretinoin 0.05% Emollient Cream. Dermatol Surg. 2005 July; 31(7): 799-804. Draelos et al: Pharmacokinetics of topical calcineurin inhibitors in adult atopic dermatitis: A randomized, investigator-blind

comparison. Journal of The American Academy of Dermatology. 2005 Oct; 53(4): 602-609.



-Draelos ZD: Concepts in Skin Care Maintenance. Cutis. 2006 Dec; 76(6S): 19-25. -Draelos ZD, Kenneally DC, Hodges LT, Billhimer W, Copas M, Margraf C: A Comparison of Hair Quality and Cosmetic

Acceptance Following the Use of Two Anti-Dandruff Shampoos. Journal of Investigative Dermatology Symposium Proceedings. 2005 Dec; 10(3): 201-204.

-Simion FA, Abrutyn EA, Draelos ZD. Abilility of moisturizers to reduce dry skin and irritation and to prevent their return. J Cosmet Sci. 2005 Nov/Dec: 56; 427-444.

-Draelos ZD, Kenneally DC, Hodges LT, Billhimer W, Copas M, Margraf C. A Comparison of Hair Quality and Cosmetic Acceptance Following the Use of Two Anti-Dandruff Shampoos. The Journal of Investigative Dermatology. 2005 Dec; 10(3): 201-204.

-Draelos, ZD. The dermatologic implications of novel deliver systems. G Ital Dermatol Vernereol 2005; 140:000-000 -Draelos ZD, Jacobson EL, Kim H, Kim M, Jacobson MK. A pilot study evaluating the efficacy of topically applied niacin

derivatives for treatment of female pattern alopecia. Journal of Cosmetic Dermatology. 2005; 4: 257-260.-Draelos, ZD. Welcome! To the Journal of Cosmetic Dermatology, Journal of Cosmetic Dermatology. 2005 January, 4(1), 1.-Draelos, ZD. Is cosmetic dermatology real medicine? Journal of Cosmetic Dermatology. 2005 June, 4(2), 53.-Draelos, ZD. The cosmeceutical conundrum. Journal of Cosmetic Dermatology. 2005 September 4(3), 149.-Draelos, ZD. The disease of cellulite. Journal of Cosmetic Dermatology. 2005 December, 4(4), 221.-Draelos, ZD. et al. A pilot study evaluating the efficacy of topically applied niacin derivatives for treatment of female pattern alopecia. Journal of Cosmetic Dermatology, 2005 December, 4(4), 258-261.-Draelos ZD. Sunscreens and hair photoprotection. Dermatol Clin. 2006 Jan;24(1): 81-4.-Draelos ZD. Compliance and Sunscreens. Dermatol. Clin. 2006 Jan; 24(1): 101-4. -Draelos ZD. The rationale for advancing the formulation of azelaic acid vehicles. Cutis. 2006 Feb; 77(2Suppl): 7-

11.Review. -Draelos ZD. The shrinking world: skin considerations in a global community. J Cosmet Dermatol. 2006 Mar; 5(1):1-2.-Draelos ZD, Green BA, Edison BL. An evaluation of a polyhydroxy acid skin care regimen in combination with azelaic acid

15% gel in rosacea patients. J Cosmet Dermatol. 2006 Mar;5(1): 23-9.-Draelos ZD, NiNardo JC. A re-evaluation of the comedogenicity concept. J Am Acad Dermatol. 2006 Mar; 54(3): 507-12.-Draelos ZD. Concepts on a multiprong approach to photoaging. Skin Therapy Lett. 2006 Apr 11(3):1-3. Review.-Draelos ZD. The effect of Cetaphil Gentle Cleanser on the skin barrier of patients with rosacea. Cutis. 2006 Apr;77(4

Suppl): 27-33.-Draelos ZD, Matzubara A, Smiles K. The effect of 2% niacinamide of facial sebum production. J Cosmet Laser Ther.

2006 Jun;8(2):96-101.-Draelos ZD. Is the paper journal obsolete? J Cosmet Dermatol. 2006 Jun; 5(2): 101-2.-Simion FA, Abrutyn ES, Draelos ZD. Ability of moisturizers to reduce dry skin and irritation and to prevent their return. Int

J Cosmet Sci. 2006 Jun; 28(3): 232.-Draelos ZD. The effect of a daily facial cleanser for normal to oily skin on the skin barrier of subjects with acne. Cutis.

2006 Jul;78(1 Suppl): 34-40.-Bikowski J, Callender VD, Del Rosso JQ, Draelos ZD, Tanghetti E. Combining clindamycin 1%-denzoyl peroxide 5% gel

with multiple therapeutic options. Cutis. 2006 Aug;78(2 Suppl 1):13-20.-Lowe N, Horwitz S, Tanghetti E, Draelos Z, Menter A. Tazarontene versus tazarontene plus hydroquinone in the treatment

of photodamaged facial skin: a multicenter, double-blind, randomized study. J Cosmet. Laser Ther. 2006 Sep; 8(3): 121-7.

-Draelos ZD. A Critical Evaluation of Procedural Cosmetic Dermatology. Journ Cosmet Sci. 2006 Sep/Oct: 57(5); 403-404.

-Draelos ZD. Anti-aging Photo-protection Developments. 2006 US Dermatology Review, Issue II, 41-42.-Draelos ZD. The facial rejuvenation algorithm. J Cosmet Dermatol. 2006 Sep;5(3):195.-Draelos ZD. The combination of 2% 4-hydroxyanisole (mequinol) and 0.01% tretinoin effectively improves the appearance

of solar lentigines in ethnic groups. J Cosmet Dermatol. 2006 Sep;5(3): 239-44.-Draelos ZD, Ertel KD, Berge CA. Facilitating facial retinization through barrier improvement. Cutis. 2006 Oct;78(4):275-

81.-Del Rosso JQ, Baum EW, Draelos ZDk Elewski BE, Fleischer AB Jr, Kakita LS, Thiboutot D. Azelaic acid gel 15%: clinical

versatility in the treatment of rosacea. Cutis. 2006 Nov;78(5 Suppl): 6-19.-Draelos ZD. Retaining the professionalism of cosmetic dermatology. J Cosmet Dermatol. 2006 Dec; 5(4):273.

-Olsen EA, Hordinsky M, Whiting D, Stough D, Hobbs S, Ellis ML, Wilson T, Rittmaster RS for the Dutasteride Alopecia Research Team which includes W Bergfeld, Z Draelos, FE Dunlap, T Funicella, S Kempers, AW Lucky, DJ Piacquadio, VPrice JL Roberts, RC Savin, JS Shavin, L Stein, D Thiboutot, E Tschen, GF Webster, and GD Weinstein. The



importance of dual 5 alph-reductase inhibition in the treatment of male pattern hair loss: Results of a randomized placebo-controlled study of dutasteride versus finasteride. J Am Ac Derm. 2006 Dec; 55(6); 1014-1023.

-Lim HW, Draelos ZD, Rigel DS, Ruenger TM. Shedding Light on Complete UV Protection. Cosmetic Dermatology. 2006 Dec: 19(12suppl); 3-8.

-Draelos ZD. From Proteins to Peptides—What They Mean to the Dermatologist. US Dermatology Review 2006. 92-95 -Bikowski J, Callender VD, Del Rosso JQ, Draelos ZD, Tanghetti E. Combining Clindamycin 1%--Benzoyl Peroxide 5% Gel

With Multiple Therapeutic Options. Cutis. 2006 Aug: 78(2S(i)); 13-20.-Draelos, ZD. The shrinking world: skin conditions in a global community. Journal of Cosmetic Dermatology, 2006 March,5(1), 1.-Draelos, ZD. et al. An evaluation of polyhydroxy acid skin care regimen in combination with azelaic acid 15% gel in rosacea patients. Journal of Cosmetic Dermatology, 2006 March, 5(1), 23-29.-Draelos, ZD. Is the paper journal obsolete? Journal of Cosmetic Dermatolgy, 2006 June, 5(2), 101-102.-Draelos, ZD. The facial rejuvenation algorithm. Journal of Cosmetic Dermatololgy, 2006 September, 5(3), 195.-Draelos, ZD. The combination of 2% 4-hydroxyanisole (mequinol) and 0.01% tretinoin effectively improves the appearance of solar lentigines in ethnic groups. Journal of Cosmetic Dermatololgy, 2006 September, 5(3), 239-244.-Draelos, ZD. Retaining the professionalism of cosmetic dermatology. Journal of Cosmetic Dermatology. December 2006, 5(4), 273.

-Draelos ZD. Dermatologic Considerations Regarding the Ideal Sunscreen. Cosmetic Medicine. 2007; 28(1): 8-13.-Badreshis-Bansal S, Draelos ZD. Insight into skin lightening cosmeceuticals for women of color. J Drugs Dermatol. 2007

Jan:6(1): 32-9.Review.-Del Rosso JQ, Draelos ZD, Jorizzo JL, Joseph WS, Ribotsky BM, Rich P. Modern methods to treat superficial fungal

disease. Cutis. 2007 Feb; 79(2 Suppl): 6-29.-Draelos ZD, Carter E, Maleoney JM, Elowski B, Poulin Y lyndo C, Garrett S: United States /Canada Dapsone Gel Study

Group. Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris. J Am Acad Dermatol. 2007 Mar; 56(3):439.ed-10. Epub 2007 Jan 17.

-Dinardo J, Draelos ZD. An animal model assessment of common dye-induced allergic contact dermatitis. J Cosmet Sci. 2007, May-Jun; 58(3): 209-14.

-Draelos ZD. How to Use Sun-Protective Cosmetics. The Skin Cancer Foundation Journal. 2007, vol XXV: 19-21.-Talbourdet S, Sadick NS, Lazou K, Bonnet-Duquennoy M, Kurfurst R, Neveu M, Heusele C, Andre P Schnebert S, Draelos

ZD, Perrier F. Modulation of gene expression as a new skin anti-aging strategy. J Drugs Dermatol. 2007 Jun; 6(6 Suppl): s25-33.

-Draelos ZD. What is anti-aging? J Cosmet Dermatol. 2007 Jun; 6(2): 73-4.-Draelos ZD. Perceptions of beauty. J Cosmet Dermatol. 2007 Sep; 6(3):143.-Draelos ZD. Skin lightening preparations and they hydroquinone controversy. Dermatol Ther. 2007 Sep-Oct; 20(5): 308-

13. -Draelos ZD, Flynn T, Narurkar V. What Role Can A Zinc Complex Have in Elastin Regeneration? Skin & Aging. 2007 Oct;

15(10): 53-58. -Lupo MP, Draelos ZD, Farris PK, Mandy SH, McDaniel DH, Taylor SC, Werschler WP. CoffeeBerry: A New, Natural

Antioxidant in Professional Antiaging Skin Care. Cosmetic Dermatology. 2007 Oct; 20(10, S4): 2-9. -Taylor SC, Draelos ZD. Issues and Innovations in Sun Protection. Skin & Aging. 2007 Nov: 58-61.

-Draelos ZD. The dermatology dispensing debate. Skin Therapy Lett. 2007 Nov; 12(9):1-3.-Draelos ZD. Defining safety tolerance limits. J Cosmet Dermatol. 2007 Dec; (4): 217.-Draelos, ZD. JCD indexing achieved! Journal of Cosmetic Dermatology. March 2007, 6(1), 1.-Draelos, ZD. What is anti-aging? Journal of Cosmetic Dermatology. June 2007, 6(2), 73-74.-Draelos, ZD. Perceptions of beauty. Journal of Cosmetic Dermatology. September 2007, 6(3), 143.-Draelos, ZD. Defining safety tolerance limits. Journal of Cosmetic Dermatology. December 2007, 6(4), 217.-Draelos, ZD. Introduction. Journal of Cosmetic Dermatology. December 2007(supplement), 6(supplement 1), 1.-Draelos, ZD. The latest cosmeceutical approaches for anti-aging. Journal of Cosmetic Dermatology. December 2007(supplement), 6(supplement 1), 2-6.

-Draelos ZD. Pigment sunscreens, photoprotection, and hair. Household and Personal Care Today. 2008 Jan.; 2-3. -Draelos ZD. Clinical Situations Conducive to Proactive Skin Health and Anti-aging Improvement. Journal of Investigative

Dermatology Symposium Proceedings (2008).-Draelos ZD. The effect of ceramide-containing skin skin care products on eczema resolution duration. Curtis. 2008 Jan;

81(1): 87-91.-Draelos ZD. Publishing the nuisance negative study. J Cosmet Dermatol. 2008 Mar; 7(1):1.



-Matheson R, Kempers S, Breneman D, Draelos Z, Johnson CE, Loss R, Hogan DJ, Schoenfeld R, Checketts S, Kircik L, Fivenson D, Hebert AA, Williams J, Hamlin R, Groisser D, Piacquadio D. Hydrocortisone Butyrate 0.1% Lotion in the Treatment of Atopic Dermatitis in Pediatric Subjects. Journal of Drugs in Dermatology. 2008 Mar; 7(3): 266-271.

-Verma SB, Draelos ZD. Cosmetic dermatology versus cosmetology: a misnomer in need of urgent correction. Indian J Dermatol Venereol Leprol. 2008 Mar-Apr; 74(2): 92-3.

-Kern D, Draelos ZD, Moore DM. Age-related NADH oxidase (ar NOX) activity of epidermal punch biopsies correlate with age and arNOX acativities of serum and saliva. Journ of Investigative Dermatology. 2008 Apr; 128(suppl 1): s57.

-Draelos ZD. Use of topical corticosteroids and topical calcineurin inhibitors for the treatment of atopic dermatitis in thin and sensitive skin areas. Curr Med Res Opin. 2008 Apr; 24(4): 985-94. Epub Feb 18. Review.

-Draelos ZD. Clinical situations conducive to proactive skin health and antiaging improvement. J Investig Dermatol Symp Proc. 2008 Apr;13(1): 25-7. Review.

-Carruthers JD, Glogau RG, Blitzer A; Facial Aesthetics Consensus Group Faculty. Advances in facial rejuvenation: botulinum toxin type a, hyaluronic acid dermal fillers, and combination therapies—consensus recommendations. Plast Reconstr Surg. 2008 May; 121(5 Suppl):5S-30S; quiz 31S-36S.

-Draelos ZD. New channels for old cosmeceuticals: aquaporin modulation. J Cosmet Dermatol. 2008 Jun; 7(2): 83 -Draelos ZD. Disclosure: A modest propsal. Clinics in Dermatology. 2009 July/Aug 24(4): 336-338.

-Draelos ZD. The ability of onion extract gel to improve the cosmetic appearance of postsurgical scars. J Cosmet Dermatol. 2008 Jun 7(2): 101-4.

-Kimball AB, Gold MH, Zib B, Davis MW, Clobetasol Propionate Emulsion Formulation Faom Phase III Clinical Study Group. Clobetasol propionate emulsion formulation foam 0.05%: review of phase II open-label and phase III randomizedcontrolled trial in steroid-responsive dermatoses in adults and adolescents. J Am Acad Dermatol. 2008 Sep; 59(3):448-54, 454.el. Epub 2008 Jun 9.

-Draelos ZD. The international cosmetic dermatologic community: trends and controversies. J Cosmet Dermatol. 2008 Sep: 7(3): 163.

-Draelos ZD, Klein G, Biancone G. A novel ultraviolet photography technique for assessing photodamage. J Cosmet Dermatol. 2008 Sep; 7(3):205-9.

-Draelos ZD. Understanding Male Skin Care Needs: The Challenge of an Evolving Market. Cosmetics and Toiletries. 2008 Sep; 123(9): 59-64.

-Draelos ZD. Moisturizing Cream Ameliorates Dryness and Desquamation in Participants Not Receiving Topical Psoriasis Treatment. Cutis. 2008 Sep; 82(3): 211-216.

-Draelos ZD. Skin-lightening challenges. Cosmetics & Toiletries. 2008 Oct; 123(10): 65-72. -Draelos ZD, Callender V, Young C, Dhawan SS. The Effect of Vehicle Formulation on Acne Medication Tolerability.

Cutis. 2008 Oct; 82(4): 281-284. -Slade HB, Fowler J, Draelos ZD, Reece BR, Cargill DI. Clinical Efficacy Evaluation of a Novel Barrier Protection Cream.

Cutis. 2008 Oct; 82(4S): 21-28. -Arbuckle R, Atkinson MJ, Clark M, Abetz L, Lohs J, Kuhagen I, Harness J, Draelos Z. Thiboutot D, Blume-Peytavi U, Copley-Merriman K. Patient experiences with oily skin: The qualitative development of content for two new patient

reported outcome questionnaires. Health and Quality of Life Outcomes. 2008; 6(80): 1-15. -Draelos, ZD. Improving Compliance in Acne Treatment: Benzoyl Peroxide Considerations. Cutis. 2008 Nov; 82(5S): 17-

20. -Draelos, ZD. The cosmeceutical realm. Clinics in Dermatology. 2008 Nov/Dec; 26(6): 627-632. -Draelos, ZD. Maintaining great hair for life. 2008 Nov/Dec; 18(6); 223. -Draelos ZD, Oresajo C, Yatskayer M, Galdi A, Hansenne I. New Technology Provides Cosmetically Elegant

Photoprotection. Cosmetic Dermatology. 2008; 21(1): 16-18. -Draelos ZD. The tolerability of Topical Tretinoin and Oral Minocycline Hydrochloride With and Without Anti-inflammatory

Skin Care Products. 2008 Cosmetic Dermatology. 2008; 21(3): 134-136. -Draelos ZD, Yarskayer M, Oresajo C, Fares H, Hansenne I. Efficacy of Ferulic Acid in Improving the Appearance of

Photoaged Skin. Cosmetic Dermatology. 2008; 21(4): 195-198. -Draelos ZD. Effects of Azelaic Acid 15% Gel on Skin Barrier in Rosacea. Cosmetic Dermatology. 2008; 21(5): 259-261. -Draelos ZD. Optimizing Redness Reduction, Part 1: Rosacea and Skin Care. Cosmetic Dermatology. 2008; 21(7): 383-

387. -Draelos ZD. Optimizing Redness Reduction, Part 2: Rosacea and Cosmeceuticals. Cosmetic Dermatology. 2008; 21(8):

433-436. -Draelos ZD. Treating Common Nail Problems with Ease. Cosmetic Dermatology. 2008; 21(9):487-488. -Draelos ZD. The Expanding Male Skin Care Market. Cosmetic Dermatology. 2008; 21(11): 588-590. -Draelos MM, Draelos ZD. Protective and Antimicrobial Peptides. Cosmetic Dermatology. 2008; 21(12): 636-637.



-Draelos, ZD. Understanding Male Skin Care Needs: The Challenge of an Evolving Market. Cosmetics and Toiletries. 2008Sept 123(9): 59-62.

-Draelos ZD. Skin-lightening Challenges. Cosmetics and Toiletries. 2008 Oct 123(10):65-72.-Draelos, ZD. Publishing the nuisance negative study. Journal of Cosmetic Dermatology. March 2008, 7(1), 1.-Draelos, ZD. New channels for old cosmeceuticals: aquaporin modulation. Journal of Cosmetic Dermatology. June 2008, 7(2), 83.-Draelos, ZD. The ability of onion extract gel to improve the cosmetic appearance of postsurgical scars. Journal of CosmeticDermatology. June 2008, 7(2), 101-104.-Draelos, ZD. The international cosmetic dermatologic community: treands and controversies. Journal of Cosmetic Dermatology. September 2008, 7(3), 163.-Draelos, ZD. Crendentialing cosmeceuticals. Journal of Cosmetic Dermatology. December 2008, 7(4), 245. -Draelos ZD. Skin Lightening Challenges. GCI. 2009 Feb; 177(2): 40-44. -Draelos ZD. 2009 March. Article published in the supplement Men’s care to March issue of Household and Personal Care

Journal. -Arbuckle R, Draelos, ZD, et al: Patient experiences with oily skin: The qualitative development of content for two new

patient reported outcome questionnaires. Pub: Oct 16, 2008. An open access article distributed under the terms of the Creative Commons Attribution License.

-Odom R, Draelos ZD, et al: Standard Management Options for Rosacea, Part 1: Overview and Broad Spectrum of Care. Cutis. 2009 July; vol 84: 43-47.

-Draelos ZD. Disclosure: a modest proposal. Clinics in Dermatology. 2009 July/August; 27(4): 336-337. -Odom R, Draelos ZD, et al: Standard Management Options for Rosacea, Part 2: Options According to Subtype. Cutis.

2009 Aug; vol 84: 97-103.-Draelos, ZD. Use of topical corticosteroids and topical calcineurin inhibitors for the treatment of atopic dermatitis in thin and

sensitive skin areas. Current Medical Research and Opinion. 2009 Aug; 24(4): 985-994.-Morre, DM, Meadows C, Hostetler B,Weston N, Kern D,Draelos, Z, Morre DJ. Age-related ENOX protein (arNox) activity

correlated with oxidative skin damage in the elderly. BioFactors. 34 (2009) 237-244.-Draelos ZD. Carotenoids: Red, Orange, and Yellow Wonders (Cosmetic Consultation). Cosmetic Dermatology. 2009 Dec

22(1):12-14.-Draelos ZD. Diverse Skin Needs and the Tolerability of Azelaic Acid 15% Gel in Rosacea (Cosmetic Consultation). Cosmetic

Dermatology. 2009 Dec 22(9):450-454.-Draelos ZD. The Efficacy of Tretinoin 0.025% Cream, Oral Minoccline, and a Skin Care Regimen in the Treatment of Acne

(Cosmetic Consultation). Cosmetic Dermatology. 2009 Dec 22(4: 175-177.-Draelos ZD. Examining Over-the-Counter Acne Treatment (Cosmetic Consultation). Cosmetic Dermatology. 2009 Dec

22(7):344-348.-Draelos ZD. Investigating Cosmeceutical Efficacy:Flavonoids (Cosmetic Cosultation). Cosmetic Dermatology. 2009 Dec 22

(3):121-123.-Draelos ZD. Mechanisms of Action of Azelaic Acid 15% Gel: Assessing Its Broad Antioxidant and Comedolytic Effects

(Cosmetic Consulation) Cosmetic Dermatology. 2009 Dec 22(6): 285-288.-Draelos ZD. Shaving for Success (Cosmetic Consultation) Cosmetic Dermatology. 2009 Dec 22(11): 554-556.-Draelos ZD. Understanding and Treating Brittle Nails (Cosmetic Consultation) Cosmetic Dermatology. 2009 Dec

22(12):598-599.-Draelos ZD. Vitamins and Healthy Skin (Cosmetic Consultation) Cosmetic Dermatology. 2009 Dec 22(8): 400-403.-Gollnick HPM, Draelos Z, Glenn MJ, Rosoph LA, Kaszuba A, Cornelison R, Gore B, Liu Y, Graber M. Adapalene-benzoyl

peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double –blind, controlled study in 1670 patients. British Journal of Dermatology. 2009: 161; 1180-1189.

-Draelos, ZD. Cosmeceutical sustainability: reaping rewards from the environment. Journal of Cosmetic Dermatology. September 2009, 8(3), 159.-Draelos, ZD. What Defines Aging? Journal of Cosmetic Dermatology. December 2009, 8(4), 237-238.-Draelos, ZD. The allure of tanned skin. Journal of Cosmetic Dermatology. March 2009, 8(1), 1-2.-Draelos, ZD. Evaluating Consumer Dermatologic Devices. Journal of Cosmetic Dermatology. June 2009, 8(2), 75-76.-Draelos, ZD. et al. An evaluation of the effect of a topical product containing C-xyloside and blueberry extract on the appearance of type II diabetic skin. Journal of Cosmetic Dermatology. June 2009, 8(2), 147-151.-Draelos ZD. Skin sanitizers-Do popular products promote or impede overall skin health? 2010 Feb 31(2):4-10.-Draelos ZD. Commentary: Healthy hair and protein loss. Journal of the American Academy of Dermatology. 2010 Mar

62(3): 409-410.



-Kircik LH, Bikowski JB, Cohen DE, Draelos ZD, Hebert A. Vehicles Matter.Formulation Development, Testing, and Approval. Supplement to Practical Dermatology. 2010 March.

-Draelos ZD. Commentary: Healthy hair and protein loss. Journal of the Amerian Academy of Dermatology. 2010 Mar 62(3): 409-410.

-Draelos ZD. The multifunctionality of 10% Sodium Sulfacetamide, 5% Sulfur Emollient Foam in the Treatment of Inflammatory Facial Dermatoses. Journal of Drugs in Dermatology. 2010 Mar 9(3): 234-236.

-Draelos ZD. Optimizing Redness Reduction. Part I: Rosacea and Skin Care. Journal of the Rosacea Research and Development Institute. 2010: vol 1(1); 7-12.

-Draelos ZD, Gold MH, Kaur M, Olayinka B, Grundy SL, Papert EJ, Hardas B. Evaluation of an Onion Extract, Centella Asiatica, and Hyaluronic Acid Cream in the Appearance of Striae Rubra. Skin Med-Dermatology for the Clinician. 2010 Mar/Apr 8(2): 80-86.

-Tanghetti E, Dhawan S,Green L, Del Rosso J, Draelos ZD, Leyden J, Shalita A, Glaser DA, Grimes P, Webster G, Barnett P, Le Gall N. Randomized Comparison of the Safety and Efficacy of Tazarotene 0.1% Cream and Adapalene 0.3% Gel in the Treatment of Patients With at Least Moderate Facial Acne Vulgaris. Journal of Drugs in Dermatology. 2010 May 9(5): 549-558.

-Draelos ZD. Case Study of Dermicol-P35 Used in Patient with past Hypersensitivity to Crosslinked Bovine Collagen DermalFiller. Dermatologic Surgery. 2010 May 36(1): 825-827.

-Draelos ZD. The Multifunctionality of 10% Sodium Sulfaacetamide, 5% Sulfur Emollient Foam in the Treatment of Inflammatory Facial Dermatoses. 2010 Mar 9(3): 234-236.

-Kircik LH, Bikowski JB, Cohen DE, Draelos ZD, Hebert A. Clinical Implications of Delivery and Application Systems. Supplement to Practical Dermatology-Vehicles Matter. 2010 June: 3-14.

- Draelos Z. Genes, jokes and dermatology. Dermatology Times. 2010 June 31(6): 3-4.- Draelos Z. Nutrition and enhancing youth-ful appearing skin. Clinics in Dermatology. Nutrition and the skin. 2010

Jul/Aug: 28(4), 400-408.- Draelos Z. Cutting down risk. Prevent spread of MRSA when shaving by eradication infections source. Dermatololgy

Times. 2010 Jul: 31(7): 48.- Gollnick HPM, Draelos Z, Glenn MJ, Rosoph LA, Kaszuba A, Cornelison R, Gore B, Liu R, and Graeber M. Adapalene-

benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: A transatlantic, randomized, double-blind, controlled study in 1670 patients. BJD. 2009, 161: 1180-1189.

- Elewski BE, Draelos Z, Dreno B, Jansen T, Layton A, Picardo M. Rosacea-Global diversity and optimized outcome: Proposed international consensus from the Rosacea International Expert Group. Journal of the European Academy of Dermatology and Venereology. 2010.

- Draelos ZD, Yatskayer M, Bhushan P, Pillai S, Oresajo C. Evaluation of a Kojic Acid, Emblica Extract, and Glycolic Acid Formulation Compared With Hydroquinone 4% for Skin Lightening. Cutis. 2010 Sept 86: 153-158.

- Draelos ZD. Healthy Aging. The Power of Antioxidants. 2010 Sept/Oct: 19-22. -Draelos, ZD, Potts A, Saenz ABA. Randomized Tolerability Analysis of Clindamycin Phosphate 1.2%-Tretinoin 0.025% Gel

Used with Benzoyl Peroxide Wash 4% for Acne Vulgaris. 2010 Dec 86(6): 310-318.-Draelos, ZD. Are sunscreens safe? Journal of Cosmetic Dermatology. March 2010, 9(1), 1-2.-Draelos, ZD. Living longer, looking lovely. Journal of Cosmetic Dermatology. June 2010, 9(2), 77-78.-Draelos, ZD. The biofilm: skin health and beauty in a contaminated world. Journal of Cosmetic Dermatology. September 2010, 9(3), 167-168.-Draelos, ZD. Genomics: the future of cosmetic dermatology. Journal of Cosmetic Dermatology. December 2010, 9(4), 265-266.-Draelos Z, Pugliese PT. Chemodenervation-from Physiology of the Skin, Third Edition. 2011 Jan: 52-59.-Draelos ZD. Hope in a bottle? Dermatology Times. 2011 Feb 32(2): 6.-Draelos Z. Wound care in 2011: Rethinking the treatment of minor wounds for standard dermatologic produres. A

supplement from the Journal of the American Academy of Dermatology, published March 2011.-Draelos, ZD. Clinical evaluation of patients with hair loss. The Chronicle of Skin and Allergy. 2011 April/May: 16.

-Draelos ZD. Camouflage technique for alopecia areata: What is a patient to do? Dermatolgic Therapy. 2011 May/June 24(3): 305-310.

-Draelos, ZD. Sunscreens: New Ways to Hide From the Sun. Euro Cosmetics. 2011 May, vol 19.-Draelos, ZD. Camouflage technique for alopecia areata: What is a patient to do? Dermatolgic Therapy. 2011 May/June

24(3): 305-310.-Draelos, ZD. The Appearance of Facial Foundation Cosmetics Applied After Metronidazole Gel 1%. Cutis. 2011 May

87(5): 251-259.



-Draelos, ZD. Myth busters-Examining the real relationship between sunscreens, aging and skin cancer. Dermatology Times. 2011 June 32(6):4-5.

-Draelos, ZD and Pugliese, PT. Microdermabrasion and Dermabrasion. Skin Inc. 2011 June: 56-61.-Draelos, ZD. Camouflage technique for alopecia areata: what is a patient to do? Dermatologic Therapy. 2011, vol 24, 305-310.-Tanghetti E, Dhawan S, Green L, Ling M, Downie J, Germain M, Kasteler JS, Kircik L, Oefelein MG, Draelos Z. Clinical

Evidence for the Role of a Topical Anti-Inflammatory Agent in Comedonal Acne: Findings From a Randomized Study of Dapsone Gel 5% in Combination With Tazarotene Cream 0.1% in Patients with Acne Vulgaris. Journal of Drugs in Dermatology. 2011 June 10(7): 783-791.

-Draelos, ZD. The Multifunctional Value of Sunscreen-containing Cosmetics. Skin Therapy Letter. 2011 July/August 16(7):1-3.

-Draelos, MT, Draelos ZD. Robotic cosmetic dermatology. Journal of Cosmetic Dermatology. 2011 June, 10(2), 87-88.-Draelos, ZD. Genetic mosaicism and Fitzpatrick skin type. Journal of Cosmetic Dermatology. 2011 September, 10(3), 169-170.-Draelos, ZD. A clinical evaluation of the comparable efficacy of hyaluronic acid-based foam and ceramide-containing emulsion cream in the treatment of mild-to-moderate atopic dermatitis. Journal of Cosmetic Dermatology. 2011 September, 10(3), 185-188.-Draelos, ZD. Eating for a lifetime of healthy skin. Journal of Cosmetic Dermatology. 2011 March, 10(1), 1-2.-Draelos, ZD. Effectiveness of Antiaging Products Lacks Evidence. Skin & Allergy News. 2012 Feb. 43(2): 1,6.-Draelos, ZD. Skin care still starts with cosmeceuticals. Currents. 2012 Jan/Feb 6-8.-Draelos, ZD. Moisturizer Selection for Dry Winter Skin. JDPA. 2012 winter 6(1):36-37.-Draelos, ZD. Drug debates. Dermatology Times. 2012 Feb 33(2): 4.-Draelos, ZD. Antipruritic Hydrogel for the treatment of Atopic Dermatitis: An open-label pilot study. Cutis. 2012 Aug, 90(2),

97-102.-Draelos, ZD. Cosmetics, diet, and the future. Dermatologic Therapy. 2012, vol 25, 267-272.-Draelos, ZD. Introduction: cosmetics, categories, and the future. Dermatologic Therapy, 2012, vol 25, 223-228.-Draelos, ZD. The rise of cosmetic dermatology in the new medical model. Journal of Cosmetic Dermatology. 2012 March, 11(1), 1-2.-Draelos, ZD. Examining the science of aging. Journal of Cosmetic Dermatology. 2012 June, 11(2), 85-86.-Draelos, ZD. Creating an attractive aging face. Journal of Cosmetic Dermatology. 2012 September, 11(3), 167-168.-Draelos, ZD. Are cosmetics safe? Journal of Cosmetic Dermatology. 2012 December, 11(4), 249-250.-Draelos, ZD. Sunless Tanning: An Alternative to Sun Exposure. Best Practices in Dermatology-supplement to Cutis. 2013

May, 10-11.-Draelos, ZD. Modern Moisturizer Myths, Misconceptions, and Truths. Cutis. 2013 June 91, 308-314.-Eichenfield, Lawrence F, Draelos, Zoe, Lucky, Anne W, Hebert, Adelaide A, Sugarman Jeffrey, Gold, Linda Stein, Rudisill,

Diane, Liu, Hong, and Manna. Preadolescent Moderate Acne Vulgaris: A Randomized Trial of the Efficacy and Safety ofTopical Adapalene-Benzoyl Peroxides. Journal of Drugs in Dermatology. 2013 June, 12(6), 611-618.

-Zaenglein, Andrea L, Shamban, Ava, Webster, Guy, Del Rosso, James, Dover, Jeffrey, Swinyer, Leonard, Stein, Linda, Lin, Xiaoming, Draelos, Zoe, Gold, Michael, and Thiboutot, Diane. A Phase IV, Open-label Study Evaluating the Use of Triple-Combination Therapy With Minocycline HCl Extended-Release Tablets, a Topical Antibiotic/Retinoid Preparation and Benzoyl Peroxide in Patients With Moderate to Severe Acne Vulgaris. Journal of Drugs in Dermatology. 2013 June,12(6), 619-625.

-Draelos, ZD, et al., Dyspigmentation, skin physiology, and a novel approach to skin lightening. 2013 Journal of Cosmetic Dermatology, vol. 12, 247-253.

-Alam, M et al(Draelos, ZD). American Society for Dermatologic Surgery Dermatologic Surgery Drug and Device Nomenclature Recommendations. Dermatologic Surgery. 2013 August, 39(8), 1158-1166.

-Eichenfield LF, Draelos, Z, Lucky AW, et al. A quick look at the noteworthy articles in dermatology research. The Journal of Clinical and Aesthetic Dermatology. 2013 August, 6(81), 611-618.

-Draelos, ZD. Cosmetic treatment of nails. Clinics in Dermatology. 2013 September/October, 31(5), 573-577.-Draelos, ZD. Aging skin: The role of diet: Facts and controversies. 2013 November/December, 31(6), 701-706.-Draelos, ZD. Dialogues in Dermatolgy interview on Aspects in Beauty. American Academy of Dermatology, 2013 November.-Draelos, ZD. To Smell or Not to Smell? That is the Question! Journal of Cosmetic Dermatology. 2013 March, 12(1), 1-2.-Draelos, ZD. The mark of a generation: understanding how cosmetic practices shape the world. Journal of Cosmetic Dermatology. 2013 June, 12(2), 85.-Draelos, ZD. The cosmetic dose: how much are you getting? Journal of Cosmetic Dermatology. 2013 September, 12(3), 189.



-Draelos, MM, Draelos, ZD. The biofilm, injectable, and cosmetic dermatology. Journal of Cosmetic Dermatology. 2013 December, 12(4), 245-246.-Draelos, ZD et al. Hydrophobically modified polymers can minimize skin irritation potential caused by surfactant-based cleansers. Journal of Cosmetic Dermatology. 2013 December, 12(4), 314-321.-Agbai, Oma , et al(Draelos, ZD). Skin cancer and photoprotection in people of color: A review and recommendations for

physicians and the public. Proof for the Journal of the America Academy of Dermatology. 2014 January.-Gold, L, et al(Draelos, ZD). Efficacy and Safety of Ivermectin 1% Cream in Treatment of Papulopustular Rosacea: Results

of Two Randomized, Double-Blind, Vehicle-Controlled Pivotal Studies. Journal of Drugs in Dermatology. 2014 March, 13(3), 316-323.

-Draelos, ZD. Truth in advertising could facilitate realistic patient expectations. Dermatology Times. 2014 June, 35(6), 6.-Draelos, ZD. The Joy of Wearing Sunscreen. The Skin Cancer Foundation Journal. 2014, vol 22, 23.-Draelos, ZD et al. A Randomized , Double-blind, Vehicle-Controlled Trial of Luliconazole Cream 1% in the Treatment of

Interdigital Tinea Pedis. The Journal of Clinical and Aesthetic Dermatology. 2014 October, 7(10). 45-52.-Draelos, ZD. Solving the case of the unfilled prescription. Dermatology Times. 2014 November, 35(11), 13.-Gold. L, Draelos, ZD. Long-Term Safety of Ivermectin 1% Cream vs Azelaic Acid 15% Gel in Treating Inflammatory

Lesions of Rosacea: Results of Two 40-Week Controlled, Investigator-Blinded Trials. Journal of Drugs in Dermatology. 2014 November, 13(11), 1380-1386.

-Draelos, ZD. Facial skin care products and cosmetics. Clinics in Dermatology. 2014 November/December, 32(6), 809-812.-Draelos, ZD. Hair, sun, regulation, and beauty. Journal of Cosmetic Dermatology. 2014 March, 13(1), 1-2.-Draelos, ZD. Aging in a polluted world. Journal of Cosmetic Dermatology. 2014 June, 13(2), 85.-Draelos, ZD. Science and the Validation of Cosmeceutical Formulations. Journal of Cosmetic Dermatology. 2014 September, 13(3), 167-168.-Draelos, ZD. Defining cosmetic issues in a world of medical necessity. Journal of Cosmetic Dermatology. 2014 December,13(4), 243-244.-Draelos, ZD. A split-face evaluation of a novel pigment-lightening agent compared with no treatment and hydroquinone. Journal of the American Academy of Dermatology. 2015 January, 72(1), 105-107.-Draelos, ZD. Demonstration of the Biphasic Release of 0.1% Halcinide Cream. Journal of Drugs in Dermatology. 2015 January, 14(1), 89-90.-Draelos, ZD. A new product category, pharmacoids. Dermatology Times, 2015 February, 36(2), 8.-Draelos, ZD. et al. A Method for Maintaining the Clinical Results of 4% Hydroquinone and 0.025% Tretinoin With a Cosmeceutical Formulation. Journal of Drugs in Dermatology. 2015 April, 14(4), 386-390.-Draelos, ZD. Cosmetic dermatology and the ‘none’ or ‘almost none’ phenomenon. Dermatology Times. 2015 June, 36(6), 3.-Draelos, ZD. Cosmetic Procedures and the distortion of beauty. Journal of Cosmetic Dermatology. 2015 March, 14(1), 1.-Draelos, ZD. Cosmetics: The Medicine of Beauty. Journal of Cosmetic Dermatology. 2015 June, 14(2), 91.-Draelos, ZD. Cosmetic Dermatology and the Distortion of Beauty. Journal of Cosmetic Dermatology. 2015 September, 14(3), 173.-Draelos, ZD. et al. A Phase 3 Randomized, Double-blind, Vehicle-Controlled Trial of Azelaic Acid Foam 15% in the Treatment of Papulopustular Rosacea. Cutis. 2015 July, 96(1), 54-61.-Draelos, ZD. Stratum Corneum Absorption Kinetics of 2 Potent Topical Corticosteroid Formulations: A Pilot Study. Cutis. 2015 August, 96(2), 135-141.-Draelos, ZD. et al. Tolerance of Fragranced and Fragrance-Free Facial Cleansers in Adults With Clinically Sensitive Skin. Cutis. 2015 October, 96(4), 269-274.-Draelos, ZD. Insurance formularies, LOL. 2015 October, 36(10), 3.-Draelos, ZD. A Split Face Evaluation of a Novel Pigment Lightening Agent Compared to No Treatment and Hydroquinone. Journal of the American Academy of Dermatology 72 (2015), pp. 105-107.-Papp KA, Bissonnette R, Gooderham M, Feldman SR, Iversen L, Soung J, Draelos Z, et al. Treatment of Plaque Psoriasis

with an Ointment Formulation of Janus Kinase Inhibitor, Tofacitinib: A Phase 2b Randomized Clinical Trial. BMC Dermatology 2016 16:15, DOI 10.1186/s12895-016-0015-4

-Draelos ZD, Kononov T, Fox T. An Open Label Clinical Trial of a Peptide Treatment Serum and Supporting Regimen Designed to Improve the Appearance of Aging Facial Skin. Journal of Drugs in Dermatology 2016 15(9):1100-1106

-Draelos ZD. The Future of Corporatized Medicine. Dermatology Times October 2016-Draelos ZD. Differences in Cutaneous Irritation of Five Commonly Used Topical Products. 2016 15(7), 870-873-Draelos ZD. A Pilot Study Investigating the Efficacy of Botanical Anti-Inflammatory Agents in an OTC Eczema Therapy.

Journal of Cosmetic Dermatology 2016 15(2):117-119



-Kligman DE, Draelos ZD. Combination Superficial Peels with Salicylic Acid and Post-Peel Retinoids. Journal of Drugs in Dermatology 2016 15(4):442-450

-Draelos ZD. The Effect of a Combination of Recombinant EGF Cosmetic Serum and a Crosslinked Hyaluronic Acid Serum as Compared to a Fibroblast-Conditioned Media Serum on the Appearance of Aging Skin. Journal of Drugs in Dermatology 2016 15(6):738-741

-Draelos ZD. Superior Pay for Non-Performance. Dermatology Times, June 2016.-Draelos, ZD, Lewis J, McHugh L, Pellegrino A, Popescu L. Journal of Cosmetic Dermatology 2016 15(1):36-42-Draelos ZDD, Stein Gold LE, Murrell DF, Hughes MH, Zane LT. Post Hoc Anayses of the Effect of Crisaborole Topical

Ointment, 2% on Atopic Dermatitis: Associated Pruritus from Phase I and 2 Clinical Studies. Journal of Drugs in Dermatology 2016 15(2):172-176

-Draelos ZD. The Well Trained Bad Dermatologist. Dermatology Times, February 2016-Nistor G, Poole AJ, Draelos Z, Lupo M, Tzikas T, Liu JH, Keristead HS. Human Stem Cell-Derived Skin Progenitors Produce

Alpha 2-HS Glycoprotein (Fetuin): A Revolutionary Cosmetic Ingredient. Journal of Drugs in Dermatology 2016 15(5):583-598

-Wood SM, Mastaloudis A, Hester SN, Gray R, Kern D, Namboong J, Draelos ZD. Protective Effects of a Novel Nutritional and Phytonutrient Blend on Ultravate Radiation-Induced Skin Damage and Inflammatory Respone Through Aging Defense Mechanisms. Journal of Cosmetic Dermatology 2016

-Draelos ZD. The Role of a Natural Mollusk Egg Derived Ingredient in Facial Appearance. J Drugs Dermatol 2017;16(7):611-616

-Barak-Shinar D, Draelos ZD. A Randomized Controlled Study of a Novel Botanical Acne Spot Treatment. J Drugs Dermatol2017;16(6):611-615

-Draelos ZD, Ertel K, Rom Dror. Five Day Study to Judge the Short Term Effect of a Benzoyl Peroxide 3% Gel on Acne Lesions. J Cosmet Dermatol 2016;15:350-357

-Draelos ZD, Karnik J, Naughton G. The Anti-Aging Effects of Low Oxygen Tension Generated Multipotent Growth Factor Containing Serum. J Drugs Dermatol 2017;16(1):30-34

-Arbuckle R, Atkinson MJ, Clark M, Abetz L, Lohs J, Kuhagen I, Harness J, Draelos Z, Thiboutot D, Blume-Peytavi U, Copley-Merriman K. Patient experiences with oily skin: The Qualitative Development of Content for Two New Patient Reported Outcome Questionniaires. Health and Quality of Life Outcomes 2008;6:80

-Draelos ZD, Cosmeceuticals for Rosacea. Clinics Dermatol 2017;35:213-217-Draelos ZD, Rodriguez DA. Kempers SE, Bruce S, Peredo M, Downie J. Chang-Lin JE, Berk DR, Ruan S, Kaoukhov A:

Treatment Response With Once-Daily Topical Dapsone Gel, 7.5% for Acne Vulgaris: Subgroup Analysis of Pooled Data from Two Randomized, Double-blind Studies. J Drugs Dermatol. 2017;16(5):611-618

-Schmieder GJ, Draelos ZD, Pariser DM, et al. Effiacacy and Safety of teh Janus Kinase 1 Inhibitor PF-04965842 in Patientswith Moderate to Severe Psoriasis: Phase 2, Randomized, Double-Blind, Placebo-Controlled Study. Br J Dermatol 2017 Sep 26. doi:10.1111/bjd.16004

-Kircik LH, Dubois J, Draelos ZD, et al. Rivotal of the Efficacy and Safety of Oxymetazoline Crem 1.0% for the Treatment of Persistant Facial Erythema Associated with Rosacea. J Drugs Dermatol 2018:17(1):97-105

-Draelos ZD, A Double-Blind Randomized Pilot Study Evauating the Safety and Efficacy of Topical MEP in the Facial Appearance Improvement of Estrogen Deficient Females. J Drugs Dermatol. 2018;17(11):1186-1189

-Draelos ZD, Donald A. The Effect of an Anti-Inflammatory Botanical Cleanser/Night Mask Combination on Facial Redness Reduction. J Drugs Dermatol 2018;17(6):671-676

-Draelos ZD, Gold MH, Weiss RA, et al. Efficacy and Safety of Oxymetazoline Cream 0.1% for Treatment of Persistaent Facial Erythema Associated with Rosacea: Findings from the 52-week Open Label REVEAL Trial. J Am Acad Dermatol 2018;78:1156-1163

-Draelos ZD, Levy SB, Lutrario C, Gunt H. Evaluation of the Performance of a Ntuer-Based Sensitive Skin Regimen in Subjects with Clinically Diagnosed Sensitive Skin. J Drugs Dermatol 2018;17(8):908-913

-Baumann LS, Blauvelt , Draelos ZD, et al. Safety and Efficacy of Hydrogen Peroxide Topical Solution, 40% (w/w), in Patients with Seborrheic Keratoses. J Am Acad Dermatol 2018;79:869-877

-Kerdel FA, Draelos, ZD, Tyring S, et al. A Phase 2 Multicenter, Double-Blind, Randomized, Vehicle-Controlled Clinical Studyto Compare the Safety and Efficacy of a Halobetasol Propionate 0.01) Lotion and Halobetasol Propoionate 0.05% Cream in the Treatment of Plaque Psoriasis. J Dermatol TReat https://doi.org/10.1080/09546634.2018.1523362

-Draelos ZD, Raymond I. The efficacy of a Ceramide-based Cream in Mild-to-Moderate Atopic Dermatitis. J Clin Aesthet Dermatol 2018;11(5):30-32

-Draelos ZD. The Science Behind Skin Care: Cleansers. J Cosmet Dermatol 2018;17(1):8-14-Draelos ZD. The Science Behind Skin Care: Moisturizers. J Cosmet Dermatol 2018:17(2):138-144


dermatology consulting services, pllcdermatology consulting services, pllc-editorial board, aging...

Documents